<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>800</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="800"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=800&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=700&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929170284"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929170284?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929170284&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929170284&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001197"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929170284</prism:url><dc:identifier>SCOPUS_ID:84929170284</dc:identifier><eid>2-s2.0-84929170284</eid><dc:title>Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1</dc:title><dc:creator>Li H.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>311-321</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.03.007</prism:doi><pii>S0891584915001197</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Hyperglycemia-induced oxidative stress is implicated in the development of cardiomyopathy in diabetes that is associated with reduced adiponectin (APN) and heme oxygenase-1 (HO-1). Brahma-related gene 1 (Brg1) assists nuclear factor-erythroid-2-related factor-2 (Nrf2) to activate HO-1 to increase myocardial antioxidant capacity in response to oxidative stress. We hypothesized that reduced adiponectin (APN) impairs HO-1 induction which contributes to the development of diabetic cardiomyopathy, and that supplementation of APN may ameliorate diabetic cardiomyopathy by activating HO-1 through Nrf2 and Brg1 in diabetes. Control (C) and streptozotocin-induced diabetic (D) rats were untreated or treated with APN adenovirus (1×10&lt;sup&gt;9&lt;/sup&gt; pfu) 3 weeks after diabetes induction and examined and terminated 1 week afterward. Rat left ventricular functions were assessed by a pressure-volume conductance system, before the rat hearts were removed to perform histological and biochemical assays. Four weeks after diabetes induction, D rats developed cardiac hypertrophy evidenced as increased ratio of heart weight to body weight, elevated myocardial collagen I content, and larger cardiomyocyte cross-sectional area (all P&lt;0.05 vs C). Diabetes elevated cardiac oxidative stress (increased 15-F&lt;inf&gt;2t&lt;/inf&gt;-isoprostane, 4-hydroxynonenal generation, 8-hydroxy-2′-deoxyguanosine, and superoxide anion generation), increased myocardial apoptosis, and impaired cardiac function (all P&lt;0.05 vs C). In D rats, myocardial HO-1 mRNA and protein expression were reduced which was associated with reduced Brg1 and nuclear Nrf2 protein expression. All these changes were either attenuated or prevented by APN. In primarily cultured cardiomyocytes (CMs) isolated from D rats or in the embryonic rat cardiomyocytes cell line H9C2 cells incubated with high glucose (HG, 25 mM), supplementation of recombined globular APN (gAd, 2 μg/mL) reversed HG-induced reductions of HO-1, Brg1, and nuclear Nrf2 protein expression and attenuated cellular oxidative stress, myocyte size, and apoptotic cells. Inhibition of HO-1 by ZnPP (10 μM) or small interfering RNA (siRNA) canceled all the above gAd beneficial effects. Moreover, inhibition of Nrf2 (either by the Nrf2 inhibitor luteolin or siRNA) or Brg1 (by siRNA) canceled gAd-induced HO-1 induction and cellular protection in CMs and in H9C2 cells incubated with HG. In summary, our present study demonstrated that APN reduced cardiac oxidative stress, ameliorated cardiomyocyte hypertrophy, and prevented left ventricular dysfunction in diabetes by concomitantly activating Nrf2 and Brg1 to facilitate HO-1 induction.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006541</affiliation-url><afid>60006541</afid><affilname>The University of Hong Kong</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Pokfulam</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112935162</affiliation-url><afid>112935162</afid><affilname>Affiliated Hospital of Guangdong Medical College</affilname><name-variant>Affiliated Hospital of Guangdong Medical College</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006541</affiliation-url><afid>60006541</afid><affilname>The University of Hong Kong</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Pokfulam</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021182</affiliation-url><afid>60021182</afid><affilname>Sun Yat-Sen University</affilname><name-variant>Sun Yat-Sen University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55776887600</author-url><authid>55776887600</authid><authname>Li H.</authname><surname>Li</surname><given-name>Haobo</given-name><initials>H.</initials><afid>60006541</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56068205300</author-url><authid>56068205300</authid><authname>Yao W.</authname><surname>Yao</surname><given-name>Weifeng</given-name><initials>W.</initials><afid>60006541</afid><afid>60021182</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56068205300</author-url><authid>56068205300</authid><authname>Yao W.</authname><surname>Yao</surname><given-name>Weifeng</given-name><initials>W.</initials><afid>60006541</afid><afid>60021182</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202411076</author-url><authid>7202411076</authid><authname>Irwin M.</authname><surname>Irwin</surname><given-name>Michael G.</given-name><initials>M.G.</initials><afid>60006541</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640007000</author-url><authid>56640007000</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tingting</given-name><initials>T.</initials><afid>60006541</afid><afid>60025761</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640007000</author-url><authid>56640007000</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tingting</given-name><initials>T.</initials><afid>60006541</afid><afid>60025761</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640313700</author-url><authid>56640313700</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Shuang</given-name><initials>S.</initials><afid>112935162</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55854375100</author-url><authid>55854375100</authid><authname>Zhang L.</authname><surname>Zhang</surname><given-name>Liangqing</given-name><initials>L.</initials><afid>112935162</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402151748</author-url><authid>7402151748</authid><authname>Xia Z.</authname><surname>Xia</surname><given-name>Zhengyuan</given-name><initials>Z.</initials><afid>60006541</afid><afid>112935162</afid><afid>60006541</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402151748</author-url><authid>7402151748</authid><authname>Xia Z.</authname><surname>Xia</surname><given-name>Zhengyuan</given-name><initials>Z.</initials><afid>60006541</afid><afid>112935162</afid><afid>60006541</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402151748</author-url><authid>7402151748</authid><authname>Xia Z.</authname><surname>Xia</surname><given-name>Zhengyuan</given-name><initials>Z.</initials><afid>60006541</afid><afid>112935162</afid><afid>60006541</afid></author><authkeywords>Adiponectin | Brahma-related gene 1 | Cardiac hypertrophy | Diabetes | Nuclear factor-erythroid-2-related factor-2</authkeywords><intid>2035911816</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929167179"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929167179?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929167179&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929167179&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500875X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929167179</prism:url><dc:identifier>SCOPUS_ID:84929167179</dc:identifier><eid>2-s2.0-84929167179</eid><dc:title>Advantageous effect of biventricular pacing on cardiac function and coronary flow: A case report</dc:title><dc:creator>Luo X.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>236-238</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.151</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002798</affiliation-url><afid>60002798</afid><affilname>Chinese University of Hong Kong</affilname><name-variant>The Chinese University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:49861690700</author-url><authid>49861690700</authid><authname>Luo X.</authname><surname>Luo</surname><given-name>Xiu Xia</given-name><initials>X.X.</initials><afid>60002798</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55624485197</author-url><authid>55624485197</authid><authname>Fang F.</authname><surname>Fang</surname><given-name>Fang</given-name><initials>F.</initials><afid>60002798</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7404976646</author-url><authid>7404976646</authid><authname>Yu C.</authname><surname>Yu</surname><given-name>Cheuk Man</given-name><initials>C.M.</initials><afid>60002798</afid></author><authkeywords>Apical wall motion | Biventricular pacing | Coronary blood flow | Right ventricular apical pacing</authkeywords><intid>535918282</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927511772"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927511772?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927511772&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927511772&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001030"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927511772</prism:url><dc:identifier>SCOPUS_ID:84927511772</dc:identifier><eid>2-s2.0-84927511772</eid><dc:title>Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase</dc:title><dc:creator>Xu Z.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>10-12</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.002</prism:doi><pii>S0022282815001030</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007711</affiliation-url><afid>60007711</afid><affilname>Jilin University</affilname><name-variant>Jilin University</name-variant><affiliation-city>Changchun</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56589201800</author-url><authid>56589201800</authid><authname>Xu Z.</authname><surname>Xu</surname><given-name>Zheng</given-name><initials>Z.</initials><afid>60007711</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26643127400</author-url><authid>26643127400</authid><authname>Cai L.</authname><surname>Cai</surname><given-name>Lu</given-name><initials>L.</initials><afid>60007711</afid></author><intid>1035629726</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929150858"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929150858?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929150858&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929150858&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008505"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929150858</prism:url><dc:identifier>SCOPUS_ID:84929150858</dc:identifier><eid>2-s2.0-84929150858</eid><dc:title>Effect of pacemaker site on B-type natriuretic peptide levels and left ventricular function in a population with high prevalence of Chagas disease</dc:title><dc:creator>De Souza S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>315-318</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.127</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030074</affiliation-url><afid>60030074</afid><affilname>Universidade Federal de Minas Gerais</affilname><name-variant>Universidade Federal de Minas Gerais</name-variant><affiliation-city>Belo Horizonte</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113059460</affiliation-url><afid>113059460</afid><affilname>Children's National Health System</affilname><name-variant>Children's National Health System</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640761500</author-url><authid>56640761500</authid><authname>De Souza S.</authname><surname>De Souza</surname><given-name>Sônia Francisca</given-name><initials>S.F.</initials><afid>60030074</afid><afid>60030074</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640761500</author-url><authid>56640761500</authid><authname>De Souza S.</authname><surname>De Souza</surname><given-name>Sônia Francisca</given-name><initials>S.F.</initials><afid>60030074</afid><afid>60030074</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14424406800</author-url><authid>14424406800</authid><authname>Nascimento B.</authname><surname>Nascimento</surname><given-name>Bruno R.</given-name><initials>B.R.</initials><afid>60030074</afid><afid>60030074</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14424406800</author-url><authid>14424406800</authid><authname>Nascimento B.</authname><surname>Nascimento</surname><given-name>Bruno R.</given-name><initials>B.R.</initials><afid>60030074</afid><afid>60030074</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26022029300</author-url><authid>26022029300</authid><authname>Nunes M.</authname><surname>Nunes</surname><given-name>Maria Do Carmo P</given-name><initials>M.D.C.P.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26022029300</author-url><authid>26022029300</authid><authname>Nunes M.</authname><surname>Nunes</surname><given-name>Maria Do Carmo P</given-name><initials>M.D.C.P.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26022029300</author-url><authid>26022029300</authid><authname>Nunes M.</authname><surname>Nunes</surname><given-name>Maria Do Carmo P</given-name><initials>M.D.C.P.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37037072800</author-url><authid>37037072800</authid><authname>Da Silva J.</authname><surname>Da Silva</surname><given-name>José Luiz P</given-name><initials>J.L.P.</initials><afid>60030074</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641010200</author-url><authid>56641010200</authid><authname>De Carvalho V.</authname><surname>De Carvalho</surname><given-name>Vinícius T.</given-name><initials>V.T.</initials><afid>60030074</afid><afid>60030074</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641010200</author-url><authid>56641010200</authid><authname>De Carvalho V.</authname><surname>De Carvalho</surname><given-name>Vinícius T.</given-name><initials>V.T.</initials><afid>60030074</afid><afid>60030074</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56641050200</author-url><authid>56641050200</authid><authname>Beaton A.</authname><surname>Beaton</surname><given-name>Andrea Z.</given-name><initials>A.Z.</initials><afid>113059460</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35869602900</author-url><authid>35869602900</authid><authname>Rocha M.</authname><surname>Rocha</surname><given-name>Manoel Otávio C</given-name><initials>M.O.C.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35869602900</author-url><authid>35869602900</authid><authname>Rocha M.</authname><surname>Rocha</surname><given-name>Manoel Otávio C</given-name><initials>M.O.C.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35869602900</author-url><authid>35869602900</authid><authname>Rocha M.</authname><surname>Rocha</surname><given-name>Manoel Otávio C</given-name><initials>M.O.C.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56401504500</author-url><authid>56401504500</authid><authname>Ribeiro A.</authname><surname>Ribeiro</surname><given-name>Antonio L.</given-name><initials>A.L.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56401504500</author-url><authid>56401504500</authid><authname>Ribeiro A.</authname><surname>Ribeiro</surname><given-name>Antonio L.</given-name><initials>A.L.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56401504500</author-url><authid>56401504500</authid><authname>Ribeiro A.</authname><surname>Ribeiro</surname><given-name>Antonio L.</given-name><initials>A.L.</initials><afid>60030074</afid><afid>60030074</afid><afid>60030074</afid></author><authkeywords>Artificial cardiac stimulation | Chagas disease | Left ventricular function | Pacemaker</authkeywords><intid>1785916574</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928121207"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928121207?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928121207&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928121207&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002228281500108X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928121207</prism:url><dc:identifier>SCOPUS_ID:84928121207</dc:identifier><eid>2-s2.0-84928121207</eid><dc:title>Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D</dc:title><dc:creator>Bochaton T.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>61-69</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.03.017</prism:doi><pii>S002228281500108X</pii><dc:description>© 2015 Elsevier Ltd. Rationale. How ischemic postconditioning can inhibit opening of the mitochondrial permeability transition pore (PTP) and subsequent cardiac myocytes death at reperfusion remains unknown. Recent studies have suggested that de-acetylation of cyclophilin D (CyPD) by sirtuin 3 (SIRT3) can modulate its binding to the PTP. Objective: The aim of the present study was to examine whether ischemic postconditioning (PostC) might activate SIRT3 and consequently prevent lethal myocardial reperfusion injury through a deacetylation of CyPD.Methods and results. Using hypoxia-reoxygenation (H/R) in H9C2 cells, we showed that SIRT3 overexpression prevented CyPD acetylation, limited PTP opening and reduced cell death by 24%. In vitro modification of the CyPD acetylation status in MEFs by site-directed mutagenesis altered capacity of PTP opening by calcium. Calcium Retention Capacity (CRC) was significantly decreased with CyPD-KQ that mimics acetylated protein compared with CyPD WT (871±266 vs 1193±263nmolesCa&lt;sup&gt;2+&lt;/sup&gt;/mg protein respectively). Cells expressing non-acetylable CyPD mutant (CyPD-KR) displayed 20% decrease in cell death compared to cells expressing CyPD WT after H/R. Correspondingly, in mice we showed that cardiac ischemic postconditioning could not reduce infarct size and CyPD acetylation in SIRT3 KO mice, and was unable to restore CRC in mitochondria as it is observed in WT mice.Conclusions. Our study suggests that the increased acetylation of CyPD following myocardial ischemia-reperfusion facilitates PTP opening and subsequent cell death. Therefore ischemic postconditioning might prevent lethal reperfusion injury through an increased SIRT3 activity and subsequent attenuation of CyPD acetylation at reperfusion.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023578</affiliation-url><afid>60023578</afid><affilname>Universite Claude Bernard Lyon 1</affilname><name-variant>Université Lyon 1</name-variant><affiliation-city>Villeurbanne</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016992</affiliation-url><afid>60016992</afid><affilname>Hopital Louis Pradel</affilname><name-variant>Hôpital Louis Pradel</name-variant><affiliation-city>Lyon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55661981300</author-url><authid>55661981300</authid><authname>Bochaton T.</authname><surname>Bochaton</surname><given-name>T.</given-name><initials>T.</initials><afid>60023578</afid><afid>60016992</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55661981300</author-url><authid>55661981300</authid><authname>Bochaton T.</authname><surname>Bochaton</surname><given-name>T.</given-name><initials>T.</initials><afid>60023578</afid><afid>60016992</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24447946700</author-url><authid>24447946700</authid><authname>Crola-Da-Silva C.</authname><surname>Crola-Da-Silva</surname><given-name>C.</given-name><initials>C.</initials><afid>60023578</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12787051300</author-url><authid>12787051300</authid><authname>Pillot B.</authname><surname>Pillot</surname><given-name>B.</given-name><initials>B.</initials><afid>60023578</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56600596500</author-url><authid>56600596500</authid><authname>Villedieu C.</authname><surname>Villedieu</surname><given-name>C.</given-name><initials>C.</initials><afid>60023578</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56600533000</author-url><authid>56600533000</authid><authname>Ferreras L.</authname><surname>Ferreras</surname><given-name>L.</given-name><initials>L.</initials><afid>60023578</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54406708900</author-url><authid>54406708900</authid><authname>Alam M.</authname><surname>Alam</surname><given-name>M. R.</given-name><initials>M.R.</initials><afid>60023578</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603975002</author-url><authid>6603975002</authid><authname>Thibault H.</authname><surname>Thibault</surname><given-name>H.</given-name><initials>H.</initials><afid>60023578</afid><afid>60016992</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603975002</author-url><authid>6603975002</authid><authname>Thibault H.</authname><surname>Thibault</surname><given-name>H.</given-name><initials>H.</initials><afid>60023578</afid><afid>60016992</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56600674300</author-url><authid>56600674300</authid><authname>Strina M.</authname><surname>Strina</surname><given-name>M.</given-name><initials>M.</initials><afid>60023578</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006029240</author-url><authid>7006029240</authid><authname>Gharib A.</authname><surname>Gharib</surname><given-name>A.</given-name><initials>A.</initials><afid>60023578</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7006444103</author-url><authid>7006444103</authid><authname>Ovize M.</authname><surname>Ovize</surname><given-name>M.</given-name><initials>M.</initials><afid>60023578</afid><afid>60016992</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7006444103</author-url><authid>7006444103</authid><authname>Ovize M.</authname><surname>Ovize</surname><given-name>M.</given-name><initials>M.</initials><afid>60023578</afid><afid>60016992</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6507967965</author-url><authid>6507967965</authid><authname>Baetz D.</authname><surname>Baetz</surname><given-name>D.</given-name><initials>D.</initials><afid>60023578</afid></author><authkeywords>Cyclophilin D | Ischemia-reperfusion | Post-conditioning | Sirtuin 3 | Survival</authkeywords><intid>2035728279</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929471504"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929471504?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929471504&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929471504&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001352"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929471504</prism:url><dc:identifier>SCOPUS_ID:84929471504</dc:identifier><eid>2-s2.0-84929471504</eid><dc:title>Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy</dc:title><dc:creator>Ludke A.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>116-128</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.019</prism:doi><pii>S0022282815001352</pii><dc:description>© 2015 Elsevier Ltd. Cell therapy to prevent cardiac dysfunction after myocardial infarction (MI) is less effective in aged patients because aged cells have decreased regenerative capacity. Allogeneic transplanted stem cells (SCs) from young donors are usually rejected. Maintaining transplanted SC immunoprivilege may dramatically improve regenerative outcomes. The uterus has distinct immune characteristics, and we showed that reparative uterine SCs home to the myocardium post-MI. Here, we identify immunoprivileged uterine SCs and assess their effects on cardiac regeneration after allogeneic transplantation. We found more than 20% of cells in the mouse uterus have undetectable MHC I expression by flow cytometry. Uterine MHC I&lt;sup&gt;(neg)&lt;/sup&gt; and MHC I&lt;sup&gt;(pos)&lt;/sup&gt; cells were separated by magnetic cell sorting. The MHC I&lt;sup&gt;(neg)&lt;/sup&gt; population expressed the SC markers CD34, Sca-1 and CD90, but did not express MHC II or c-kit. In vitro, MHC I&lt;sup&gt;(neg)&lt;/sup&gt; and &lt;sup&gt;(pos)&lt;/sup&gt; SCs show colony formation and endothelial differentiation capacity. In mixed leukocyte co-culture, MHC I&lt;sup&gt;(neg)&lt;/sup&gt; cells showed reduced cell death and leukocyte proliferation compared to MHC I&lt;sup&gt;(pos)&lt;/sup&gt; cells. MHC I&lt;sup&gt;(neg)&lt;/sup&gt; and &lt;sup&gt;(pos)&lt;/sup&gt; cells had significantly greater angiogenic capacity than mesenchymal stem cells. The benefits of intramyocardial injection of allogeneic MHC I&lt;sup&gt;(neg)&lt;/sup&gt; cells after MI were comparable to syngeneic bone marrow cell transplantation, with engraftment in cardiac tissue and limited recruitment of CD4 and CD8 cells up to 21days post-MI. MHC I&lt;sup&gt;(neg)&lt;/sup&gt; cells preserved cardiac function, decreased infarct size and improved regeneration post-MI. This new source of immunoprivileged cells can induce neovascularization and could be used as allogeneic cell therapy for regenerative medicine.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019991</affiliation-url><afid>60019991</afid><affilname>Toronto General Research Institute University of Toronto</affilname><name-variant>University Health Network</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073546</affiliation-url><afid>60073546</afid><affilname>Second Affiliated Hospital of Harbin Medical University</affilname><name-variant>The Second Affiliated Hospital of Harbin Medical University</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000338</affiliation-url><afid>60000338</afid><affilname>Shanxi Medical University</affilname><name-variant>Shanxi Medical University</name-variant><affiliation-city>Taiyuan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35744928900</author-url><authid>35744928900</authid><authname>Ludke A.</authname><surname>Ludke</surname><given-name>Ana</given-name><initials>A.</initials><afid>60019991</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56206229300</author-url><authid>56206229300</authid><authname>Wu J.</authname><surname>Wu</surname><given-name>Jun</given-name><initials>J.</initials><afid>60019991</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647769800</author-url><authid>56647769800</authid><authname>Nazari M.</authname><surname>Nazari</surname><given-name>Mansoreh</given-name><initials>M.</initials><afid>60019991</afid><afid>60016849</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647769800</author-url><authid>56647769800</authid><authname>Nazari M.</authname><surname>Nazari</surname><given-name>Mansoreh</given-name><initials>M.</initials><afid>60019991</afid><afid>60016849</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56425624000</author-url><authid>56425624000</authid><authname>Hatta K.</authname><surname>Hatta</surname><given-name>Kota</given-name><initials>K.</initials><afid>60019991</afid><afid>60016849</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56425624000</author-url><authid>56425624000</authid><authname>Hatta K.</authname><surname>Hatta</surname><given-name>Kota</given-name><initials>K.</initials><afid>60019991</afid><afid>60016849</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56647395000</author-url><authid>56647395000</authid><authname>Shao Z.</authname><surname>Shao</surname><given-name>Zhengbo</given-name><initials>Z.</initials><afid>60019991</afid><afid>60073546</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56647395000</author-url><authid>56647395000</authid><authname>Shao Z.</authname><surname>Shao</surname><given-name>Zhengbo</given-name><initials>Z.</initials><afid>60019991</afid><afid>60073546</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56518412500</author-url><authid>56518412500</authid><authname>Li S.</authname><surname>Li</surname><given-name>Shu Hong</given-name><initials>S.H.</initials><afid>60019991</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56647223600</author-url><authid>56647223600</authid><authname>Song H.</authname><surname>Song</surname><given-name>Huifang</given-name><initials>H.</initials><afid>60019991</afid><afid>60000338</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56647223600</author-url><authid>56647223600</authid><authname>Song H.</authname><surname>Song</surname><given-name>Huifang</given-name><initials>H.</initials><afid>60019991</afid><afid>60000338</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56205771100</author-url><authid>56205771100</authid><authname>Ni N.</authname><surname>Ni</surname><given-name>Nathan C.</given-name><initials>N.C.</initials><afid>60019991</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7103031251</author-url><authid>7103031251</authid><authname>Weisel R.</authname><surname>Weisel</surname><given-name>Richard D.</given-name><initials>R.D.</initials><afid>60019991</afid><afid>60016849</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7103031251</author-url><authid>7103031251</authid><authname>Weisel R.</authname><surname>Weisel</surname><given-name>Richard D.</given-name><initials>R.D.</initials><afid>60019991</afid><afid>60016849</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55491325500</author-url><authid>55491325500</authid><authname>Li R.</authname><surname>Li</surname><given-name>Ren Ke</given-name><initials>R.K.</initials><afid>60019991</afid><afid>60016849</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55491325500</author-url><authid>55491325500</authid><authname>Li R.</authname><surname>Li</surname><given-name>Ren Ke</given-name><initials>R.K.</initials><afid>60019991</afid><afid>60016849</afid></author><authkeywords>Cell therapy | Immune tolerance | Myocardial infarction | Stem cell | Uterus</authkeywords><intid>2035958871</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929176515"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929176515?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929176515&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929176515&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315004970"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929176515</prism:url><dc:identifier>SCOPUS_ID:84929176515</dc:identifier><eid>2-s2.0-84929176515</eid><dc:title>The complex mural cell: Pericyte function in health and disease</dc:title><dc:creator>Van Dijk C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>75-89</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.258</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. Pericytes are perivascular cells that can be distinguished from vascular smooth muscle cells by their specific morphology and expression of distinct molecular markers. Found in the microvascular beds distributed throughout the body, they are well known for their regulation of a healthy vasculature. In this review, we examine the mechanism of pericyte support to vasomotion, and the known pathways that regulate pericyte response in angiogenesis and neovascular stabilization. We will also discuss the role of pericytes in vascular basement membrane and endothelial barrier function regulation. In contrast, recent findings have indicated that pericyte dysfunction, characterized by changes in pericyte contractility or pericyte loss of microvascular coverage, plays an important role in onset and progression of vascular-related and fibrogenic diseases. From a therapeutic point of view, pericytes have recently been identified as a putative pool of endogenous mesenchymal stem cells that could be activated in response to tissue injury to contribute to the regenerative process on multiple levels. Wewill discuss the mechanisms viawhich pericytes are involved in disease onset and development in a number of pathophysiological conditions, as well as present the evidence that supports a role for multipotent pericytes in tissue regeneration. The emerging field of pericyte research will not only contribute to the identification of new drug targets in pericyte dysfunction associated diseases, but may also boost the use of this cell type in future cell-based regenerative strategies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032724</affiliation-url><afid>60032724</afid><affilname>University Medical Center Utrecht</affilname><name-variant>University Medical Center Utrecht</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032724</affiliation-url><afid>60032724</afid><affilname>University Medical Center Utrecht</affilname><name-variant>University Medical Center Utrecht</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640852300</author-url><authid>56640852300</authid><authname>Van Dijk C.</authname><surname>Van Dijk</surname><given-name>Christian G M</given-name><initials>C.G.M.</initials><afid>60032724</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641773800</author-url><authid>56641773800</authid><authname>Nieuweboer F.</authname><surname>Nieuweboer</surname><given-name>Frederieke E.</given-name><initials>F.E.</initials><afid>60032724</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640611400</author-url><authid>56640611400</authid><authname>Pei J.</authname><surname>Pei</surname><given-name>Jia Yi</given-name><initials>J.Y.</initials><afid>60032724</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640002200</author-url><authid>56640002200</authid><authname>Xu Y.</authname><surname>Xu</surname><given-name>Yan Juan</given-name><initials>Y.J.</initials><afid>60032724</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55082272100</author-url><authid>55082272100</authid><authname>Burgisser P.</authname><surname>Burgisser</surname><given-name>Petra</given-name><initials>P.</initials><afid>60032724</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56641127800</author-url><authid>56641127800</authid><authname>Van Mulligen E.</authname><surname>Van Mulligen</surname><given-name>Elise</given-name><initials>E.</initials><afid>60032724</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8571624800</author-url><authid>8571624800</authid><authname>El Azzouzi H.</authname><surname>El Azzouzi</surname><given-name>Hamid</given-name><initials>H.</initials><afid>60032724</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005277014</author-url><authid>7005277014</authid><authname>Duncker D.</authname><surname>Duncker</surname><given-name>Dirk J.</given-name><initials>D.J.</initials><afid>60032114</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004730916</author-url><authid>7004730916</authid><authname>Verhaar M.</authname><surname>Verhaar</surname><given-name>Marianne C.</given-name><initials>M.C.</initials><afid>60032724</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56640196600</author-url><authid>56640196600</authid><authname>Cheng C.</authname><surname>Cheng</surname><given-name>Caroline</given-name><initials>C.</initials><afid>60032724</afid><afid>60032114</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56640196600</author-url><authid>56640196600</authid><authname>Cheng C.</authname><surname>Cheng</surname><given-name>Caroline</given-name><initials>C.</initials><afid>60032724</afid><afid>60032114</afid></author><authkeywords>Cardiovascular disease | Pericytes | Vascular disease</authkeywords><intid>1035913617</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928575549"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928575549?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928575549&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928575549&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0027510715000706"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928575549</prism:url><dc:identifier>SCOPUS_ID:84928575549</dc:identifier><eid>2-s2.0-84928575549</eid><dc:title>Electrophysiologic and cellular characteristics of cardiomyocytes after X-ray irradiation</dc:title><dc:creator>Frieß J.</dc:creator><prism:publicationName>Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis</prism:publicationName><prism:issn>00275107</prism:issn><prism:eIssn>18792871</prism:eIssn><prism:volume>777</prism:volume><prism:pageRange>1-10</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mrfmmm.2015.03.012</prism:doi><pii>S0027510715000706</pii><dc:description>© 2015. The aim of this study was to investigate possible effects of ionizing irradiation on the electrophysiological functionality of cardiac myocytes in vitro. Primary chicken cardiomyocytes with spontaneous beating activity were irradiated with X-rays (dose range of 0.5-7. Gy). Functional alterations of cardiac cell cultures were evaluated up to 7 days after irradiation using microelectrode arrays. As examined endpoints, cell proliferation, apoptosis, reactive oxygen species (ROS) and DNA damage were evaluated. The beat rate of the cardiac networks increased in a dose-dependent manner over one week. The duration of single action potentials was slightly shortened. Additionally, we observed lower numbers of mitotic and S-phase cells at certain time points after irradiation. Also, the number of cells with γH2AX foci increased as a function of the dose. No significant changes in the level of ROS were detected. Induction of apoptosis was generally negligibly low. This is the first report to directly show alterations in cardiac electrophysiology caused by ionizing radiation, which were detectable up to one week after irradiation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109997837</affiliation-url><afid>109997837</afid><affilname>University of Applied Science Aschaffenburg</affilname><name-variant>University for Applied Sciences Aschaffenburg</name-variant><affiliation-city>Aschaffenburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011226</affiliation-url><afid>60011226</afid><affilname>Technische Universitat Darmstadt</affilname><name-variant>Technische Universität Darmstadt</name-variant><affiliation-city>Darmstadt</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008155</affiliation-url><afid>60008155</afid><affilname>GSI Helmholtz Centre for Heavy Ion Research GmbH</affilname><name-variant>GSI</name-variant><affiliation-city>Darmstadt</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56607167900</author-url><authid>56607167900</authid><authname>Frieß J.</authname><surname>Frieß</surname><given-name>Johannes L.</given-name><initials>J.L.</initials><afid>109997837</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54398044300</author-url><authid>54398044300</authid><authname>Heselich A.</authname><surname>Heselich</surname><given-name>Anja</given-name><initials>A.</initials><afid>60011226</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56214446900</author-url><authid>56214446900</authid><authname>Ritter S.</authname><surname>Ritter</surname><given-name>Sylvia</given-name><initials>S.</initials><afid>60008155</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56606913500</author-url><authid>56606913500</authid><authname>Haber A.</authname><surname>Haber</surname><given-name>Angelina</given-name><initials>A.</initials><afid>60011226</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56606782700</author-url><authid>56606782700</authid><authname>Kaiser N.</authname><surname>Kaiser</surname><given-name>Nicole</given-name><initials>N.</initials><afid>60011226</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56606818700</author-url><authid>56606818700</authid><authname>Layer P.</authname><surname>Layer</surname><given-name>Paul G.</given-name><initials>P.G.</initials><afid>60011226</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602267920</author-url><authid>6602267920</authid><authname>Thielemann C.</authname><surname>Thielemann</surname><given-name>Christiane</given-name><initials>C.</initials><afid>109997837</afid></author><authkeywords>Cardiomyocytes | Electrophysiology | Ionizing radiation | MEA technology | X-rays</authkeywords><intid>1785804013</intid><source-id>4800154008</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929167599"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929167599?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929167599&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929167599&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166354215001072"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929167599</prism:url><dc:identifier>SCOPUS_ID:84929167599</dc:identifier><eid>2-s2.0-84929167599</eid><dc:title>AIM2 co-immunization favors specific multifunctional CD8&lt;sup&gt;+&lt;/sup&gt; T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis</dc:title><dc:creator>Chai D.</dc:creator><prism:publicationName>Antiviral Research</prism:publicationName><prism:issn>01663542</prism:issn><prism:eIssn>18729096</prism:eIssn><prism:volume>119</prism:volume><prism:pageRange>68-77</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.antiviral.2015.04.015</prism:doi><pii>S0166354215001072</pii><dc:description>© 2015 Elsevier B.V. Coxsackievirus B3 (CVB3) infection can cause acute myocarditis and chronic myocarditis, leading to dilated cardiomyopathy (DCM) with no effective therapeutic strategy. Therefore, we investigated the potential of absent in melanoma 2 (AIM2) to enhance the therapeutic efficacy of DNA vaccine against CVB3-induced chronic myocarditis. Mice were infected with CVB3 and then intranasally immunized with chitosan-pcDNA3.1 (mock), chitosan-pAIM2 (CS-pAIM2), chitosan-pVP1 (CS-pVP1), or chitosan-pAIM2 plus chitosan-pVP1 (CS-pAIM2/CS-pVP1) at 7, 21, and 35 d. Therapeutic efficacies of various vaccines were evaluated at day 56 d. Compared with CS-pVP1 immunization, CS-pAIM2/CS-pVP1 co-immunization significantly increased survival rate, improved cardiac function, as well as decreased myocardial injury and fibrosis, this result indicated that CVB3-induced chronic myocarditis was alleviated. CVB3-specific T lymphocyte proliferation and cytotoxic T lymphocyte responses of the CS-pAIM2/CS-pVP1 co-immunization group were also increased. More interestingly, CS-pAIM2/CS-pVP1 co-immunization could facilitate CVB3-specific multifunctional CD8&lt;sup&gt;+&lt;/sup&gt; T cell induction in the intestinal mucosa, and this induction was closely correlated with myocardial scores, this result indicated that CS-pAIM2/CS-pVP1 vaccine exhibits therapeutic efficacy by enhancing multifunctional CD8&lt;sup&gt;+&lt;/sup&gt; T cells. This study may represent a novel therapy for CVB3-induced chronic myocarditis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010432</affiliation-url><afid>60010432</afid><affilname>Soochow University</affilname><name-variant>Suzhou University</name-variant><affiliation-city>Suzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56179922600</author-url><authid>56179922600</authid><authname>Chai D.</authname><surname>Chai</surname><given-name>Dafei</given-name><initials>D.</initials><afid>60010432</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56365578600</author-url><authid>56365578600</authid><authname>Yue Y.</authname><surname>Yue</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60010432</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56180249300</author-url><authid>56180249300</authid><authname>Xu W.</authname><surname>Xu</surname><given-name>Wei</given-name><initials>W.</initials><afid>60010432</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55635800200</author-url><authid>55635800200</authid><authname>Dong C.</authname><surname>Dong</surname><given-name>Chunsheng</given-name><initials>C.</initials><afid>60010432</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202792229</author-url><authid>7202792229</authid><authname>Xiong S.</authname><surname>Xiong</surname><given-name>Sidong</given-name><initials>S.</initials><afid>60010432</afid></author><authkeywords>AIM2 | Chitosan | Chronic myocarditis | Coxsackievirus B3 | DNA vaccine | Multifunctional CD8&lt;sup&gt;+&lt;/sup&gt; T cells</authkeywords><intid>2035912304</intid><source-id>19617</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929179812"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929179812?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929179812&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929179812&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008906"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929179812</prism:url><dc:identifier>SCOPUS_ID:84929179812</dc:identifier><eid>2-s2.0-84929179812</eid><dc:title>A response to "the importance of vasodilator therapy before or during angiography, is ICD necessary or not?" by Tamer Kýrat and Nuri Köse</dc:title><dc:creator>Chyrchel M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>208-209</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.166</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021323</affiliation-url><afid>60021323</afid><affilname>Collegium Medicum Uniwersytet Jagiellonskiego</affilname><name-variant>Jagiellonian University Medical College</name-variant><affiliation-city>Krakow</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021323</affiliation-url><afid>60021323</afid><affilname>Collegium Medicum Uniwersytet Jagiellonskiego</affilname><name-variant>Jagiellonian University Medical College</name-variant><affiliation-city>Krakow</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603205253</author-url><authid>6603205253</authid><authname>Chyrchel M.</authname><surname>Chyrchel</surname><given-name>Michał</given-name><initials>M.</initials><afid>60021323</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506220215</author-url><authid>6506220215</authid><authname>Dziewierz A.</authname><surname>Dziewierz</surname><given-name>Artur</given-name><initials>A.</initials><afid>60021323</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56468921300</author-url><authid>56468921300</authid><authname>Dudek D.</authname><surname>Dudek</surname><given-name>Dariusz</given-name><initials>D.</initials><afid>60021323</afid></author><authkeywords>Cardiac arrest | Coronary spasm | Implantable cardioverter defibrillator | Myocardial infarction | Variant angina | Ventricular fibrillation</authkeywords><intid>1785919433</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929180219"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929180219?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929180219&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929180219&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008530"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929180219</prism:url><dc:identifier>SCOPUS_ID:84929180219</dc:identifier><eid>2-s2.0-84929180219</eid><dc:title>Endomyocardial biopsy in Anderson-Fabry disease: The key in uncertain cases</dc:title><dc:creator>Tschöpe C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>284-286</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.130</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026245</affiliation-url><afid>60026245</afid><affilname>Charite - Universitatsmedizin Berlin</affilname><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025844</affiliation-url><afid>60025844</afid><affilname>Hospital Universitario Puerta de Hierro</affilname><name-variant>Hospital Universitario Puerta de Hierro</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Deutsches Herzzentrum Berlin (DHZB)</affilname><name-variant>Dept. of Cardiology</name-variant><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026245</affiliation-url><afid>60026245</afid><affilname>Charite - Universitatsmedizin Berlin</affilname><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115034216</affiliation-url><afid>115034216</afid><affilname>Berliner Zentrum für Regenerative Therapien (BCRT)</affilname><name-variant>Berliner Zentrum für Regenerative Therapien (BCRT)</name-variant><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026245</affiliation-url><afid>60026245</afid><affilname>Charite - Universitatsmedizin Berlin</affilname><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003819329</author-url><authid>7003819329</authid><authname>Tschöpe C.</authname><surname>Tschöpe</surname><given-name>C.</given-name><initials>C.</initials><afid>60026245</afid><afid>115034216</afid><afid>60026245</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003819329</author-url><authid>7003819329</authid><authname>Tschöpe C.</authname><surname>Tschöpe</surname><given-name>C.</given-name><initials>C.</initials><afid>60026245</afid><afid>115034216</afid><afid>60026245</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003819329</author-url><authid>7003819329</authid><authname>Tschöpe C.</authname><surname>Tschöpe</surname><given-name>C.</given-name><initials>C.</initials><afid>60026245</afid><afid>115034216</afid><afid>60026245</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56008538500</author-url><authid>56008538500</authid><authname>Dominguez F.</authname><surname>Dominguez</surname><given-name>F.</given-name><initials>F.</initials><afid>60025844</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6505946454</author-url><authid>6505946454</authid><authname>Canaan-Kühl S.</authname><surname>Canaan-Kühl</surname><given-name>S.</given-name><initials>S.</initials><afid>60026245</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23033428400</author-url><authid>23033428400</authid><authname>Blaschke D.</authname><surname>Blaschke</surname><given-name>D.</given-name><initials>D.</initials><afid>60026245</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26643567500</author-url><authid>26643567500</authid><authname>Kühl U.</authname><surname>Kühl</surname><given-name>U.</given-name><initials>U.</initials><afid>60026245</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35499467500</author-url><authid>35499467500</authid><authname>Pieske B.</authname><surname>Pieske</surname><given-name>B.</given-name><initials>B.</initials><afid>60026245</afid><afid/><afid>60026245</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35499467500</author-url><authid>35499467500</authid><authname>Pieske B.</authname><surname>Pieske</surname><given-name>B.</given-name><initials>B.</initials><afid>60026245</afid><afid/><afid>60026245</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35499467500</author-url><authid>35499467500</authid><authname>Pieske B.</authname><surname>Pieske</surname><given-name>B.</given-name><initials>B.</initials><afid>60026245</afid><afid/><afid>60026245</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005423154</author-url><authid>7005423154</authid><authname>Haverkamp W.</authname><surname>Haverkamp</surname><given-name>W.</given-name><initials>W.</initials><afid>60026245</afid></author><authkeywords>Anderson fabry disease | Endomyocardial biopsy | Female carriers</authkeywords><intid>35917590</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929174331"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929174331?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929174331&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929174331&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008967"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929174331</prism:url><dc:identifier>SCOPUS_ID:84929174331</dc:identifier><eid>2-s2.0-84929174331</eid><dc:title>HDAC inhibition: A novel therapeutic target for attenuating myocardial ischemia and reperfusion injury by reversing cardiac remodeling</dc:title><dc:creator>Wang J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>126-127</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.172</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080982</affiliation-url><afid>60080982</afid><affilname>Hubei General Hospital</affilname><name-variant>Renmin Hospital of Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:43761761700</author-url><authid>43761761700</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jichun</given-name><initials>J.</initials><afid>60080982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7404710009</author-url><authid>7404710009</authid><authname>Hu X.</authname><surname>Hu</surname><given-name>Xiaorong</given-name><initials>X.</initials><afid>60080982</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36077353100</author-url><authid>36077353100</authid><authname>Jiang H.</authname><surname>Jiang</surname><given-name>Hong</given-name><initials>H.</initials><afid>60080982</afid></author><authkeywords>Cardiac remodeling | Histone deacetylases (HDACs) | Myocardial ischemia and reperfusion injury</authkeywords><intid>1035911874</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929169718"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929169718?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929169718&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929169718&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009365"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929169718</prism:url><dc:identifier>SCOPUS_ID:84929169718</dc:identifier><eid>2-s2.0-84929169718</eid><dc:title>Ligands involved in conditioning may enhance the protection afforded by remote ischemia and reperfusion</dc:title><dc:creator>Andreadou I.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>273-274</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.203</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028900</affiliation-url><afid>60028900</afid><affilname>University of Athens</affilname><name-variant>University of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015528</affiliation-url><afid>60015528</afid><affilname>Attikon University Hospital</affilname><name-variant>Attikon University Hospital</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701535265</author-url><authid>6701535265</authid><authname>Andreadou I.</authname><surname>Andreadou</surname><given-name>Ioanna</given-name><initials>I.</initials><afid>60028900</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55296706200</author-url><authid>55296706200</authid><authname>Farmakis D.</authname><surname>Farmakis</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60015528</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003565182</author-url><authid>7003565182</authid><authname>Iliodromitis E.</authname><surname>Iliodromitis</surname><given-name>Efstathios K.</given-name><initials>E.K.</initials><afid>60015528</afid></author><authkeywords>Cardioprotection | Morphine | Remote conditioning | RISK</authkeywords><intid>1785919179</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928599266"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928599266?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928599266&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928599266&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S092544391500112X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928599266</prism:url><dc:identifier>SCOPUS_ID:84928599266</dc:identifier><eid>2-s2.0-84928599266</eid><dc:title>P-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling</dc:title><dc:creator>García R.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1520-1530</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.04.006</prism:doi><pii>S092544391500112X</pii><dc:description>© 2015 Elsevier B.V. Transforming growth factor-β (TGF-β) induces miR-21 expression which contributes to fibrotic events in the left ventricle (LV) under pressure overload. SMAD effectors of TGF-β signaling interact with DROSHA to promote primary miR-21 processing into precursor miR-21 (pre-miR-21). We hypothesize that p-SMAD-2 and -3 also interact with DICER1 to regulate the processing of pre-miR-21 to mature miR-21 in cardiac fibroblasts under experimental and clinical pressure overload. The subjects of the study were mice undergoing transverse aortic constriction (TAC) and patients with aortic stenosis (AS). In vitro, NIH-3T3 fibroblasts transfected with pre-miR-21 responded to TGF-β1 stimulation by overexpressing miR-21. Overexpression and silencing of SMAD2/3 resulted in higher and lower production of mature miR-21, respectively. DICER1 co-precipitated along with SMAD2/3 and both proteins were up-regulated in the LV from TAC-mice. Pre-miR-21 was isolated bound to the DICER1 maturation complex. Immunofluorescence analysis revealed co-localization of p-SMAD2/3 and DICER1 in NIH-3T3 and mouse cardiac fibroblasts. DICER1-p-SMAD2/3 protein-protein interaction was confirmed by in situ proximity ligation assay. Myocardial up-regulation of DICER1 constituted a response to pressure overload in TAC-mice. DICER mRNA levels correlated directly with those of TGF-β1, SMAD2 and SMAD3. In the LV from AS patients, DICER mRNA was up-regulated and its transcript levels correlated directly with TGF-β1, SMAD2, and SMAD3. Our results support that p-SMAD2/3 interacts with DICER1 to promote pre-miR-21 processing to mature miR-21. This new TGFβ-dependent regulatory mechanism is involved in miR-21 overexpression in cultured fibroblasts, and in the pressure overloaded LV of mice and human patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008552</affiliation-url><afid>60008552</afid><affilname>Universidad de Cantabria, Facultad de Medicina</affilname><name-variant>Facultad de Medicina</name-variant><affiliation-city>Santander</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113126296</affiliation-url><afid>113126296</afid><affilname>Instituto de Investigación Marqués de Valdecilla (IDIVAL)</affilname><name-variant>IDIVAL-Instituto de Investigación Marqués de Valdecilla</name-variant><affiliation-city>Santander</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020591</affiliation-url><afid>60020591</afid><affilname>Hospital Universitario Marques de Valdecilla</affilname><name-variant>Hosp. Univ. Marques de Valdecilla</name-variant><affiliation-city>Santander</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017994</affiliation-url><afid>60017994</afid><affilname>Yale University School of Medicine</affilname><name-variant>Yale University School of Medicine</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017994</affiliation-url><afid>60017994</afid><affilname>Yale University School of Medicine</affilname><name-variant>Yale University School of Medicine</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033320</affiliation-url><afid>60033320</afid><affilname>Universidad de Navarra</affilname><name-variant>Universidad de Navarra</name-variant><affiliation-city>Pamplona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26422175200</author-url><authid>26422175200</authid><authname>García R.</authname><surname>García</surname><given-name>Raquel</given-name><initials>R.</initials><afid>60008552</afid><afid>113126296</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26422175200</author-url><authid>26422175200</authid><authname>García R.</authname><surname>García</surname><given-name>Raquel</given-name><initials>R.</initials><afid>60008552</afid><afid>113126296</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6601972853</author-url><authid>6601972853</authid><authname>Nistal J.</authname><surname>Nistal</surname><given-name>J. Francisco</given-name><initials>J.F.</initials><afid>113126296</afid><afid>60020591</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6601972853</author-url><authid>6601972853</authid><authname>Nistal J.</authname><surname>Nistal</surname><given-name>J. Francisco</given-name><initials>J.F.</initials><afid>113126296</afid><afid>60020591</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36193158500</author-url><authid>36193158500</authid><authname>Merino D.</authname><surname>Merino</surname><given-name>David</given-name><initials>D.</initials><afid>60008552</afid><afid>113126296</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36193158500</author-url><authid>36193158500</authid><authname>Merino D.</authname><surname>Merino</surname><given-name>David</given-name><initials>D.</initials><afid>60008552</afid><afid>113126296</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56428562900</author-url><authid>56428562900</authid><authname>Price N.</authname><surname>Price</surname><given-name>Nathan L.</given-name><initials>N.L.</initials><afid>60017994</afid><afid>60017994</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56428562900</author-url><authid>56428562900</authid><authname>Price N.</authname><surname>Price</surname><given-name>Nathan L.</given-name><initials>N.L.</initials><afid>60017994</afid><afid>60017994</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56637154300</author-url><authid>56637154300</authid><authname>Fernández-Hernando C.</authname><surname>Fernández-Hernando</surname><given-name>Carlos</given-name><initials>C.</initials><afid>60017994</afid><afid>60017994</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56637154300</author-url><authid>56637154300</authid><authname>Fernández-Hernando C.</authname><surname>Fernández-Hernando</surname><given-name>Carlos</given-name><initials>C.</initials><afid>60017994</afid><afid>60017994</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:12242026200</author-url><authid>12242026200</authid><authname>Beaumont J.</authname><surname>Beaumont</surname><given-name>Javier</given-name><initials>J.</initials><afid>60033320</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7404585374</author-url><authid>7404585374</authid><authname>González A.</authname><surname>González</surname><given-name>Arantxa</given-name><initials>A.</initials><afid>60033320</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003271474</author-url><authid>7003271474</authid><authname>Hurlé M.</authname><surname>Hurlé</surname><given-name>María A.</given-name><initials>M.A.</initials><afid>60008552</afid><afid>113126296</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003271474</author-url><authid>7003271474</authid><authname>Hurlé M.</authname><surname>Hurlé</surname><given-name>María A.</given-name><initials>M.A.</initials><afid>60008552</afid><afid>113126296</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35723144100</author-url><authid>35723144100</authid><authname>Villar A.</authname><surname>Villar</surname><given-name>Ana V.</given-name><initials>A.V.</initials><afid>60008552</afid><afid>113126296</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35723144100</author-url><authid>35723144100</authid><authname>Villar A.</authname><surname>Villar</surname><given-name>Ana V.</given-name><initials>A.V.</initials><afid>60008552</afid><afid>113126296</afid></author><authkeywords>DICER | Myocardial fibrosis | P-SMAD2/3 | Pre-miR-21 | Pressure overload | TGF-β</authkeywords><intid>2035809591</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930200751"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930200751?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930200751&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930200751&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2052297515000335"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930200751</prism:url><dc:identifier>SCOPUS_ID:84930200751</dc:identifier><eid>2-s2.0-84930200751</eid><dc:title>Factors associated with methicillin-resistant coagulase-negative staphylococci as causing organisms in deep sternal wound infections after cardiac surgery</dc:title><dc:creator>Sommerstein R.</dc:creator><prism:publicationName>New Microbes and New Infections</prism:publicationName><prism:issn>20522975</prism:issn><prism:volume>6</prism:volume><prism:pageRange>15-21</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.nmni.2015.04.003</prism:doi><pii>S2052297515000335</pii><dc:description>© 2015 The Authors. Established preoperative antibiotic prophylaxis in cardiac surgery is ineffective against methicillin-resistant coagulase-negative staphylococci (CoNS). This case-control study aimed to determine factors predicting deep sternal wound infections due to methicillin-resistant CoNS. All cardiac surgery patients undergoing sternotomy between June 2009 and March 2013 prospectively documented in a Swiss tertiary care center were included. Among 1999 patients, 82 (4.1%) developed deep sternal wound infection. CoNS were causal in 36 (44%) patients, with 25/36 (69%) being methicillin resistant. Early reintervention for noninfectious causes (odds ratio (OR) 4.3; 95% confidence interval (CI) 1.9-9.5) was associated with methicillin-resistant CoNS deep sternal wound infection. Among CoNS deep sternal wound infection, perioperative antimicrobial therapy (p 0.002), early reintervention for noninfectious causes (OR 7.9; 95% CI 0.9-71.1) and time between surgery and diagnosis of infection over 21 days (OR 10.8; 95% CI 1.2-97.8) were associated with methicillin resistance. These findings may help to better tailor preoperative antimicrobial prophylaxis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112837929</affiliation-url><afid>112837929</afid><affilname>Division of Infectious Diseases and Hospital Epidemiology</affilname><name-variant>Division of Infectious Diseases, Epidemiology, Biostatistics and Prevention Institute</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56614118300</author-url><authid>56614118300</authid><authname>Sommerstein R.</authname><surname>Sommerstein</surname><given-name>R.</given-name><initials>R.</initials><afid>112837929</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662794000</author-url><authid>56662794000</authid><authname>Kohler P.</authname><surname>Kohler</surname><given-name>P.</given-name><initials>P.</initials><afid>112837929</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202944848</author-url><authid>7202944848</authid><authname>Wilhelm M.</authname><surname>Wilhelm</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>60019619</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25031971100</author-url><authid>25031971100</authid><authname>Kuster S.</authname><surname>Kuster</surname><given-name>S. P.</given-name><initials>S.P.</initials><afid>112837929</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55599359900</author-url><authid>55599359900</authid><authname>Sax H.</authname><surname>Sax</surname><given-name>H.</given-name><initials>H.</initials><afid>112837929</afid></author><authkeywords>Cardiac surgery | Coagulase-negative staphylococci | Methicillin resistance | Sternotomy | Surgical site infection</authkeywords><intid>1786088379</intid><source-id>21100369843</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929166290"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929166290?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929166290&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929166290&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1551714415000762"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929166290</prism:url><dc:identifier>SCOPUS_ID:84929166290</dc:identifier><eid>2-s2.0-84929166290</eid><dc:title>Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study</dc:title><dc:creator>Lee S.</dc:creator><prism:publicationName>Contemporary Clinical Trials</prism:publicationName><prism:issn>15517144</prism:issn><prism:eIssn>15592030</prism:eIssn><prism:volume>43</prism:volume><prism:pageRange>20-24</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cct.2015.04.005</prism:doi><pii>S1551714415000762</pii><dc:description>© 2015. Background: The rates of stent failure after percutaneous coronary intervention have decreased since the introduction of the drug-eluting stent (DES). However, chronic kidney disease (CKD) and diabetes mellitus (DM) remain strong clinical predictors of poor prognosis despite DES implantation. Sarpogrelate, a selective serotonin (5-hydroxytryptamine (HT)2a [5-HT2A]) receptor antagonist, has antiproliferative effects, reducing neointimal hyperplasia and smooth muscle cell proliferation, as well as potent antiplatelet action, inhibiting 5-HT-induced platelet aggregation. However, efficacy and safety data for sarpogrelate in patients with CKD or DM are limited. We aim to determine whether sarpogrelate has beneficial effects in patients with CDK or DM treated with DES implantation. Methods/design: The SERENADE trial is a multicenter, open-label, prospective, randomized study that will test the superiority of triple anti-platelet therapy (TAT; aspirin, clopidogrel, and sarpogrelate) to conventional dual antiplatelet therapy (DAT; aspirin and clopidogrel) in preventing late lumen loss 9. months after the index procedure in patients with CKD or DM. A total of 220 patients diagnosed with coronary artery disease with DM or CKD will be randomized to the TAT or DAT groups (1:1 ratio) after DES implantation. The primary endpoint is late lumen loss at 9. months assessed by quantitative coronary angiography. Secondary efficacy endpoints are composites of major adverse cardiovascular events including cardiac death, nonfatal myocardial infarction, and target lesion revascularization. Secondary safety endpoints are major bleeding events and hepatic or renal impairment. Discussion: The SERENADE trial will provide insight on the efficacy of adjunctive therapy with sarpogrelate after DES implantation for patients with high-risk profiles such as CKD or DM. Trial registration: National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov NCT02294643).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60098516</affiliation-url><afid>60098516</afid><affilname>Seoul National University Bundang Hospital</affilname><name-variant>Seoul National University College of Medicine</name-variant><affiliation-city>Seongnam</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021119</affiliation-url><afid>60021119</afid><affilname>Seoul National University Hospital</affilname><name-variant>Seoul National University Hospital</name-variant><affiliation-city>Jongno-gu</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013682</affiliation-url><afid>60013682</afid><affilname>Seoul National University</affilname><name-variant>Seoul National University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56609845300</author-url><authid>56609845300</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Seung Ah</given-name><initials>S.A.</initials><afid>60098516</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35273808100</author-url><authid>35273808100</authid><authname>Suh J.</authname><surname>Suh</surname><given-name>Jung Won</given-name><initials>J.W.</initials><afid>60098516</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56515582200</author-url><authid>56515582200</authid><authname>Park J.</authname><surname>Park</surname><given-name>Jin Joo</given-name><initials>J.J.</initials><afid>60098516</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56496241100</author-url><authid>56496241100</authid><authname>Yoon C.</authname><surname>Yoon</surname><given-name>Chang Hwan</given-name><initials>C.H.</initials><afid>60098516</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16400657200</author-url><authid>16400657200</authid><authname>Cho Y.</authname><surname>Cho</surname><given-name>Young Suk</given-name><initials>Y.S.</initials><afid>60098516</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:34772316800</author-url><authid>34772316800</authid><authname>Youn T.</authname><surname>Youn</surname><given-name>Tae Jin</given-name><initials>T.J.</initials><afid>60098516</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35274374100</author-url><authid>35274374100</authid><authname>Chae I.</authname><surname>Chae</surname><given-name>In Ho</given-name><initials>I.H.</initials><afid>60098516</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:33567809200</author-url><authid>33567809200</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Hyo Soo</given-name><initials>H.S.</initials><afid>60021119</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:49663680000</author-url><authid>49663680000</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Sang Hyun</given-name><initials>S.H.</initials><afid>60013682</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35274349200</author-url><authid>35274349200</authid><authname>Choi D.</authname><surname>Choi</surname><given-name>Dong Ju</given-name><initials>D.J.</initials><afid>60098516</afid></author><authkeywords>Chronic kidney disease | Clinical trial | Diabetes melitus | Drug eluting stent | Randomized controlled trial</authkeywords><intid>535918276</intid><source-id>130115</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927613389"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927613389?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927613389&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927613389&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0898656815001175"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927613389</prism:url><dc:identifier>SCOPUS_ID:84927613389</dc:identifier><eid>2-s2.0-84927613389</eid><dc:title>MicroRNA regulation of Wnt signaling pathways in development and disease</dc:title><dc:creator>Song J.</dc:creator><prism:publicationName>Cellular Signalling</prism:publicationName><prism:issn>08986568</prism:issn><prism:eIssn>18733913</prism:eIssn><prism:volume>27</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1380-1391</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cellsig.2015.03.018</prism:doi><pii>S0898656815001175</pii><dc:description>© 2015 Elsevier Inc. Wnt signaling pathways and microRNAs (miRNAs) are critical regulators of development. Aberrant Wnt signaling pathways and miRNA levels lead to developmental defects and diverse human pathologies including but not limited to cancer. Wnt signaling pathways regulate a plethora of cellular processes during embryonic development and maintain homeostasis of adult tissues. A majority of Wnt signaling components are regulated by miRNAs which are small noncoding RNAs that are expressed in both animals and plants. In animal cells, miRNAs fine tune gene expression by pairing primarily to the 3'untranslated region of protein coding mRNAs to repress target mRNA translation and/or induce target degradation. miRNA-mediated regulation of signaling transduction pathways is important in modulating dose-sensitive response of cells to signaling molecules. This review discusses components of the Wnt signaling pathways that are regulated by miRNAs in the context of development and diseases. A fundamental understanding of miRNA functions in Wnt signaling transduction pathways may yield new insight into crosstalks of regulatory mechanisms essential for development and disease pathophysiology leading to novel therapeutics.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023004</affiliation-url><afid>60023004</afid><affilname>University of Delaware</affilname><name-variant>University of Delaware</name-variant><affiliation-city>Newark</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37029446500</author-url><authid>37029446500</authid><authname>Song J.</authname><surname>Song</surname><given-name>Jia L.</given-name><initials>J.L.</initials><afid>60023004</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56498685600</author-url><authid>56498685600</authid><authname>Nigam P.</authname><surname>Nigam</surname><given-name>Priya</given-name><initials>P.</initials><afid>60023004</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56592866000</author-url><authid>56592866000</authid><authname>Tektas S.</authname><surname>Tektas</surname><given-name>Senel S.</given-name><initials>S.S.</initials><afid>60023004</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004245792</author-url><authid>7004245792</authid><authname>Selva E.</authname><surname>Selva</surname><given-name>Erica</given-name><initials>E.</initials><afid>60023004</afid></author><authkeywords>Cancer | Non-canonical Wnt signaling | Post-transcriptional regulation | Regulatory network | β-catenin</authkeywords><intid>35647438</intid><source-id>18487</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929163675"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929163675?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929163675&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929163675&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006646"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929163675</prism:url><dc:identifier>SCOPUS_ID:84929163675</dc:identifier><eid>2-s2.0-84929163675</eid><dc:title>Secreted Frizzled-Related Protein 3 (sFRP3) in acute coronary syndromes</dc:title><dc:creator>Ueland T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>217-219</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.401</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069109</affiliation-url><afid>60069109</afid><affilname>Research Institute of Internal Medicine</affilname><name-variant>Research Institute for Internal Medicine</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026108</affiliation-url><afid>60026108</afid><affilname>Rikshospitalet-Radiumhospitalet HF</affilname><name-variant>Rikshospitalet-Radiumhospitalet Medical Centre</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026108</affiliation-url><afid>60026108</afid><affilname>Rikshospitalet-Radiumhospitalet HF</affilname><name-variant>Rikshospitalet-Radiumhospitalet Medical Centre</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010348</affiliation-url><afid>60010348</afid><affilname>Universitetet i Oslo</affilname><name-variant>University of Oslo</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010348</affiliation-url><afid>60010348</afid><affilname>Universitetet i Oslo</affilname><name-variant>University of Oslo</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031699</affiliation-url><afid>60031699</afid><affilname>Sahlgrenska Universitetssjukhuset</affilname><name-variant>Sahlgrenska University Hospital</name-variant><affiliation-city>Molndal</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031699</affiliation-url><afid>60031699</afid><affilname>Sahlgrenska Universitetssjukhuset</affilname><name-variant>Sahlgrenska University Hospital</name-variant><affiliation-city>Molndal</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021255</affiliation-url><afid>60021255</afid><affilname>Universitetet i Tromso</affilname><name-variant>University of Tromso</name-variant><affiliation-city>Tromso</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7007162539</author-url><authid>7007162539</authid><authname>Ueland T.</authname><surname>Ueland</surname><given-name>Thor</given-name><initials>T.</initials><afid>60069109</afid><afid>60010348</afid><afid>60021255</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7007162539</author-url><authid>7007162539</authid><authname>Ueland T.</authname><surname>Ueland</surname><given-name>Thor</given-name><initials>T.</initials><afid>60069109</afid><afid>60010348</afid><afid>60021255</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7007162539</author-url><authid>7007162539</authid><authname>Ueland T.</authname><surname>Ueland</surname><given-name>Thor</given-name><initials>T.</initials><afid>60069109</afid><afid>60010348</afid><afid>60021255</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005021397</author-url><authid>7005021397</authid><authname>Caidahl K.</authname><surname>Caidahl</surname><given-name>Kenneth</given-name><initials>K.</initials><afid>60031699</afid><afid>60031699</afid><afid>60012311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005021397</author-url><authid>7005021397</authid><authname>Caidahl K.</authname><surname>Caidahl</surname><given-name>Kenneth</given-name><initials>K.</initials><afid>60031699</afid><afid>60031699</afid><afid>60012311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005021397</author-url><authid>7005021397</authid><authname>Caidahl K.</authname><surname>Caidahl</surname><given-name>Kenneth</given-name><initials>K.</initials><afid>60031699</afid><afid>60031699</afid><afid>60012311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54893454200</author-url><authid>54893454200</authid><authname>Askevold E.</authname><surname>Askevold</surname><given-name>Erik T.</given-name><initials>E.T.</initials><afid>60069109</afid><afid>60026108</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54893454200</author-url><authid>54893454200</authid><authname>Askevold E.</authname><surname>Askevold</surname><given-name>Erik T.</given-name><initials>E.T.</initials><afid>60069109</afid><afid>60026108</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102200365</author-url><authid>7102200365</authid><authname>Karlsson T.</authname><surname>Karlsson</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60031699</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005034028</author-url><authid>7005034028</authid><authname>Hartford M.</authname><surname>Hartford</surname><given-name>Marianne</given-name><initials>M.</initials><afid>60031699</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>Pål</given-name><initials>P.</initials><afid>60069109</afid><afid>60026108</afid><afid>60010348</afid><afid>60010348</afid><afid>60021255</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>Pål</given-name><initials>P.</initials><afid>60069109</afid><afid>60026108</afid><afid>60010348</afid><afid>60010348</afid><afid>60021255</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>Pål</given-name><initials>P.</initials><afid>60069109</afid><afid>60026108</afid><afid>60010348</afid><afid>60010348</afid><afid>60021255</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>Pål</given-name><initials>P.</initials><afid>60069109</afid><afid>60026108</afid><afid>60010348</afid><afid>60010348</afid><afid>60021255</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101644682</author-url><authid>7101644682</authid><authname>Aukrust P.</authname><surname>Aukrust</surname><given-name>Pål</given-name><initials>P.</initials><afid>60069109</afid><afid>60026108</afid><afid>60010348</afid><afid>60010348</afid><afid>60021255</afid></author><authkeywords>Acute coronary syndrome | Atherosclerosis | sFRP3</authkeywords><intid>535918241</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929178837"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929178837?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929178837&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929178837&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008761"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929178837</prism:url><dc:identifier>SCOPUS_ID:84929178837</dc:identifier><eid>2-s2.0-84929178837</eid><dc:title>Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction: A systematic review and meta-analysis</dc:title><dc:creator>Ren Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>268-270</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.152</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107076630</affiliation-url><afid>107076630</afid><affilname>Chongqing Hospital of Traditional Chinese Medicine</affilname><name-variant>Chongqing Municipal Hospital of Traditional Chinese Medicine</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113451372</affiliation-url><afid>113451372</afid><affilname>Guangdong Provincial Hospital of Traditional Chinese Medical</affilname><name-variant>Guangdong Provincial Hospital of Traditional Chinese Medical</name-variant><affiliation-city>Zhuhai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025345</affiliation-url><afid>60025345</afid><affilname>Guangzhou University</affilname><name-variant>Guangzhou University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105672742</affiliation-url><afid>105672742</afid><affilname>National Center for Cardiovascular Diseases</affilname><name-variant>National Center for Cardiovascular Disease</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640328500</author-url><authid>56640328500</authid><authname>Ren Y.</authname><surname>Ren</surname><given-name>Yi</given-name><initials>Y.</initials><afid>107076630</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56401527900</author-url><authid>56401527900</authid><authname>Zeng R.</authname><surname>Zeng</surname><given-name>Rui Xiang</given-name><initials>R.X.</initials><afid>113451372</afid><afid>60025345</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56401527900</author-url><authid>56401527900</authid><authname>Zeng R.</authname><surname>Zeng</surname><given-name>Rui Xiang</given-name><initials>R.X.</initials><afid>113451372</afid><afid>60025345</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34872666500</author-url><authid>34872666500</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jian Jun</given-name><initials>J.J.</initials><afid>105672742</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56512826900</author-url><authid>56512826900</authid><authname>Guo L.</authname><surname>Guo</surname><given-name>Li Heng</given-name><initials>L.H.</initials><afid>113451372</afid><afid>60025345</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56512826900</author-url><authid>56512826900</authid><authname>Guo L.</authname><surname>Guo</surname><given-name>Li Heng</given-name><initials>L.H.</initials><afid>113451372</afid><afid>60025345</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640409100</author-url><authid>56640409100</authid><authname>He D.</authname><surname>He</surname><given-name>De Ying</given-name><initials>D.Y.</initials><afid>107076630</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56641917800</author-url><authid>56641917800</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yong</given-name><initials>Y.</initials><afid>107076630</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56640682500</author-url><authid>56640682500</authid><authname>Liao P.</authname><surname>Liao</surname><given-name>Peng Da</given-name><initials>P.D.</initials><afid>113451372</afid><afid>60025345</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56640682500</author-url><authid>56640682500</authid><authname>Liao P.</authname><surname>Liao</surname><given-name>Peng Da</given-name><initials>P.D.</initials><afid>113451372</afid><afid>60025345</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56200385400</author-url><authid>56200385400</authid><authname>Zhang M.</authname><surname>Zhang</surname><given-name>Min Zhou</given-name><initials>M.Z.</initials><afid>113451372</afid><afid>60025345</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56200385400</author-url><authid>56200385400</authid><authname>Zhang M.</authname><surname>Zhang</surname><given-name>Min Zhou</given-name><initials>M.Z.</initials><afid>113451372</afid><afid>60025345</afid></author><authkeywords>Acute myocardial infarction | Atrial fibrillation | C-reactive protein</authkeywords><intid>1785918967</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929175678"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929175678?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929175678&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929175678&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008414"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929175678</prism:url><dc:identifier>SCOPUS_ID:84929175678</dc:identifier><eid>2-s2.0-84929175678</eid><dc:title>Ascending aortic aneurysm and acute type A aortic dissection in a patient with congenital severe coarctation of the aorta</dc:title><dc:creator>Jiang Y.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>18-19</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.118</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073509</affiliation-url><afid>60073509</afid><affilname>West China Hospital</affilname><name-variant>West China Hospital of Sichuan University</name-variant><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016521</affiliation-url><afid>60016521</afid><affilname>Sichuan University</affilname><name-variant>Sichuan University</name-variant><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56453627500</author-url><authid>56453627500</authid><authname>Jiang Y.</authname><surname>Jiang</surname><given-name>Yaowen</given-name><initials>Y.</initials><afid>60073509</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56148143900</author-url><authid>56148143900</authid><authname>Ling Y.</authname><surname>Ling</surname><given-name>Yunfei</given-name><initials>Y.</initials><afid>60016521</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640280900</author-url><authid>56640280900</authid><authname>Zhu D.</authname><surname>Zhu</surname><given-name>Dan</given-name><initials>D.</initials><afid>60073509</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56453693300</author-url><authid>56453693300</authid><authname>Cao Y.</authname><surname>Cao</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60073509</afid></author><authkeywords>Aortic dissection | Ascending aortic aneurysm | Coarctation of the aorta</authkeywords><intid>1785917776</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928685524"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928685524?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928685524&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928685524&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1569904815000804"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928685524</prism:url><dc:identifier>SCOPUS_ID:84928685524</dc:identifier><eid>2-s2.0-84928685524</eid><dc:title>Carotid chemoreceptors do not mediate hypoxic-induced gasping and autoresuscitation in newborn rats</dc:title><dc:creator>Lun R.</dc:creator><prism:publicationName>Respiratory Physiology and Neurobiology</prism:publicationName><prism:issn>15699048</prism:issn><prism:eIssn>18781519</prism:eIssn><prism:volume>212-214</prism:volume><prism:pageRange>33-38</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.resp.2015.04.006</prism:doi><pii>S1569904815000804</pii><dc:description>© 2015 Elsevier B.V. Experiments were carried out on 48, 5-6-day-old rat pups to investigate the influence of carotid denervation on their time to last gasp during a single period of hypoxia, and on their ability to autoresuscitate from primary apnea during repeated hypoxic challenge. One group of pups was studied with intact carotid chemoreceptors and one group was studied following surgical denervation of the carotid chemoreceptors. Carotid denervation eliminated the early tachypneic phase during exposure to hypoxia and delayed the time to arousal/excitement but did not alter the time to primary apnea, the time to last gasp or the total number of gasps during exposure to a single period of unrelenting hypoxia. Furthermore, carotid denervation did not alter the number of successful autoresuscitations from primary apnea during repeated hypoxic exposure. Thus, the carotid chemoreceptors are not essential for the initiation or maintenance of gasping nor are they are integral to gasping effecting successful autoresuscitation from hypoxic-induced apnea in newborn rats.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002306</affiliation-url><afid>60002306</afid><affilname>University of Calgary</affilname><name-variant>University of Calgary</name-variant><affiliation-city>Calgary</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56610364500</author-url><authid>56610364500</authid><authname>Lun R.</authname><surname>Lun</surname><given-name>Rongzhi</given-name><initials>R.</initials><afid>60002306</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56097230700</author-url><authid>56097230700</authid><authname>Zhang C.</authname><surname>Zhang</surname><given-name>Chunfen</given-name><initials>C.</initials><afid>60002306</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005358571</author-url><authid>7005358571</authid><authname>Fewell J.</authname><surname>Fewell</surname><given-name>James E.</given-name><initials>J.E.</initials><afid>60002306</afid></author><authkeywords>Autoresuscitation | Carotid chemoreceptors | Hypoxic-induced gasping</authkeywords><intid>535824205</intid><source-id>24030</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929072900"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929072900?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929072900&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929072900&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929072900</prism:url><dc:identifier>SCOPUS_ID:84929072900</dc:identifier><eid>2-s2.0-84929072900</eid><dc:title>Isolation, characterization and cardiac differentiation of human thymus tissue derived mesenchymal stromal cells</dc:title><dc:creator>Lin Z.</dc:creator><prism:publicationName>Journal of Cellular Biochemistry</prism:publicationName><prism:issn>07302312</prism:issn><prism:eIssn>10974644</prism:eIssn><prism:volume>116</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1205-1212</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1002/jcb.25072</prism:doi><dc:description>© 2014 Wiley Periodicals, Inc. © 2014 Wiley Periodicals, Inc. Mesenchymal stromal cells (MSCs) are promising candidate donor cells for replacement of cardiomyocyte loss during ischemia and in vitro generation of myocardial tissue. We have successfully isolated MSCs from the discarded neonatal thymus gland during cardiac surgery. The thymus MSCs were characterized by cell-surface antigen expression. These cells have high ability for proliferation and are able to differentiate into osteoblasts and adipocytes in vitro. For cardiac differentiation, the cells were divided into 3 groups: untreated control; 5-azacytidine group and sequential exposure to 5-azacytidine, bone morphogenetic protein 4, and basic fibroblast growth factor. Thymus MSCs showed a fibrolast-like morphology and some differentiated cells increased in size, formed a ball-like appearance over time and spontaneously contracting cells were observed in sequential exposure group. Immunostaining studies, cardiac specific genes/protein expression confirmed the cardiomyocyte phenotype of the differentiated cells. These results demonstrate that thymus MSCs can be a promising cellular source for cardiac cell therapy and tissue engineering. J. Cell. Biochem. 116: 1205-1212, 2015.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018310</affiliation-url><afid>60018310</afid><affilname>Nanjing Medical University</affilname><name-variant>Nanjing Medical University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56637380400</author-url><authid>56637380400</authid><authname>Lin Z.</authname><surname>Lin</surname><given-name>Ze Bang</given-name><initials>Z.B.</initials><afid>60018310</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102420665</author-url><authid>7102420665</authid><authname>Qian B.</authname><surname>Qian</surname><given-name>Bo</given-name><initials>B.</initials><afid>60018310</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56637695900</author-url><authid>56637695900</authid><authname>Yang Y.</authname><surname>Yang</surname><given-name>Yu Zhong</given-name><initials>Y.Z.</initials><afid>60018310</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55992737500</author-url><authid>55992737500</authid><authname>Zhou K.</authname><surname>Zhou</surname><given-name>Kai</given-name><initials>K.</initials><afid>60018310</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55716307200</author-url><authid>55716307200</authid><authname>Sun J.</authname><surname>Sun</surname><given-name>Jian</given-name><initials>J.</initials><afid>60018310</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56637705300</author-url><authid>56637705300</authid><authname>Mo X.</authname><surname>Mo</surname><given-name>Xu Ming</given-name><initials>X.M.</initials><afid>60018310</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:14720414700</author-url><authid>14720414700</authid><authname>Wu K.</authname><surname>Wu</surname><given-name>Kai Hong</given-name><initials>K.H.</initials><afid>60018310</afid></author><authkeywords>CARDIOMYOCYTE | DIFFERENTIATION | MESENCHYMAL STROMAL CELLS | THYMUS TISSUE</authkeywords><intid>2035896545</intid><source-id>17598</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928728099"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928728099?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928728099&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928728099&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0045782515001127"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928728099</prism:url><dc:identifier>SCOPUS_ID:84928728099</dc:identifier><eid>2-s2.0-84928728099</eid><dc:title>Isogeometric Kirchhoff-Love shell formulations for general hyperelastic materials</dc:title><dc:creator>Kiendl J.</dc:creator><prism:publicationName>Computer Methods in Applied Mechanics and Engineering</prism:publicationName><prism:issn>00457825</prism:issn><prism:volume>291</prism:volume><prism:pageRange>280-303</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cma.2015.03.010</prism:doi><pii>S0045782515001127</pii><dc:description>© 2015 Elsevier B.V. We present formulations for compressible and incompressible hyperelastic thin shells which can use general 3D constitutive models. The necessary plane stress condition is enforced analytically for incompressible materials and iteratively for compressible materials. The thickness stretch is statically condensed and the shell kinematics are completely described by the first and second fundamental forms of the midsurface. We use C&lt;sup&gt;1&lt;/sup&gt;-continuous isogeometric discretizations to build the numerical models. Numerical tests, including structural dynamics simulations of a bioprosthetic heart valve, show the good performance and applicability of the presented methods.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015197</affiliation-url><afid>60015197</afid><affilname>Universita degli Studi di Pavia</affilname><name-variant>Università di Pavia</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004354</affiliation-url><afid>60004354</afid><affilname>Iowa State University</affilname><name-variant>Iowa State University</name-variant><affiliation-city>Ames</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110986474</affiliation-url><afid>110986474</afid><affilname>Istituto di Matematica Applicata e Tecnologie Informatiche - CNR</affilname><name-variant>Istituto di Matematica Applicata e Tecnologie Informatiche-CNR</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35098985900</author-url><authid>35098985900</authid><authname>Kiendl J.</authname><surname>Kiendl</surname><given-name>Josef</given-name><initials>J.</initials><afid>60015197</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35100307700</author-url><authid>35100307700</authid><authname>Hsu M.</authname><surname>Hsu</surname><given-name>Ming Chen</given-name><initials>M.C.</initials><afid>60004354</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56610968800</author-url><authid>56610968800</authid><authname>Wu M.</authname><surname>Wu</surname><given-name>Michael C H</given-name><initials>M.C.H.</initials><afid>60004354</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8398321500</author-url><authid>8398321500</authid><authname>Reali A.</authname><surname>Reali</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60015197</afid><afid>110986474</afid><afid>60019722</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8398321500</author-url><authid>8398321500</authid><authname>Reali A.</authname><surname>Reali</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60015197</afid><afid>110986474</afid><afid>60019722</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8398321500</author-url><authid>8398321500</authid><authname>Reali A.</authname><surname>Reali</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60015197</afid><afid>110986474</afid><afid>60019722</afid></author><authkeywords>Finite strain | Hyperelastic | Incompressibility | Isogeometric | Kirchhoff-Love | Thin shell</authkeywords><intid>35840453</intid><source-id>18158</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929180201"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929180201?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929180201&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929180201&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009286"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929180201</prism:url><dc:identifier>SCOPUS_ID:84929180201</dc:identifier><eid>2-s2.0-84929180201</eid><dc:title>Rosuvastatin and risk of acute pancreatitis</dc:title><dc:creator>Kalkan K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>293</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.195</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113149498</affiliation-url><afid>113149498</afid><affilname>Malkara State Hospital</affilname><name-variant>Malkara State Hospital</name-variant><affiliation-city>Tekirdag</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015566</affiliation-url><afid>60015566</afid><affilname>Ataturk University, Faculty of Medicine</affilname><name-variant>Atatürk University</name-variant><affiliation-city>Erzurum</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55355185600</author-url><authid>55355185600</authid><authname>Kalkan K.</authname><surname>Kalkan</surname><given-name>Kamuran</given-name><initials>K.</initials><afid>113149498</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641508900</author-url><authid>56641508900</authid><authname>Aksu U.</authname><surname>Aksu</surname><given-name>Uʇur</given-name><initials>U.</initials><afid>60015566</afid></author><authkeywords>Acute pancreatitis | Rosuvastatin</authkeywords><intid>35916890</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929484261"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929484261?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929484261&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929484261&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001303"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929484261</prism:url><dc:identifier>SCOPUS_ID:84929484261</dc:identifier><eid>2-s2.0-84929484261</eid><dc:title>CALibrating the CALumenin gene: New insights in overcoming the vascular CALcification CALamity?</dc:title><dc:creator>Daskalopoulos E.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>81-83</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.014</prism:doi><pii>S0022282815001303</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000874</affiliation-url><afid>60000874</afid><affilname>Universite Catholique de Louvain</affilname><name-variant>Université Catholique de Louvain</name-variant><affiliation-city>Louvain-la-Neuve</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101859051</affiliation-url><afid>101859051</afid><affilname>Cardiovascular Research Institute</affilname><name-variant>Cardiovascular Research Institute</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56647982300</author-url><authid>56647982300</authid><authname>Daskalopoulos E.</authname><surname>Daskalopoulos</surname><given-name>Evangelos P.</given-name><initials>E.P.</initials><afid>60000874</afid><afid>101859051</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56647982300</author-url><authid>56647982300</authid><authname>Daskalopoulos E.</authname><surname>Daskalopoulos</surname><given-name>Evangelos P.</given-name><initials>E.P.</initials><afid>60000874</afid><afid>101859051</afid></author><intid>1785964585</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928988830"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928988830?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928988830&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928988830&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0277539515000655"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928988830</prism:url><dc:identifier>SCOPUS_ID:84928988830</dc:identifier><eid>2-s2.0-84928988830</eid><dc:title>"Harvesting our collective intelligence": Black British feminism in post-race times</dc:title><dc:creator>Mirza H.</dc:creator><prism:publicationName>Women's Studies International Forum</prism:publicationName><prism:issn>02775395</prism:issn><prism:volume>51</prism:volume><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.wsif.2015.03.006</prism:doi><pii>S0277539515000655</pii><dc:description>© 2015 Elsevier Ltd. At the heart of the contingent and critical project of black British feminism is the postcolonial impulse to chart counter-narratives and memories of racialised and gendered domination. This paper takes up this challenge by exploring the struggles of a new generation of black British feminists, 30. years after the landmark publication of Feminist Review's special issue Many Voices One Chant and the edited collection Black British Feminism which followed. The paper explores the changing articulation of black British feminism at a time where foundational categories such as 'blackness' as a political construct continue to have purchase but where new forms of activism are more fleeting and contingent in response to the changing post-racial terrain.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010964</affiliation-url><afid>60010964</afid><affilname>Goldsmiths College</affilname><name-variant>Goldsmiths College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004183367</author-url><authid>7004183367</authid><authname>Mirza H.</authname><surname>Mirza</surname><given-name>Heidi Safia</given-name><initials>H.S.</initials><afid>60010964</afid></author><intid>35883486</intid><source-id>24359</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929966082"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929966082?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929966082&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929966082&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167876015001622"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929966082</prism:url><dc:identifier>SCOPUS_ID:84929966082</dc:identifier><eid>2-s2.0-84929966082</eid><dc:title>Reduced emotional and cardiovascular reactivity to emotionally evocative stimuli in major depressive disorder</dc:title><dc:creator>Jin A.</dc:creator><prism:publicationName>International Journal of Psychophysiology</prism:publicationName><prism:issn>01678760</prism:issn><prism:eIssn>18727697</prism:eIssn><prism:volume>97</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>66-74</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijpsycho.2015.04.014</prism:doi><pii>S0167876015001622</pii><dc:description>© 2015 Elsevier B.V. Major Depressive Disorder (MDD) is a highly debilitating mental health concern that affects a large number of adults in the United States. The emotional context insensitivity (ECI) hypothesis argues that individuals with MDD disengage from the environment to defend themselves from futile activity. In the current study, electrocardiogram and pupillometry were recorded from 50 participants (MDD n=. 25, never depressed control n=. 25) during the display of emotionally evocative images, sounds, and movie clips. Individuals with MDD reported reduced change in happiness to positively- and negatively-valenced images and sounds. Heart rate reactivity also was reduced in individuals with MDD when viewing images and watching movie clips. These results suggest that individuals with MDD may have some difficulty engaging with certain environmental stimuli.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017198</affiliation-url><afid>60017198</afid><affilname>Charles Stark Draper Lab Inc</affilname><name-variant>Draper Laboratory</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007740</affiliation-url><afid>60007740</afid><affilname>University of South Florida Tampa</affilname><name-variant>University of South Florida</name-variant><affiliation-city>Tampa</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622378800</author-url><authid>56622378800</authid><authname>Jin A.</authname><surname>Jin</surname><given-name>Alvin B.</given-name><initials>A.B.</initials><afid>60017198</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56623068600</author-url><authid>56623068600</authid><authname>Steding L.</authname><surname>Steding</surname><given-name>Lindsey H.</given-name><initials>L.H.</initials><afid>60007740</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:18635751100</author-url><authid>18635751100</authid><authname>Webb A.</authname><surname>Webb</surname><given-name>Andrea K.</given-name><initials>A.K.</initials><afid>60017198</afid></author><authkeywords>Cardiovascular | Depression | Emotion | Pupillometry | Reactivity</authkeywords><intid>1786043334</intid><source-id>14902</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929168465"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929168465?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929168465&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929168465&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500830X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929168465</prism:url><dc:identifier>SCOPUS_ID:84929168465</dc:identifier><eid>2-s2.0-84929168465</eid><dc:title>Takayasu arteritis involving the left main coronary artery treated with a bioresorbable vascular scaffold</dc:title><dc:creator>Camuglia A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>1-3</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.107</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030222</affiliation-url><afid>60030222</afid><affilname>London Health Sciences Centre</affilname><name-variant>London Health Sciences Centre</name-variant><affiliation-city>London</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031004</affiliation-url><afid>60031004</afid><affilname>University of Queensland</affilname><name-variant>The University of Queensland</name-variant><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23481144200</author-url><authid>23481144200</authid><authname>Camuglia A.</authname><surname>Camuglia</surname><given-name>Anthony C.</given-name><initials>A.C.</initials><afid>60030222</afid><afid>60031004</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23481144200</author-url><authid>23481144200</authid><authname>Camuglia A.</authname><surname>Camuglia</surname><given-name>Anthony C.</given-name><initials>A.C.</initials><afid>60030222</afid><afid>60031004</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56180084700</author-url><authid>56180084700</authid><authname>Randhawa V.</authname><surname>Randhawa</surname><given-name>Varinder K.</given-name><initials>V.K.</initials><afid>60030222</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56277789000</author-url><authid>56277789000</authid><authname>Lavi S.</authname><surname>Lavi</surname><given-name>Shahar</given-name><initials>S.</initials><afid>60030222</afid></author><authkeywords>Bioresorbable vascular scaffold | Left main coronary artery disease | Takayasu arteritis</authkeywords><intid>1535915909</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928978848"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928978848?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928978848&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928978848&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010345"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928978848</prism:url><dc:identifier>SCOPUS_ID:84928978848</dc:identifier><eid>2-s2.0-84928978848</eid><dc:title>Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data</dc:title><dc:creator>Tornvall P.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>87-91</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.816</prism:doi><pii>S0021915015010345</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objective: Myocardial Infarction with Non-Obstructed Coronary Arteries (MINOCA) is common, but the causes are to a large extent unknown. Thus, we aimed to study the prevalence of myocarditis and "true" myocardial infarction determined by cardiac magnetic resonance (CMR) imaging in MINOCA patients, and risk markers for these two conditions in this population. Methods: A search was made in the PubMed and Cochrane databases using the search terms "Myocardial infarction", "Coronary angiography", "Normal coronary arteries" and "MRI". All relevant abstracts were read and seven of the studies fulfilled the inclusion criteria; studies describing case series of patients fulfilling the diagnosis of acute myocardial infarction with normal or non-obstructive coronary arteries on coronary angiography that were investigated with CMR imaging. Data from five of these studies are presented. Results: A total of 556 patients from 5 different sites were included. Fifty-one percent were men with a mean age of 52±16 years. Thirty-three per cent of the patients had myocarditis (n=183), whereas 21% of the patients had infarction on CMR (n=115). Young age and a high CRP were associated with myocarditis whereas male sex, treated hyperlipidemia, high troponin ratio and low CRP were associated with "true" myocardial infarction. Conclusion and relevance: The results of this meta-analysis of individual data showed that myocarditis and "true" myocardial infarction are common in MINOCA when determined by CMR imaging. This information emphasizes the importance of performing CMR imaging in MINOCA patients and can be used clinically to guide diagnostics and treatment of MINOCA patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003434</affiliation-url><afid>60003434</afid><affilname>Hopital Haut-Leveque C.H.U de Bordeaux</affilname><affiliation-city>Pessac</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030553</affiliation-url><afid>60030553</afid><affilname>Universite de Rennes 1</affilname><name-variant>Université de Rennes I</name-variant><affiliation-city>Rennes</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109984842</affiliation-url><afid>109984842</afid><affilname>University Hospital Jean Minjoz</affilname><name-variant>University Hospital Jean Minjoz</name-variant><affiliation-city/><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009681</affiliation-url><afid>60009681</afid><affilname>Hospital de Galdakao</affilname><name-variant>Hospital de Galdakao</name-variant><affiliation-city>Galdacano</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003434</affiliation-url><afid>60003434</afid><affilname>Hopital Haut-Leveque C.H.U de Bordeaux</affilname><affiliation-city>Pessac</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033237</affiliation-url><afid>60033237</afid><affilname>Hospital General Universitario Gregorio Maranon</affilname><name-variant>Hospital General Universitario Gregorio Marañón</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019295</affiliation-url><afid>60019295</afid><affilname>Karolinska University Hospital</affilname><name-variant>Karolinska University Hospital</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068729</affiliation-url><afid>60068729</afid><affilname>Ulleval University Hospital</affilname><name-variant>Ullevaal University Hospital</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004839362</author-url><authid>7004839362</authid><authname>Tornvall P.</authname><surname>Tornvall</surname><given-name>P.</given-name><initials>P.</initials><afid>60012311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23088540600</author-url><authid>23088540600</authid><authname>Gerbaud E.</authname><surname>Gerbaud</surname><given-name>E.</given-name><initials>E.</initials><afid>60003434</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54934478100</author-url><authid>54934478100</authid><authname>Behaghel A.</authname><surname>Behaghel</surname><given-name>A.</given-name><initials>A.</initials><afid>60030553</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25521307600</author-url><authid>25521307600</authid><authname>Chopard R.</authname><surname>Chopard</surname><given-name>R.</given-name><initials>R.</initials><afid>109984842</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55326292900</author-url><authid>55326292900</authid><authname>Collste O.</authname><surname>Collste</surname><given-name>O.</given-name><initials>O.</initials><afid>60012311</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56624346500</author-url><authid>56624346500</authid><authname>Laraudogoitia E.</authname><surname>Laraudogoitia</surname><given-name>E.</given-name><initials>E.</initials><afid>60009681</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:25628168800</author-url><authid>25628168800</authid><authname>Leurent G.</authname><surname>Leurent</surname><given-name>G.</given-name><initials>G.</initials><afid>60030553</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55820664600</author-url><authid>55820664600</authid><authname>Meneveau N.</authname><surname>Meneveau</surname><given-name>N.</given-name><initials>N.</initials><afid>109984842</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:15830132600</author-url><authid>15830132600</authid><authname>Montaudon M.</authname><surname>Montaudon</surname><given-name>M.</given-name><initials>M.</initials><afid>60003434</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6602244699</author-url><authid>6602244699</authid><authname>Perez-David E.</authname><surname>Perez-David</surname><given-name>E.</given-name><initials>E.</initials><afid>60033237</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35957379400</author-url><authid>35957379400</authid><authname>Sörensson P.</authname><surname>Sörensson</surname><given-name>P.</given-name><initials>P.</initials><afid>60019295</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7006435302</author-url><authid>7006435302</authid><authname>Agewall S.</authname><surname>Agewall</surname><given-name>S.</given-name><initials>S.</initials><afid>60068729</afid></author><authkeywords>Cardiac magnetic resonance imaging | Infarction | Myocardial infarction | Myocarditis | Normal coronary angiography</authkeywords><intid>1785877203</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929156061"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929156061?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929156061&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929156061&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008141"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929156061</prism:url><dc:identifier>SCOPUS_ID:84929156061</dc:identifier><eid>2-s2.0-84929156061</eid><dc:title>Diagnostic performance of myocardial perfusion imaging with SPECT, CT and MR compared to fractional flow reserve as reference standard</dc:title><dc:creator>Yang Z.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>103-105</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.091</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073564</affiliation-url><afid>60073564</afid><affilname>General Hospital of Jinan Military Command</affilname><name-variant>General Hospital of PLA</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073564</affiliation-url><afid>60073564</afid><affilname>General Hospital of Jinan Military Command</affilname><name-variant>General Hospital of PLA</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113245468</affiliation-url><afid>113245468</afid><affilname>Laiwu City People's Hospital</affilname><name-variant>Laiwu City People's Hospital</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105815681</affiliation-url><afid>105815681</afid><affilname>Jinan Maternity and Child Care Hospital</affilname><name-variant>Jinan Maternal and Child Care Hospital</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073564</affiliation-url><afid>60073564</afid><affilname>General Hospital of Jinan Military Command</affilname><name-variant>General Hospital of PLA</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101872142</affiliation-url><afid>101872142</afid><affilname>Institute of Drug and Instrument Control</affilname><name-variant>Institute of Drug and Instrument Control of Jinan Military Area Command</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56442876600</author-url><authid>56442876600</authid><authname>Yang Z.</authname><surname>Yang</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60073564</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56449764100</author-url><authid>56449764100</authid><authname>Zheng H.</authname><surname>Zheng</surname><given-name>Hong</given-name><initials>H.</initials><afid>60073564</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56395908100</author-url><authid>56395908100</authid><authname>Zhou T.</authname><surname>Zhou</surname><given-name>Tao</given-name><initials>T.</initials><afid>113245468</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640094300</author-url><authid>56640094300</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Lin Feng</given-name><initials>L.F.</initials><afid>105815681</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640141300</author-url><authid>56640141300</authid><authname>Hu X.</authname><surname>Hu</surname><given-name>Xiao Fang</given-name><initials>X.F.</initials><afid>60073564</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37102296300</author-url><authid>37102296300</authid><authname>Peng Z.</authname><surname>Peng</surname><given-name>Zhao Hui</given-name><initials>Z.H.</initials><afid>60073564</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56640104200</author-url><authid>56640104200</authid><authname>Jiang Y.</authname><surname>Jiang</surname><given-name>Yu Zhu</given-name><initials>Y.Z.</initials><afid>101872142</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:26643373500</author-url><authid>26643373500</authid><authname>Li M.</authname><surname>Li</surname><given-name>Min</given-name><initials>M.</initials><afid>60073564</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35784996900</author-url><authid>35784996900</authid><authname>Sun G.</authname><surname>Sun</surname><given-name>Gang</given-name><initials>G.</initials><afid>60073564</afid></author><authkeywords>Computed tomography | Coronary disease | Fractional flow reserve | Magnetic resonance perfusion | Single-photon emission computed tomography</authkeywords><intid>2035913072</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929223323"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929223323?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929223323&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929223323&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008293"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929223323</prism:url><dc:identifier>SCOPUS_ID:84929223323</dc:identifier><eid>2-s2.0-84929223323</eid><dc:title>Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?</dc:title><dc:creator>Lidani K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>233-235</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.106</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015043</affiliation-url><afid>60015043</afid><affilname>Universidade Federal do Parana</affilname><name-variant>Universidade Federal do Paraná</name-variant><affiliation-city>Curitiba</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55604098800</author-url><authid>55604098800</authid><authname>Lidani K.</authname><surname>Lidani</surname><given-name>Kárita Cláudia Freitas</given-name><initials>K.C.F.</initials><afid>60015043</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36645718100</author-url><authid>36645718100</authid><authname>Beltrame M.</authname><surname>Beltrame</surname><given-name>Marcia Holsbach</given-name><initials>M.H.</initials><afid>60015043</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36902236800</author-url><authid>36902236800</authid><authname>Luz P.</authname><surname>Luz</surname><given-name>Paola Rosa</given-name><initials>P.R.</initials><afid>60015043</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36136319300</author-url><authid>36136319300</authid><authname>Sandri T.</authname><surname>Sandri</surname><given-name>Thaisa Lucas</given-name><initials>T.L.</initials><afid>60015043</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603660359</author-url><authid>6603660359</authid><authname>Nisihara R.</authname><surname>Nisihara</surname><given-name>Renato Mitsunori</given-name><initials>R.M.</initials><afid>60015043</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56641849200</author-url><authid>56641849200</authid><authname>De Messias-Reaso I.</authname><surname>De Messias-Reaso</surname><given-name>Iara José</given-name><initials>I.J.</initials><afid>60015043</afid></author><authkeywords>Cardiomyopathy | Chagas disease | Pentraxin 3</authkeywords><intid>1535915889</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929305046"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929305046?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929305046&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929305046&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0024320515002180"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929305046</prism:url><dc:identifier>SCOPUS_ID:84929305046</dc:identifier><eid>2-s2.0-84929305046</eid><dc:title>Proliferation of rat cardiac stem cells is induced by 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside in vitro</dc:title><dc:creator>Song F.</dc:creator><prism:publicationName>Life Sciences</prism:publicationName><prism:issn>00243205</prism:issn><prism:eIssn>18790631</prism:eIssn><prism:volume>132</prism:volume><prism:pageRange>68-76</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.lfs.2015.04.001</prism:doi><pii>S0024320515002180</pii><dc:description>© 2015 Elsevier Inc. Abstract Aim To study the effects of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-d-glucoside (THSG) on proliferation of rat cardiac stem cells (CSCs) in vitro. Materials and methods C-kit&lt;sup&gt;+&lt;/sup&gt; cells were isolated from neonatal (1 day old) Sprague-Dawley rats by using flow cytometry. Optimal THSG treatment times and doses for growth of CSCs were analyzed. CSCs were treated with various THSG doses (0, 1, 10, and 100 μM) for 12 h. Results Sorted c-kit&lt;sup&gt;+&lt;/sup&gt; cells exhibited self-renewing and clonogenic capabilities. Cell Counting Kit (CCK-8) and Proliferating Cell Nuclear Antigen (PCNA) ELISA test positive cells were significantly increased in THSG-treated groups compared with untreated controls. The percentage of S-phase cells also increased after THSG treatment. Moreover, we show that some c-kit&lt;sup&gt;+&lt;/sup&gt; cells spontaneously express vascular endothelial growth factor (VEGF), T-box transcription factor (Tbx5), hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2), hyperpolarization-activated cyclic nucleotide gated 4 (HCN4), alpha myosin heavy chain (αMHC), and beta myosin heavy chain (βMHC) mRNA, and stem cell antigen 1 (Sca-1), cardiac troponin-I, GATA-4, Nkx2.5, and connexin 43 protein were also assessed in CSCs. However, their expression was significantly increased with THSG treatment when compared to untreated controls. Conclusion THSG can increase proliferation of rat CSCs in vitro and thus, shows promise as a potential treatment strategy for stimulating endogenous stem cells to help repair the injured heart after myocardial infarction in patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088187</affiliation-url><afid>60088187</afid><affilname>The Fourth Military Medical University</affilname><name-variant>Fourth Military Medical University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088187</affiliation-url><afid>60088187</afid><affilname>The Fourth Military Medical University</affilname><name-variant>Fourth Military Medical University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55857753400</author-url><authid>55857753400</authid><authname>Song F.</authname><surname>Song</surname><given-name>Fan</given-name><initials>F.</initials><afid>60088187</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56438227600</author-url><authid>56438227600</authid><authname>Zhao J.</authname><surname>Zhao</surname><given-name>Jing</given-name><initials>J.</initials><afid>60088187</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644223900</author-url><authid>56644223900</authid><authname>Hua F.</authname><surname>Hua</surname><given-name>Fei</given-name><initials>F.</initials><afid>60088187</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56439848400</author-url><authid>56439848400</authid><authname>Nian L.</authname><surname>Nian</surname><given-name>Lun</given-name><initials>L.</initials><afid>60088187</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643300700</author-url><authid>56643300700</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xuan Xuan</given-name><initials>X.X.</initials><afid>60088187</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56320264400</author-url><authid>56320264400</authid><authname>Yang Q.</authname><surname>Yang</surname><given-name>Qian</given-name><initials>Q.</initials><afid>60088187</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56477678800</author-url><authid>56477678800</authid><authname>Xie Y.</authname><surname>Xie</surname><given-name>Yan Hua</given-name><initials>Y.H.</initials><afid>60088187</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56565905600</author-url><authid>56565905600</authid><authname>Tang H.</authname><surname>Tang</surname><given-name>Hai Feng</given-name><initials>H.F.</initials><afid>60088187</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:10640971300</author-url><authid>10640971300</authid><authname>Sun J.</authname><surname>Sun</surname><given-name>Ji Yuan</given-name><initials>J.Y.</initials><afid>60088187</afid><afid>60088187</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:10640971300</author-url><authid>10640971300</authid><authname>Sun J.</authname><surname>Sun</surname><given-name>Ji Yuan</given-name><initials>J.Y.</initials><afid>60088187</afid><afid>60088187</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7410338693</author-url><authid>7410338693</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Si Wang</given-name><initials>S.W.</initials><afid>60088187</afid><afid>60088187</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7410338693</author-url><authid>7410338693</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Si Wang</given-name><initials>S.W.</initials><afid>60088187</afid><afid>60088187</afid></author><authkeywords>2, 3, 5, 4′-Tetrahydroxystilbene-2-O-β-d-glucoside proliferation | Cardiac stem cells | Myocardial infarction</authkeywords><intid>535947200</intid><article-number>14352</article-number><source-id>20473</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928503313"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928503313?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928503313&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928503313&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S174680941500052X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928503313</prism:url><dc:identifier>SCOPUS_ID:84928503313</dc:identifier><eid>2-s2.0-84928503313</eid><dc:title>Robust decentralised control of a hydrodynamic human circulatory system simulator</dc:title><dc:creator>Misgeld B.</dc:creator><prism:publicationName>Biomedical Signal Processing and Control</prism:publicationName><prism:issn>17468094</prism:issn><prism:eIssn>17468108</prism:eIssn><prism:volume>20</prism:volume><prism:pageRange>35-44</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bspc.2015.04.004</prism:doi><pii>S174680941500052X</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. A novel feedback controlled hydrodynamic human circulatory system simulator, well-suited for in-vitro validation of cardiac assist devices, is presented in this paper. The cardiovascular system simulator consists of high-bandwidth actuators allowing a high precision hardware-in-the-loop hydrodynamic interface in connection with physiological circulatory models calculated in real-time. The hydrodynamically coupled process dynamics consist of several actuator loops and demand a multivariable control design approach in the face of system nonlinearities and uncertainties. Based on a detailed model employing the Lagrange formalism, a robust decentralised controller is designed. Fixed structural constraints and the minimisation of the H&lt;inf&gt;∞&lt;/inf&gt;-norm necessitate the application of nonsmooth optimisation techniques. The robust decentralised norm-optimal controller is tested in extensive in-vitro experiments and shows good performance with regard to reference tracking and system coupling. In-vitro experiments include multivariable reference step tests and frequency analysis tests of the vascular impedance transfer function.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016653</affiliation-url><afid>60016653</afid><affilname>Rheinisch-Westfalische Technische Hochschule Aachen</affilname><name-variant>RWTH Aachen</name-variant><affiliation-city>Aachen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108364031</affiliation-url><afid>108364031</afid><affilname>Bytec Medizintechnik GmbH</affilname><name-variant>BYTEC Medizintechnik GmbH</name-variant><affiliation-city/><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60078396</affiliation-url><afid>60078396</afid><affilname>Fresenius Medical Care AG &amp; Co. KGaA</affilname><name-variant>Fresenius Medical Care Deutschland GmbH</name-variant><affiliation-city>Bad Homburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6504592448</author-url><authid>6504592448</authid><authname>Misgeld B.</authname><surname>Misgeld</surname><given-name>Berno J E</given-name><initials>B.J.E.</initials><afid>60016653</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55975446700</author-url><authid>55975446700</authid><authname>Rüschen D.</authname><surname>Rüschen</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60016653</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:48061454700</author-url><authid>48061454700</authid><authname>Schwandtner S.</authname><surname>Schwandtner</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60016653</afid><afid>108364031</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:48061454700</author-url><authid>48061454700</authid><authname>Schwandtner S.</authname><surname>Schwandtner</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60016653</afid><afid>108364031</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24399166100</author-url><authid>24399166100</authid><authname>Heinke S.</authname><surname>Heinke</surname><given-name>Stefanie</given-name><initials>S.</initials><afid>60078396</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23390792200</author-url><authid>23390792200</authid><authname>Walter M.</authname><surname>Walter</surname><given-name>Marian</given-name><initials>M.</initials><afid>60016653</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004971042</author-url><authid>7004971042</authid><authname>Leonhardt S.</authname><surname>Leonhardt</surname><given-name>Steffen</given-name><initials>S.</initials><afid>60016653</afid></author><authkeywords>Hardware-in-the-loop | Mock circulatory loop | Multivariable control | Robust control | Ventricular assist device</authkeywords><intid>1535793038</intid><source-id>4700152237</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928729308"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928729308?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928729308&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928729308&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0013935115001280"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928729308</prism:url><dc:identifier>SCOPUS_ID:84928729308</dc:identifier><eid>2-s2.0-84928729308</eid><dc:title>Land use regression models for crustal and traffic-related PM&lt;inf&gt;2.5&lt;/inf&gt; constituents in four areas of the SAPALDIA study</dc:title><dc:creator>Aguilera I.</dc:creator><prism:publicationName>Environmental Research</prism:publicationName><prism:issn>00139351</prism:issn><prism:eIssn>10960953</prism:eIssn><prism:volume>140</prism:volume><prism:pageRange>377-384</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envres.2015.04.011</prism:doi><pii>S0013935115001280</pii><dc:description>© 2015 Elsevier Inc. Many studies have documented adverse health effects of long-term exposure to fine particulate matter (PM&lt;inf&gt;2.5&lt;/inf&gt;), but there is still limited knowledge regarding the causal relationship between specific sources of PM&lt;inf&gt;2.5&lt;/inf&gt; and such health effects. The spatial variability of PM&lt;inf&gt;2.5&lt;/inf&gt; constituents and sources, as a exposure assessment strategy for investigating source contributions to health effects, has been little explored so far.Between 2011 and 2012, three measurement campaigns of PM and nitrogen dioxide (NO&lt;inf&gt;2&lt;/inf&gt;) were performed in 80 sites across four areas of the Swiss Study on Air Pollution and Lung and heart Diseases in Adults (SAPALDIA). Reflectance analysis and energy dispersive X-ray fluorescence (XRF) were performed on PM&lt;inf&gt;2.5&lt;/inf&gt; filter samples to estimate light absorbance and trace element concentrations, respectively. Three air pollution source factors were identified using principal-component factor analysis: vehicular, crustal, and long-range transport. Land use regression (LUR) models were developed for temporally-adjusted scores of each factor, combining the four study areas. Model performance was assessed using two cross-validation methods.Model explained variance was high for the vehicular factor (R&lt;sup&gt;2&lt;/sup&gt;=0.76), moderate for the crustal factor (R&lt;sup&gt;2&lt;/sup&gt;=0.46), and low for the long-range transport factor (R&lt;sup&gt;2&lt;/sup&gt;=0.19). The cross-validation methods suggested that models for the vehicular and crustal factors moderately accounted for both the between and within-area variability, and therefore can be applied to the four study areas to estimate long-term exposures within the SAPALDIA study population.The combination of source apportionment techniques and LUR modelling may help in identifying air pollution sources and disentangling their contribution to observed health effects in epidemiologic studies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023146</affiliation-url><afid>60023146</afid><affilname>Swiss Tropical and Public Health Institute (Swiss TPH)</affilname><name-variant>Swiss Tropical Institute</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60081591</affiliation-url><afid>60081591</afid><affilname>Indian Institute of Technology Bombay, Centre for Environmental Science and Engineering</affilname><name-variant>Indian Institute of Technology Bombay</name-variant><affiliation-city>Mumbai</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015481</affiliation-url><afid>60015481</afid><affilname>University of Washington Seattle</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">22</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23487806800</author-url><authid>23487806800</authid><authname>Aguilera I.</authname><surname>Aguilera</surname><given-name>Inmaculada</given-name><initials>I.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23487806800</author-url><authid>23487806800</authid><authname>Aguilera I.</authname><surname>Aguilera</surname><given-name>Inmaculada</given-name><initials>I.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36898240000</author-url><authid>36898240000</authid><authname>Eeftens M.</authname><surname>Eeftens</surname><given-name>Marloes</given-name><initials>M.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36898240000</author-url><authid>36898240000</authid><authname>Eeftens M.</authname><surname>Eeftens</surname><given-name>Marloes</given-name><initials>M.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56514674800</author-url><authid>56514674800</authid><authname>Meier R.</authname><surname>Meier</surname><given-name>Reto</given-name><initials>R.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56514674800</author-url><authid>56514674800</authid><authname>Meier R.</authname><surname>Meier</surname><given-name>Reto</given-name><initials>R.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26537429600</author-url><authid>26537429600</authid><authname>Ducret-Stich R.</authname><surname>Ducret-Stich</surname><given-name>Regina E.</given-name><initials>R.E.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26537429600</author-url><authid>26537429600</authid><authname>Ducret-Stich R.</authname><surname>Ducret-Stich</surname><given-name>Regina E.</given-name><initials>R.E.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7409908587</author-url><authid>7409908587</authid><authname>Schindler C.</authname><surname>Schindler</surname><given-name>Christian</given-name><initials>C.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7409908587</author-url><authid>7409908587</authid><authname>Schindler C.</authname><surname>Schindler</surname><given-name>Christian</given-name><initials>C.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26537497100</author-url><authid>26537497100</authid><authname>Ineichen A.</authname><surname>Ineichen</surname><given-name>Alex</given-name><initials>A.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26537497100</author-url><authid>26537497100</authid><authname>Ineichen A.</authname><surname>Ineichen</surname><given-name>Alex</given-name><initials>A.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:9742746000</author-url><authid>9742746000</authid><authname>Phuleria H.</authname><surname>Phuleria</surname><given-name>Harish C.</given-name><initials>H.C.</initials><afid>60023146</afid><afid>60023588</afid><afid>60081591</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:9742746000</author-url><authid>9742746000</authid><authname>Phuleria H.</authname><surname>Phuleria</surname><given-name>Harish C.</given-name><initials>H.C.</initials><afid>60023146</afid><afid>60023588</afid><afid>60081591</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:9742746000</author-url><authid>9742746000</authid><authname>Phuleria H.</authname><surname>Phuleria</surname><given-name>Harish C.</given-name><initials>H.C.</initials><afid>60023146</afid><afid>60023588</afid><afid>60081591</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603739830</author-url><authid>6603739830</authid><authname>Probst-Hensch N.</authname><surname>Probst-Hensch</surname><given-name>Nicole</given-name><initials>N.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603739830</author-url><authid>6603739830</authid><authname>Probst-Hensch N.</authname><surname>Probst-Hensch</surname><given-name>Nicole</given-name><initials>N.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36752454900</author-url><authid>36752454900</authid><authname>Tsai M.</authname><surname>Tsai</surname><given-name>Ming Yi</given-name><initials>M.Y.</initials><afid>60023146</afid><afid>60023588</afid><afid>60015481</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36752454900</author-url><authid>36752454900</authid><authname>Tsai M.</authname><surname>Tsai</surname><given-name>Ming Yi</given-name><initials>M.Y.</initials><afid>60023146</afid><afid>60023588</afid><afid>60015481</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36752454900</author-url><authid>36752454900</authid><authname>Tsai M.</authname><surname>Tsai</surname><given-name>Ming Yi</given-name><initials>M.Y.</initials><afid>60023146</afid><afid>60023588</afid><afid>60015481</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7006806977</author-url><authid>7006806977</authid><authname>Künzli N.</authname><surname>Künzli</surname><given-name>Nino</given-name><initials>N.</initials><afid>60023146</afid><afid>60023588</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7006806977</author-url><authid>7006806977</authid><authname>Künzli N.</authname><surname>Künzli</surname><given-name>Nino</given-name><initials>N.</initials><afid>60023146</afid><afid>60023588</afid></author><authkeywords>Factor analysis | Land use regression | PM&lt;inf&gt;2.5&lt;/inf&gt; | Sapaldia | Source apportionment</authkeywords><intid>1785840728</intid><source-id>21524</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927734155"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927734155?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927734155&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927734155&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1043661815000596"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927734155</prism:url><dc:identifier>SCOPUS_ID:84927734155</dc:identifier><eid>2-s2.0-84927734155</eid><dc:title>Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study</dc:title><dc:creator>Campo G.</dc:creator><prism:publicationName>Pharmacological Research</prism:publicationName><prism:issn>10436618</prism:issn><prism:eIssn>10961186</prism:eIssn><prism:volume>97</prism:volume><prism:pageRange>1-6</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.phrs.2015.03.020</prism:doi><pii>S1043661815000596</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Verbascoside, a phenolic compound, showed several favorable biological activities, including an antiplatelet activity. No in vivo studies tested its efficacy and safety in subjects with cardiovascular (CV) factors. The aim of this randomized, single-center, double-blind, phase II study was to assess the efficacy and tolerability of verbascoside intake for the modulation of platelet aggregation (PA) values in subjects with cardiovascular (CV) risk factors. One-hundred subjects with at least one CV risk factor (age &gt;65 years, diabetes mellitus, hypertension, current cigarettes use, hyperlidemia, waist circumference &gt;102 cm in male or &gt;88 cm in female) were enrolled and randomly assigned to receive placebo or verbascoside 50 mg or verbascoside 100 mg. PA was measured at baseline and after 2 weeks of study drug assumption, with light transmittance aggregometry (arachidonic acid, AA, 1 μM and adenosine diphosphate, ADP, 5 μM). Two weeks of treatment with placebo or verbascoside 50 mg did not modify PA values (both after AA and ADP stimuli). On the contrary, after 2 weeks of verbascoside 100 mg, PA values decreased significantly (from 51 ± 13% to 39 ± 15%, p &lt; 0.01 after AA; from 60 ± 12% to 49 ± 15%, p = 0.01 after ADP). No serious adverse events were reported during the study, and no subjects discontinued the study because of adverse events. We conclude that long-term intake of verbascoside 100 mg significantly reduces PA values in subjects with CV risk factors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105702717</affiliation-url><afid>105702717</afid><affilname>Cardiovascular Institute</affilname><name-variant>Cardiovascular Institute</name-variant><affiliation-city>Ferarra</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113158179</affiliation-url><afid>113158179</afid><affilname>Laboratorio per le Tecnologie Delle Terapie Avanzate Center</affilname><name-variant>Laboratorio Per le Tecnologie Delle Terapie Avanzate Center</name-variant><affiliation-city>Ferarra</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112945663</affiliation-url><afid>112945663</afid><affilname>E.S. Health Science Foundation</affilname><name-variant>E.S. Health Science Foundation</name-variant><affiliation-city>Cotignola</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8937083300</author-url><authid>8937083300</authid><authname>Campo G.</authname><surname>Campo</surname><given-name>Gianluca</given-name><initials>G.</initials><afid>105702717</afid><afid>113158179</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8937083300</author-url><authid>8937083300</authid><authname>Campo G.</authname><surname>Campo</surname><given-name>Gianluca</given-name><initials>G.</initials><afid>105702717</afid><afid>113158179</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55245988000</author-url><authid>55245988000</authid><authname>Pavasini R.</authname><surname>Pavasini</surname><given-name>Rita</given-name><initials>R.</initials><afid>105702717</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55572240700</author-url><authid>55572240700</authid><authname>Biscaglia S.</authname><surname>Biscaglia</surname><given-name>Simone</given-name><initials>S.</initials><afid>105702717</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56594557100</author-url><authid>56594557100</authid><authname>Ferri A.</authname><surname>Ferri</surname><given-name>Alessandra</given-name><initials>A.</initials><afid>105702717</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56574294500</author-url><authid>56574294500</authid><authname>Andrenacci E.</authname><surname>Andrenacci</surname><given-name>Elisa</given-name><initials>E.</initials><afid>105702717</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:21234353100</author-url><authid>21234353100</authid><authname>Tebaldi M.</authname><surname>Tebaldi</surname><given-name>Matteo</given-name><initials>M.</initials><afid>105702717</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36047514600</author-url><authid>36047514600</authid><authname>Ferrari R.</authname><surname>Ferrari</surname><given-name>Roberto</given-name><initials>R.</initials><afid>105702717</afid><afid>113158179</afid><afid>112945663</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36047514600</author-url><authid>36047514600</authid><authname>Ferrari R.</authname><surname>Ferrari</surname><given-name>Roberto</given-name><initials>R.</initials><afid>105702717</afid><afid>113158179</afid><afid>112945663</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36047514600</author-url><authid>36047514600</authid><authname>Ferrari R.</authname><surname>Ferrari</surname><given-name>Roberto</given-name><initials>R.</initials><afid>105702717</afid><afid>113158179</afid><afid>112945663</afid></author><authkeywords>Aspirin | Cardiovascular risk factors | Light transmission aggregometry | Platelet aggregation | Verbascoside</authkeywords><intid>1035662611</intid><article-number>2808</article-number><source-id>21169</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925740927"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925740927?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925740927&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925740927&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0309174015000492"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925740927</prism:url><dc:identifier>SCOPUS_ID:84925740927</dc:identifier><eid>2-s2.0-84925740927</eid><dc:title>Reverse electron transport effects on NADH formation and metmyoglobin reduction</dc:title><dc:creator>Belskie K.</dc:creator><prism:publicationName>Meat Science</prism:publicationName><prism:issn>03091740</prism:issn><prism:volume>105</prism:volume><prism:pageRange>89-92</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.meatsci.2015.02.012</prism:doi><pii>S0309174015000492</pii><dc:description>© 2015 Elsevier Ltd. The objective was to determine if NADH generated via reverse electron flow in beef mitochondria can be used for electron transport-mediated reduction and metmyoglobin reductase pathways. Beef mitochondria were isolated from bovine hearts (n = 5) and reacted with combinations of succinate, NAD, and mitochondrial inhibitors to measure oxygen consumption and NADH formation. Mitochondria and metmyoglobin were reacted with succinate, NAD, and mitochondrial inhibitors to measure electron transport-mediated metmyoglobin reduction and metmyoglobin reductase activity. Addition of succinate and NAD increased oxygen consumption, NADH formation, electron transport-mediated metmyoglobin reduction, and reductase activity (p. &lt;. 0.05). Addition of antimycin A prevented electron flow beyond complex III, therefore, decreasing oxygen consumption and electron transport-mediated metmyoglobin reduction. Addition of rotenone prevented reverse electron flow, increased oxygen consumption, increased electron transport-mediated metmyoglobin reduction, and decreased NADH formation. Succinate and NAD can generate NADH in bovine tissue postmortem via reverse electron flow and this NADH can be used by both electron transport-mediated and metmyoglobin reductase pathways.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022659</affiliation-url><afid>60022659</afid><affilname>University of Connecticut</affilname><name-variant>University of Connecticut</name-variant><affiliation-city>Storrs</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032759</affiliation-url><afid>60032759</afid><affilname>Oklahoma State University System</affilname><name-variant>Oklahoma State University</name-variant><affiliation-city>Stillwater</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56574245200</author-url><authid>56574245200</authid><authname>Belskie K.</authname><surname>Belskie</surname><given-name>K. M.</given-name><initials>K.M.</initials><afid>60022659</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55327684300</author-url><authid>55327684300</authid><authname>Van Buiten C.</authname><surname>Van Buiten</surname><given-name>C. B.</given-name><initials>C.B.</initials><afid>60022659</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23480539000</author-url><authid>23480539000</authid><authname>Ramanathan R.</authname><surname>Ramanathan</surname><given-name>R.</given-name><initials>R.</initials><afid>60032759</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35320191300</author-url><authid>35320191300</authid><authname>Mancini R.</authname><surname>Mancini</surname><given-name>R. A.</given-name><initials>R.A.</initials><afid>60022659</afid></author><authkeywords>Meat color | Metmyoglobin reduction | Mitochondria | Myoglobin | Oxygen consumption</authkeywords><intid>1035343840</intid><source-id>21219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927933336"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927933336?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927933336&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927933336&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915001106"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927933336</prism:url><dc:identifier>SCOPUS_ID:84927933336</dc:identifier><eid>2-s2.0-84927933336</eid><dc:title>Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting Mitochondrial Transcription Factor A (TFAM)</dc:title><dc:creator>Quiñones-Lombraña A.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1420-1427</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.04.004</prism:doi><pii>S0925443915001106</pii><dc:description>© 2015 Elsevier B.V. The regulation of mitochondrial biogenesis is under the control of nuclear genes including the master Mitochondrial Transcription Factor A (. TFAM). Recent evidence suggests that the expression of TFAM is regulated by microRNAs (miRNAs) in various cellular contexts. Here, we show that hsa-. miR-. 155-. 5p, a prominent miRNA encoded in chromosome 21, controls the expression of TFAM at the post-transcriptional level. In human fibroblasts derived from a diploid donor, downregulation of TFAM by hsa-. miR-. 155-. 5p decreased mitochondrial DNA (mtDNA) content. In contrast, downregulation of TFAM by hsa-. miR-. 155-. 5p did not decrease mtDNA content in fibroblasts derived from a donor with Down syndrome (DS, trisomy 21). In line, downregulation of mitochondrial TFAM levels through hsa-. miR-. 155-. 5p decreased mitochondrial mass in diploid fibroblasts but not in trisomic cells. Due to the prevalence of mitochondrial dysfunction and cardiac abnormalities in subjects with DS, we examined the presence of potential associations between hsa-. miR-. 155-. 5p and TFAM expression in heart samples from donors with and without DS. There were significant negative associations between hsa-. miR-. 155-. 5p and TFAM expression in heart samples from donors with and without DS. These results suggest that regulation of TFAM by hsa-. miR-. 155-. 5p impacts mitochondrial biogenesis in the diploid setting but not in the DS setting.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032083</affiliation-url><afid>60032083</afid><affilname>University at Buffalo State University of New York</affilname><name-variant>State University of New York at Buffalo</name-variant><affiliation-city>Buffalo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24333105600</author-url><authid>24333105600</authid><authname>Quiñones-Lombraña A.</authname><surname>Quiñones-Lombraña</surname><given-name>Adolfo</given-name><initials>A.</initials><afid>60032083</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402723572</author-url><authid>7402723572</authid><authname>Blanco J.</authname><surname>Blanco</surname><given-name>Javier G.</given-name><initials>J.G.</initials><afid>60032083</afid></author><authkeywords>Down syndrome | Hsa-miR-155-5p | Mitochondrial biogenesis | TFAM</authkeywords><intid>535702022</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929193457"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929193457?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929193457&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929193457&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009171"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929193457</prism:url><dc:identifier>SCOPUS_ID:84929193457</dc:identifier><eid>2-s2.0-84929193457</eid><dc:title>Extreme prolongation of sinus node recovery time in a coronary artery disease patient</dc:title><dc:creator>Dilaveris P.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>260-261</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.184</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003720</affiliation-url><afid>60003720</afid><affilname>Hippokration General Hospital</affilname><name-variant>Hippokration General Hospital</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003329632</author-url><authid>7003329632</authid><authname>Dilaveris P.</authname><surname>Dilaveris</surname><given-name>Polychronis</given-name><initials>P.</initials><afid>60003720</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004175719</author-url><authid>7004175719</authid><authname>Tsioufis C.</authname><surname>Tsioufis</surname><given-name>Costas</given-name><initials>C.</initials><afid>60003720</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003575589</author-url><authid>7003575589</authid><authname>Gatzoulis K.</authname><surname>Gatzoulis</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>60003720</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35399054300</author-url><authid>35399054300</authid><authname>Tousoulis D.</authname><surname>Tousoulis</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60003720</afid></author><authkeywords>Coronary artery disease | Sick sinus syndrome | Sinus node recovery time</authkeywords><intid>2035910632</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929162626"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929162626?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929162626&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929162626&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008827"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929162626</prism:url><dc:identifier>SCOPUS_ID:84929162626</dc:identifier><eid>2-s2.0-84929162626</eid><dc:title>High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A significant association beyond definitions</dc:title><dc:creator>Mangiacapra F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>124-125</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.158</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Campus Bio-Medico University</affilname><name-variant>Department of Cardiovascular Sciences</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068582</affiliation-url><afid>60068582</afid><affilname>Cardiovascular Center of Aalst</affilname><name-variant>Cardiovascular Center</name-variant><affiliation-city>Aalst</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24780790600</author-url><authid>24780790600</authid><authname>Mangiacapra F.</authname><surname>Mangiacapra</surname><given-name>Fabio</given-name><initials>F.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56023619700</author-url><authid>56023619700</authid><authname>Cavallari I.</authname><surname>Cavallari</surname><given-name>Ilaria</given-name><initials>I.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35741641000</author-url><authid>35741641000</authid><authname>Ricottini E.</authname><surname>Ricottini</surname><given-name>Elisabetta</given-name><initials>E.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55255982800</author-url><authid>55255982800</authid><authname>Pellicano M.</authname><surname>Pellicano</surname><given-name>Mariano</given-name><initials>M.</initials><afid>60068582</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003518203</author-url><authid>7003518203</authid><authname>Barbato E.</authname><surname>Barbato</surname><given-name>Emanuele</given-name><initials>E.</initials><afid>60068582</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006231137</author-url><authid>7006231137</authid><authname>Di Sciascio G.</authname><surname>Di Sciascio</surname><given-name>Germano</given-name><initials>G.</initials><afid/></author><authkeywords>Percutaneous coronary intervention | Periprocedural myocardial infarction | Platelet reactivity</authkeywords><intid>35915494</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927560405"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927560405?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927560405&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927560405&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1752928X15000529"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927560405</prism:url><dc:identifier>SCOPUS_ID:84927560405</dc:identifier><eid>2-s2.0-84927560405</eid><dc:title>Physician liability for procedure related injury: Focused on central venous catheterization</dc:title><dc:creator>Lee S.</dc:creator><prism:publicationName>Journal of Forensic and Legal Medicine</prism:publicationName><prism:issn>1752928X</prism:issn><prism:eIssn>18787487</prism:eIssn><prism:volume>33</prism:volume><prism:pageRange>20-22</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jflm.2015.03.010</prism:doi><pii>S1752928X15000529</pii><dc:description>© 2015 Elsevier Ltd and Faculty of Forensic and Legal Medicine. Central venous catheterization (CVC) is one of essential procedures in critical care medicine. CVC is relatively safe when performed by experienced physicians. Complications may occur due to various risk factors. Although the incidence of CVC-related complications is not high, a serious risk may ensue in cases of such complications. Procedure related complications could lead to civil and criminal lawsuits. This study reviewed the occurrence patterns and rulings of the courts related to CVC in South Korea and tried to find pitfalls that medical professionals should keep in mind before, during and after medical procedures. Various patterns of CVC-related lawsuits have been raised. During the procedure, physicians should perform their duty considering risk factors such as patients' underlying diseases and age. In addition, before the procedure, physicians must obtain written consent for CVC from patients or their legal guardians including explanation of rare complications that could be lethal. After the completion of CVC, surveillance of anticipated complications including chest radiographs should be conducted for the immediate management of any possible complications.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002877</affiliation-url><afid>60002877</afid><affilname>Dankook University</affilname><name-variant>Dankook University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001018</affiliation-url><afid>60001018</afid><affilname>Ewha Womans University</affilname><name-variant>Ewha Womans University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014237</affiliation-url><afid>60014237</afid><affilname>Chung-Ang University</affilname><name-variant>Chung-Ang University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56589245900</author-url><authid>56589245900</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Seok Bae</given-name><initials>S.B.</initials><afid>60002877</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23974584000</author-url><authid>23974584000</authid><authname>Bae H.</authname><surname>Bae</surname><given-name>Hyuna</given-name><initials>H.</initials><afid>60001018</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56589227200</author-url><authid>56589227200</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Sung Eun</given-name><initials>S.E.</initials><afid>60014237</afid></author><authkeywords>CVC(central venous catheterization) | Liability | Malpractice lawsuit | Procedure related injury</authkeywords><intid>1785636023</intid><source-id>5100154502</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927665356"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927665356?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927665356&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927665356&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306456515000443"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927665356</prism:url><dc:identifier>SCOPUS_ID:84927665356</dc:identifier><eid>2-s2.0-84927665356</eid><dc:title>Ice slurry ingestion reduces both core and facial skin temperatures in a warm environment</dc:title><dc:creator>Onitsuka S.</dc:creator><prism:publicationName>Journal of Thermal Biology</prism:publicationName><prism:issn>03064565</prism:issn><prism:eIssn>18790992</prism:eIssn><prism:volume>51</prism:volume><prism:pageRange>105-109</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jtherbio.2015.03.008</prism:doi><pii>S0306456515000443</pii><dc:description>© 2015 Elsevier Ltd. Internal body cooling by ingesting ice slurry has recently attracted attention. Because ice slurries are ingested through the mouth, it is possible that this results in conductive cooling of the facial skin and brain. However, no studies have investigated this possibility. Thus, the aim of this study was to investigate the effects of ice slurry ingestion on forehead skin temperature at the point of conductive cooling between the forehead skin and brain. Eight male subjects ingested either 7.5g/kg of ice slurry (-1°C; ICE), a cold sports drink (4°C; COOL), or a warm sports drink (37°C; CON) for 15min in a warm environment (30°C, 80% relative humidity). Then, they remained at rest for 1h. As physiological indices, rectal temperature (T&lt;inf&gt;re&lt;/inf&gt;), mean skin temperature, forehead skin temperature (T&lt;inf&gt;head&lt;/inf&gt;), heart rate, nude body mass, and urine specific gravity were measured. Subjective thermal sensation (TS) was measured at 5-min intervals throughout the experiment. With ICE, T&lt;inf&gt;re&lt;/inf&gt; and T&lt;inf&gt;head&lt;/inf&gt; were significantly reduced compared with CON and COOL conditions (p&lt;0.05). The results of the other physiological indices were not significantly different. TS with ICE was significantly lower than that with CON and COOL (p&lt;0.05) and was correlated with T&lt;inf&gt;re&lt;/inf&gt; or T&lt;inf&gt;head&lt;/inf&gt; (p&lt;0.05). These results indicate that ice slurry ingestion may induce conductive cooling between forehead skin and brain, and reduction in core and forehead skin temperature reduced thermal sensation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030788</affiliation-url><afid>60030788</afid><affilname>Hiroshima University</affilname><name-variant>Hiroshima University</name-variant><affiliation-city>Higashihiroshima</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56592511300</author-url><authid>56592511300</authid><authname>Onitsuka S.</authname><surname>Onitsuka</surname><given-name>Sumire</given-name><initials>S.</initials><afid>60030788</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56590942100</author-url><authid>56590942100</authid><authname>Zheng X.</authname><surname>Zheng</surname><given-name>Xinyan</given-name><initials>X.</initials><afid>60030788</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55793187572</author-url><authid>55793187572</authid><authname>Hasegawa H.</authname><surname>Hasegawa</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60030788</afid></author><authkeywords>Cold drink | Conductive cooling | Forehead skin temperature | Ice slurry | Thermal sensation | Thermoregulation</authkeywords><intid>1035644065</intid><source-id>14901</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929178937"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929178937?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929178937&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929178937&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0277953615002749"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929178937</prism:url><dc:identifier>SCOPUS_ID:84929178937</dc:identifier><eid>2-s2.0-84929178937</eid><dc:title>A systematic approach to implementing and evaluating clinical guidelines: The results of fifteen years of Preventive Child Health Care guidelines in the Netherlands</dc:title><dc:creator>Fleuren M.</dc:creator><prism:publicationName>Social Science and Medicine</prism:publicationName><prism:issn>02779536</prism:issn><prism:eIssn>18735347</prism:eIssn><prism:volume>136-137</prism:volume><prism:pageRange>35-43</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.socscimed.2015.05.001</prism:doi><pii>S0277953615002749</pii><dc:description>© 2015 Elsevier Ltd. Preventive Child Health Care (PCHC) services are delivered to all children in the Netherlands by approximately 5500 doctors, nurses and doctor's assistants. In 1996, The Dutch Ministry of Health, Welfare and Sports asked for the development of evidence-based PCHC guidelines. Since 1998, twenty-five guidelines have been published. Levels of implementation affect outcomes and so implementation and evaluation of the actual use of guidelines are essential. At the outset, there was a national implementation plan with six main activities: a) determinant analysis before the implementation of a guideline, b) innovation strategies tailored to the determinants, c) dissemination to all professionals, d) ongoing evaluation of the awareness and use of the guidelines, e) trained implementation coordinator(s) in each PCHC organization and f) a national help desk.The awareness and use of the guidelines in random samples of doctors, nurses and doctor's assistants were surveyed using questionnaires. The respondents stated (on a 7-point scale) the proportion of all children they had exposed to given core elements in a guideline. The aim is for at least 90% of the professionals to be aware of the guideline and for 80% to perform the core elements for all (or nearly all) children. The six main activities, with the exception of ongoing evaluation, were gradually put into place, albeit only gradually, between 1998 and 2015 for all guidelines.In 2012, the use of individual core elements in all guidelines, dating from before 2012, varied from 28% to 100%. One guideline met both criteria of 90% awareness and 80% use, and three guidelines nearly met these criteria.Looking back on fifteen years of PCHC guidelines, we may conclude that the guidelines produced recently are implemented in accordance with the national implementation plan. Unfortunately, the evaluation of guideline use continues to be a difficulty.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019984</affiliation-url><afid>60019984</afid><affilname>Netherlands Organisation for Applied Scientific Research - TNO</affilname><name-variant>TNO</name-variant><affiliation-city>Delft</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115235627</affiliation-url><afid>115235627</afid><affilname>Dutch Centre for Child Health (NCJ)</affilname><name-variant>Dutch Centre for Child Health (NCJ)</name-variant><affiliation-city>Utrecht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603014122</author-url><authid>6603014122</authid><authname>Fleuren M.</authname><surname>Fleuren</surname><given-name>Margot A H</given-name><initials>M.A.H.</initials><afid>60019984</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16417854100</author-url><authid>16417854100</authid><authname>van Dommelen P.</authname><surname>van Dommelen</surname><given-name>Paula</given-name><initials>P.</initials><afid>60019984</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56641641400</author-url><authid>56641641400</authid><authname>Dunnink T.</authname><surname>Dunnink</surname><given-name>Trudy</given-name><initials>T.</initials><afid>115235627</afid></author><authkeywords>Clinical practice guidelines | Determinants | Evaluation | Implementation | Involving stakeholders</authkeywords><intid>1785918571</intid><source-id>18983</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928794703"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928794703?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928794703&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928794703&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303846715000074"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928794703</prism:url><dc:identifier>SCOPUS_ID:84928794703</dc:identifier><eid>2-s2.0-84928794703</eid><dc:title>Risk factors for glioblastoma therapy associated complications</dc:title><dc:creator>Ening G.</dc:creator><prism:publicationName>Clinical Neurology and Neurosurgery</prism:publicationName><prism:issn>03038467</prism:issn><prism:eIssn>18726968</prism:eIssn><prism:volume>134</prism:volume><prism:pageRange>55-59</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clineuro.2015.01.006</prism:doi><pii>S0303846715000074</pii><dc:description>© 2015 Published by Elsevier B.V. Abstract Objective Thromboembolic events, seizures, neurologic symptoms and adverse effects from corticosteroids and chemotherapies are frequent clinical complications seen in Glioblastoma (GB) patients. The exact impact these have on dismal patient outcome has not been fully elucidated. We aimed at assessing treatment associated complications, evaluating the impact on survival and defining risk factors. Methods Two hundred and thirty three consecutive adult patients operated on for newly diagnosed GB at a single tertiary institution over a 5-year-period (2006-2011) were assessed. Demographic parameters (age, gender, comorbidity status quantified by the Charlson-comorbidity-index (CCI), functional status computed by the Karnofsky Performance Scale (KPS), tumor characteristics (size, location, IDH-1 mutation and MGMT-Promotor-methylation-status) and treatment parameters (volumetrically quantified extent of resection and adjuvant therapy) were retrospectively reviewed. Complications assessed were recorded as neurological (N), surgical (S) and medical (M). Independent risk factor analysis was performed by the univariate and multivariate logistic regression method. Survival analysis was plotted by the Kaplan-Meier-method, influence of complication occurrence was evaluated by the log-rank test. Results One hundred and fifty nine (68.2%) patients had a total of 281 complications (90 N, 174 M and 17 S). Univariate analysis identified age (P = 0.003), KPS &lt; 70 (P = 0.002), CCI &gt; 3 (P = 0.03), eloquent tumor location (P = 0.001) and therapy other than the standard radio-chemotherapy with temozolomide therapy (P = 0.034) as risk factors for complications. Multivariate analysis extracted the eloquent tumor location (P = 0.007, odds ratio 1.94) as a significant predictor for complications. Having a complication significantly decreased patient survival (P = 0.015). Conclusions Complications significantly decrease GB patient survival. Age, poor functional status, other than standard adjuvant therapy and eloquent tumor location proved as significant risk factors for encountering a therapy associated complication. Not extensive surgery or tumor size but surgery at eloquent locations impacts complication occurrence the strongest with a 2 fold increased complication occurrence risk.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005322</affiliation-url><afid>60005322</afid><affilname>Universitat Bochum</affilname><name-variant>Ruhr-Universität Bochum</name-variant><affiliation-city>Bochum</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001972</affiliation-url><afid>60001972</afid><affilname>Universitatsklinikum Mannheim</affilname><name-variant>University of Heidelberg</name-variant><affiliation-city>Mannheim</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003280</affiliation-url><afid>60003280</afid><affilname>Universitatsklinikum Heidelberg</affilname><affiliation-city>Heidelberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017059</affiliation-url><afid>60017059</afid><affilname>German Cancer Research Center</affilname><name-variant>German Cancer Research Center (DKFZ)</name-variant><affiliation-city>Heidelberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613451300</author-url><authid>56613451300</authid><authname>Ening G.</authname><surname>Ening</surname><given-name>Genevieve</given-name><initials>G.</initials><afid>60005322</afid><afid>60001972</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613451300</author-url><authid>56613451300</authid><authname>Ening G.</authname><surname>Ening</surname><given-name>Genevieve</given-name><initials>G.</initials><afid>60005322</afid><afid>60001972</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56613427500</author-url><authid>56613427500</authid><authname>Osterheld F.</authname><surname>Osterheld</surname><given-name>Fransiska</given-name><initials>F.</initials><afid>60001972</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8547671300</author-url><authid>8547671300</authid><authname>Capper D.</authname><surname>Capper</surname><given-name>David</given-name><initials>D.</initials><afid>60003280</afid><afid>60017059</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8547671300</author-url><authid>8547671300</authid><authname>Capper D.</authname><surname>Capper</surname><given-name>David</given-name><initials>D.</initials><afid>60003280</afid><afid>60017059</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55208934800</author-url><authid>55208934800</authid><authname>Schmieder K.</authname><surname>Schmieder</surname><given-name>Kirsten</given-name><initials>K.</initials><afid>60005322</afid><afid>60001972</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55208934800</author-url><authid>55208934800</authid><authname>Schmieder K.</authname><surname>Schmieder</surname><given-name>Kirsten</given-name><initials>K.</initials><afid>60005322</afid><afid>60001972</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9038712600</author-url><authid>9038712600</authid><authname>Brenke C.</authname><surname>Brenke</surname><given-name>Christopher</given-name><initials>C.</initials><afid>60005322</afid><afid>60001972</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9038712600</author-url><authid>9038712600</authid><authname>Brenke C.</authname><surname>Brenke</surname><given-name>Christopher</given-name><initials>C.</initials><afid>60005322</afid><afid>60001972</afid></author><authkeywords>Glioblastoma | Medical | Neurological | Surgical complications | Survival</authkeywords><intid>1535850092</intid><article-number>3966</article-number><source-id>14895</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928952792"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928952792?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928952792&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928952792&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S037887411500269X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928952792</prism:url><dc:identifier>SCOPUS_ID:84928952792</dc:identifier><eid>2-s2.0-84928952792</eid><dc:title>Ethnoveterinary plants for the treatment of camels in Shiwalik regions of Kathua district of Jammu &amp; Kashmir, India</dc:title><dc:creator>Sharma R.</dc:creator><prism:publicationName>Journal of Ethnopharmacology</prism:publicationName><prism:issn>03788741</prism:issn><prism:eIssn>18727573</prism:eIssn><prism:volume>169</prism:volume><prism:pageRange>170-175</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jep.2015.04.018</prism:doi><pii>S037887411500269X</pii><dc:description>© 2015 Elsevier Ireland Ltd. Ethnopharmacological relevance Camel is an important mode of transportation in the hot and hilly tracts of Shiwaliks of Kathua districts. The camel owners of the region lack the modern veterinary facilities and therefore depend heavily upon local treatments for the animal. This ethnoveterinary knowledge of plants is acquired by them from their forefathers and generally moves from one generation to another orally. The oral mode of transferring this valuable knowledge is vulnerable to erosion with the passage of time and generations. Material and methods Ethnoveterinary information was collected by interviewing 38 camel keepers and traditional healers as per the questionnaire. The data collected was analysed quantitatively using three indices viz. use-value (UV), informant consensus factor (ICF), and fidelity level (Fl %). Results A total of 41 plants were found to be of ethnoveterinary importance in the present study. Herbs and trees (41.5% each) were the most used life forms. The most used plant part was fruit (27.9%). Rhizome, root and whole plant parts collectively contributed to 18.6%. Most of the ethnoveterinary practices (65.9%) used oral mode of medication. The values of UV and Fl (%) shows that the most important species for curing the ailing camels were Curcuma longa, Trachyspermum ammi, Brassica campestris, Tamarindus indica, Phyllanthus emblica, Cassia fistula, Eruca sativa, Plumbago zeylanica etc. The high values of ICF (0.91-0.99) show that the informants share the knowledge for the treatment of camels amongst themselves on regular basis. Conclusion A good number of plants are utilised by the informants to cure camels. Most of the preparations used fruits and leaves. Only 18.6% of the practices required destructive collection and such species need sustainable use and conservation. Some of the species like Tamarindus indica, Cassia fistula, Eruca sativa, Albizia lebbeck and Citrus medica require further phytochemical and pharmacological studies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031541</affiliation-url><afid>60031541</afid><affilname>University of Jammu</affilname><name-variant>University of Jammu</name-variant><affiliation-city>Jammu</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110041007</affiliation-url><afid>110041007</afid><affilname>Govt. Degree College</affilname><name-variant>Govt. Degree College Pulwama</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55685413700</author-url><authid>55685413700</authid><authname>Sharma R.</authname><surname>Sharma</surname><given-name>R.</given-name><initials>R.</initials><afid>60031541</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55892396500</author-url><authid>55892396500</authid><authname>Manhas R.</authname><surname>Manhas</surname><given-name>R. K.</given-name><initials>R.K.</initials><afid>110041007</afid></author><authkeywords>Camel | Ethnoveterinary | Fidelity level | Informant consensus factor | Shiwaliks | Use-value</authkeywords><intid>1785877084</intid><source-id>23015</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925409326"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925409326?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925409326&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925409326&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715002417"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925409326</prism:url><dc:identifier>SCOPUS_ID:84925409326</dc:identifier><eid>2-s2.0-84925409326</eid><dc:title>Developmental effects of parental exposure to soil contaminated with urban metals</dc:title><dc:creator>Garcia E.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>520</prism:volume><prism:pageRange>206-212</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.02.088</prism:doi><pii>S0048969715002417</pii><dc:description>© 2015 Elsevier B.V. Soil is a highly complex material, and because of rapid population growth, intense industrial activity and petrochemical development, it has suffered from contamination with substances of various origins. These environmental contaminants may have detrimental effects on human health, particularly during development. Due to the ability to transmit contaminants to the fetus, evaluating the effects of exposure of pregnant women on the psychomotor development of their offspring is of particular interest. Therefore, this study aimed to investigate the effects of exposure of female rats to an urban soil influenced by the dispersion of air contaminants during periods of pre-pregnancy, pregnancy and lactation on offspring development. Using physiological, behavioral and hematological parameters, deleterious effects on offspring were assessed. In behavioral parameters, parental exposure during pregnancy and lactation resulted in no significant differences in the evaluated parameters when compared to the control group. In contrast, pups from the pre-pregnancy group displayed decreased locomotor and exploratory activity in addition to increased levels of anxiety. Furthermore, offspring of rats exposed to contaminated urban soil during pre-pregnancy demonstrated significant changes in weight gain and development length and a reduction in the number of platelets compared to controls. Significantly, pups born to mothers exposed to contaminated urban soil during the pregnancy displayed changes in birth weight, weight gain during the growth, development length, incisor eruption and opening of the ears in addition to a reduction in their physical performance and a change in the number of lymphocytes. These results clearly show the negative influence of parental exposure to contaminated urban soil on the general development of the rats during the periods studied. These data indicate that developing organisms are highly sensitive to external factors. Further, they demonstrate the utility of these various biomarkers for identifying and displaying toxic effects of exposure to contaminated soils.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105891680</affiliation-url><afid>105891680</afid><affilname>Universidade Federal do Rio Grande (FURG)</affilname><name-variant>Universidade Federal do Rio Grande - FURG</name-variant><affiliation-city/><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105891680</affiliation-url><afid>105891680</afid><affilname>Universidade Federal do Rio Grande (FURG)</affilname><name-variant>Universidade Federal do Rio Grande - FURG</name-variant><affiliation-city/><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402250152</author-url><authid>7402250152</authid><authname>Garcia E.</authname><surname>Garcia</surname><given-name>Edariane Menestrino</given-name><initials>E.M.</initials><afid>105891680</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26026197900</author-url><authid>26026197900</authid><authname>da Silva Junior F.</authname><surname>da Silva Junior</surname><given-name>Flavio Manoel Rodrigues</given-name><initials>F.M.R.</initials><afid>105891680</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12446744200</author-url><authid>12446744200</authid><authname>Soares M.</authname><surname>Soares</surname><given-name>Maria Cristina Flores</given-name><initials>M.C.F.</initials><afid>105891680</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12445335100</author-url><authid>12445335100</authid><authname>Muccillo-Baisch A.</authname><surname>Muccillo-Baisch</surname><given-name>Ana Luiza</given-name><initials>A.L.</initials><afid>105891680</afid></author><authkeywords>Experimental | Health effects | Soil</authkeywords><intid>1035290930</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928402499"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928402499?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928402499&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928402499&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378874115002184"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928402499</prism:url><dc:identifier>SCOPUS_ID:84928402499</dc:identifier><eid>2-s2.0-84928402499</eid><dc:title>The influence of compatibility of processed radix Aconiti Kusnezoffii on the pharmacokinetic of four components in Glycyrrhiza uralensis Fisch</dc:title><dc:creator>Zhou B.</dc:creator><prism:publicationName>Journal of Ethnopharmacology</prism:publicationName><prism:issn>03788741</prism:issn><prism:eIssn>18727573</prism:eIssn><prism:volume>169</prism:volume><prism:pageRange>1-7</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jep.2015.03.059</prism:doi><pii>S0378874115002184</pii><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Ethnopharmacological relevance Glycyrrhiza uralensis Fisch. and processed radix Aconiti kusnezoffii are the main components in many Chinese traditional patent medicines with the ratio of 1:1, which are used for treatment of rheumatoid arthritis, heart failure and so on. Glycyrrhizic acid, glycyrrhetic acid, liquiritigenin and isoliquiritigenin are the essential bioactive triterpenes and flavones in the extract of G. uralensis, which were analysis by a simple but accurate method. Materials and methods In the present study, a specific HPLC method was developed and validated for simultaneous determination of pharmacokinetic parameters of glycyrrhizic acid, glycyrrhetic acid, liquiritigenin and isoliquiritigenin in G. uralensis after oral administration of single herb extract and a combination of two herbs extracts respectively. Results The calibration curves of the four components had good linearity higher than 0.9991 in the measured range. The intra-day and inter-day precisions (RSD) at different levels were both within 9.73%, and the accuracies (RE) were in the range of -7.9-8.0%. Compared with pharmacokinetic parameters of G. uralensis administered orally, values of AUC and C&lt;inf&gt;max&lt;/inf&gt; of liquiritigenin and isoliquiritigenin decreased significantly (p&lt;0.05), plasma concentrations of glycyrrhizic acid rose slightly and bimodal phenomenon of concentration-time of isoliquiritigenin and glycyrrhetinic acid disappeared after combined administration. Discussion and conclusions Some components in the extract of processed radix A. kusnezoffii showed different effects on the pharmacokinetics of the four ingredients in G. uralensis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019533</affiliation-url><afid>60019533</afid><affilname>Tianjin University</affilname><name-variant>Tianjin University</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073686</affiliation-url><afid>60073686</afid><affilname>Medical College of Chinese People's Armed Police Forces</affilname><name-variant>Medical College of Chinese People's Armed Police Forces</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019533</affiliation-url><afid>60019533</afid><affilname>Tianjin University</affilname><name-variant>Tianjin University</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55845156200</author-url><authid>55845156200</authid><authname>Zhou B.</authname><surname>Zhou</surname><given-name>Bin</given-name><initials>B.</initials><afid>60019533</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23007163300</author-url><authid>23007163300</authid><authname>Zhang J.</authname><surname>Zhang</surname><given-name>Jingze</given-name><initials>J.</initials><afid>60073686</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55706897200</author-url><authid>55706897200</authid><authname>Wu S.</authname><surname>Wu</surname><given-name>Shanshan</given-name><initials>S.</initials><afid>60019533</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56604807700</author-url><authid>56604807700</authid><authname>Zhuo Q.</authname><surname>Zhuo</surname><given-name>Qu</given-name><initials>Q.</initials><afid>60019533</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34770191600</author-url><authid>34770191600</authid><authname>Gao W.</authname><surname>Gao</surname><given-name>Wenyuan</given-name><initials>W.</initials><afid>60019533</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55308818800</author-url><authid>55308818800</authid><authname>Hao J.</authname><surname>Hao</surname><given-name>Juan</given-name><initials>J.</initials><afid>60019533</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:25936537800</author-url><authid>25936537800</authid><authname>Man S.</authname><surname>Man</surname><given-name>Shuli</given-name><initials>S.</initials><afid>60019533</afid></author><authkeywords>Glycyrrhetic acid | Glycyrrhiza uralensis | Glycyrrhizic acid | Isoliquiritigenin | Liquiritigenin | Pharmacokinetic</authkeywords><intid>1535778613</intid><source-id>23015</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926287784"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926287784?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926287784&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926287784&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022103115000244"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926287784</prism:url><dc:identifier>SCOPUS_ID:84926287784</dc:identifier><eid>2-s2.0-84926287784</eid><dc:title>The politics of luck: Political ideology and the perceived relationship between luck and success</dc:title><dc:creator>Gromet D.</dc:creator><prism:publicationName>Journal of Experimental Social Psychology</prism:publicationName><prism:issn>00221031</prism:issn><prism:eIssn>10960465</prism:eIssn><prism:volume>59</prism:volume><prism:pageRange>40-46</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jesp.2015.03.002</prism:doi><pii>S0022103115000244</pii><dc:description>© 2015 Elsevier Inc. Three studies examined how individuals' beliefs about the relation between luck and success vary with political ideology. Conservative participants endorsed luck as influential to success considerably less than liberal participants (Studies 1 and 2). The ideologically polarizing effect of luck was shown to be related to its emphasis on random chance: Polarization was not found in response to an external attribution for success that was unrelated to chance (Study 2), and was specific to the challenge that random chance poses to deservingness (Study 3). Moreover, conservatives' support for the notion that luck contributes to success was related to their belief that luck is a quality of the person (which does not rely on random chance), whereas liberals' support was not (Study 3). These findings demonstrate that there is ideological disagreement over how success is achieved, which may be at the heart of the ideological divide over wealth redistribution.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022452</affiliation-url><afid>60022452</afid><affilname>University of Pennsylvania, Wharton School</affilname><name-variant>University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029241</affiliation-url><afid>60029241</afid><affilname>University of California, Santa Barbara</affilname><name-variant>University of California</name-variant><affiliation-city>Santa Barbara</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15839360600</author-url><authid>15839360600</authid><authname>Gromet D.</authname><surname>Gromet</surname><given-name>Dena M.</given-name><initials>D.M.</initials><afid>60022452</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:49861401700</author-url><authid>49861401700</authid><authname>Hartson K.</authname><surname>Hartson</surname><given-name>Kimberly A.</given-name><initials>K.A.</initials><afid>60029241</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8445712600</author-url><authid>8445712600</authid><authname>Sherman D.</authname><surname>Sherman</surname><given-name>David K.</given-name><initials>D.K.</initials><afid>60029241</afid></author><authkeywords>Attributions | Luck | Political ideology | Success</authkeywords><intid>1535430147</intid><source-id>15499</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928742191"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928742191?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928742191&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928742191&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S027323001500094X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928742191</prism:url><dc:identifier>SCOPUS_ID:84928742191</dc:identifier><eid>2-s2.0-84928742191</eid><dc:title>Toxicological risk assessment of elemental gold following oral exposure to sheets and nanoparticles - A review</dc:title><dc:creator>Hadrup N.</dc:creator><prism:publicationName>Regulatory Toxicology and Pharmacology</prism:publicationName><prism:issn>02732300</prism:issn><prism:eIssn>10960295</prism:eIssn><prism:volume>72</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>216-221</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yrtph.2015.04.017</prism:doi><pii>S027323001500094X</pii><dc:description>© 2015 Elsevier Inc. Elemental gold is used as a food coloring agent and in dental fillings. In addition, gold nanoparticles are gaining increasing attention due to their potential use as inert carriers for medical purposes. Although elemental gold is considered to be inert, there is evidence to suggest the release of gold ions from its surface. Elemental gold, or the released ions, is, to some extent, absorbed in the gastrointestinal tract. Gold is distributed to organs such as the liver, heart, kidneys and lungs. The main excretion route of absorbed gold is through urine. Data on the oral toxicity of elemental gold is limited. The acute toxicity of elemental gold seems to be low, as rats were unaffected by a single dose of 2000. mg nanoparticles/kg of body weight. Information on repeated dose toxicity is very limited. Skin rashes have been reported in humans following the ingestion of liquors containing gold. In addition, gold released from dental restorations has been reported to increase the risk of developing gold hypersensitivity. Regarding genotoxicity, in vitro studies indicate that gold nanoparticles induce DNA damage in mammalian cells. In vivo, gold nanoparticles induce genotoxic effects in Drosophila melanogaster; however, genotoxicity studies in mammals are lacking. Overall, based on the literature and taking low human exposure into account, elemental gold via the oral route is not considered to pose a health concern to humans in general.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011373</affiliation-url><afid>60011373</afid><affilname>Danmarks Tekniske Universitet</affilname><name-variant>Technical University of Denmark</name-variant><affiliation-city>Lyngby</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011373</affiliation-url><afid>60011373</afid><affilname>Danmarks Tekniske Universitet</affilname><name-variant>Technical University of Denmark</name-variant><affiliation-city>Lyngby</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011373</affiliation-url><afid>60011373</afid><affilname>Danmarks Tekniske Universitet</affilname><name-variant>Technical University of Denmark</name-variant><affiliation-city>Lyngby</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6508024943</author-url><authid>6508024943</authid><authname>Hadrup N.</authname><surname>Hadrup</surname><given-name>Niels</given-name><initials>N.</initials><afid>60011373</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8615109600</author-url><authid>8615109600</authid><authname>Sharma A.</authname><surname>Sharma</surname><given-name>Anoop K.</given-name><initials>A.K.</initials><afid>60011373</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56611501100</author-url><authid>56611501100</authid><authname>Poulsen M.</authname><surname>Poulsen</surname><given-name>Morten</given-name><initials>M.</initials><afid>60011373</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56611379600</author-url><authid>56611379600</authid><authname>Nielsen E.</authname><surname>Nielsen</surname><given-name>Elsa</given-name><initials>E.</initials><afid>60011373</afid></author><authkeywords>Au | Colloidal | Elemental | Gold | Metallic | Nanoparticle | Oral | Risk assessment | Toxicity | Toxicology</authkeywords><intid>35838708</intid><source-id>25176</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928124753"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928124753?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928124753&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928124753&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1055790315000974"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928124753</prism:url><dc:identifier>SCOPUS_ID:84928124753</dc:identifier><eid>2-s2.0-84928124753</eid><dc:title>Three new, early diverging Carex (Cariceae, Cyperaceae) lineages from East and Southeast Asia with important evolutionary and biogeographic implications</dc:title><dc:creator>Starr J.</dc:creator><prism:publicationName>Molecular Phylogenetics and Evolution</prism:publicationName><prism:issn>10557903</prism:issn><prism:eIssn>10959513</prism:eIssn><prism:volume>88</prism:volume><prism:pageRange>105-120</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ympev.2015.04.001</prism:doi><pii>S1055790315000974</pii><dc:description>© 2015 Elsevier Inc. Traditional Cariceae and Carex (1966 spp.) classifications recognised five genera (. Carex, Cymophyllus, Kobresia, Schoenoxiphium, Uncinia) and four subgenera (. Carex, Vignea, Vigneastra, Psyllophora). However, molecular studies have shown that only Carex, divided into five major lineages (the Core Carex, Schoenoxiphium, Core Unispicate, Vignea and Siderostictae Clades), is natural. These studies have also suggested that many early diverging tribal lineages are East Asian in origin, but the sampling of East Asian groups has been poor, and support for relationships within and among major Cariceae clades has been weak. To test deep patterns of relationship in Carex we assembled the longest sequence dataset yet (ITS, ETS 1f, matK, ndhF, rps16; ca. 4400. bp) with taxonomic sampling focused on critical East and Southeast Asian Carex sections that have blurred subgeneric limits (. Decorae, Graciles, Mundae) or have been at the heart of theories on tribal origins (. Hemiscaposae, Indicae, Surculosae, Euprepes, Mapaniifoliae, Hypolytroides). Results indicate that subg. Vigneastra is highly polyphyletic (in five of seven major lineages recognised), and they provide the strongest support yet seen for all previously recognised major Cariceae clades in a single analysis (≥93% BS). Moreover, results provide strong evidence for three previously unrecognised early diverging East and Southeast Asian lineages: a ". Hypolytroides Clade" (sect. Hypolytroides) sister to the Siderostictae Clade, and for a ". Dissitiflora Lineage" (sect. Mundae) and a morphologically diverse "Small Core Carex Clade" (sects. Graciles, Decorae, Mapaniifoliae, Euprepes, Indicae) as successive sisters to approximately 1400 species in the Core Carex Clade. Our findings also suggest that morphological diversification may have occurred in clades dominated by Asian species followed by canalization to a narrower range of morphologies in species-rich, cosmopolitan lineages.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006039</affiliation-url><afid>60006039</afid><affilname>Musee canadien de la nature</affilname><name-variant>Canadian Museum of Nature</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009697</affiliation-url><afid>60009697</afid><affilname>University of Manitoba</affilname><name-variant>University of Manitoba</name-variant><affiliation-city>Winnipeg</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7101906509</author-url><authid>7101906509</authid><authname>Starr J.</authname><surname>Starr</surname><given-name>Julian R.</given-name><initials>J.R.</initials><afid>60028897</afid><afid>60006039</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7101906509</author-url><authid>7101906509</authid><authname>Starr J.</authname><surname>Starr</surname><given-name>Julian R.</given-name><initials>J.R.</initials><afid>60028897</afid><afid>60006039</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56600204200</author-url><authid>56600204200</authid><authname>Janzen F.</authname><surname>Janzen</surname><given-name>Francesco H.</given-name><initials>F.H.</initials><afid>60028897</afid><afid>60006039</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56600204200</author-url><authid>56600204200</authid><authname>Janzen F.</authname><surname>Janzen</surname><given-name>Francesco H.</given-name><initials>F.H.</initials><afid>60028897</afid><afid>60006039</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35617931300</author-url><authid>35617931300</authid><authname>Ford B.</authname><surname>Ford</surname><given-name>Bruce A.</given-name><initials>B.A.</initials><afid>60009697</afid></author><authkeywords>Biogeography | Major clades | Pollination | Sedges</authkeywords><intid>2035728821</intid><source-id>18965</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929325137"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929325137?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929325137&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929325137&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0379073815001565"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929325137</prism:url><dc:identifier>SCOPUS_ID:84929325137</dc:identifier><eid>2-s2.0-84929325137</eid><dc:title>Advanced analytical method of nereistoxin using mixed-mode cationic exchange solid-phase extraction and GC/MS</dc:title><dc:creator>Park Y.</dc:creator><prism:publicationName>Forensic Science International</prism:publicationName><prism:issn>03790738</prism:issn><prism:eIssn>18726283</prism:eIssn><prism:volume>252</prism:volume><prism:pageRange>143-149</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.forsciint.2015.04.010</prism:doi><pii>S0379073815001565</pii><dc:description>© 2015. Nereistoxin(NTX) was originated from a marine annelid worm Lumbriconereis heteropoda and its analogue pesticides including cartap, bensultap, thiocyclam and thiobensultap have been commonly used in agriculture, because of their low toxicity and high insecticidal activity. However, NTX has been reported about its inhibitory neuro toxicity in human and animal body, by blocking nicotinic acetylcholine receptor and it cause significant neuromuscular toxicity, resulting in respiratory failure. We developed a new method to determine NTX in biological fluid. The method involves mixed-mode cationic exchange based solid phase extraction and gas chromatography/mass spectrometry for final identification and quantitative analysis. The limit of detection and recovery were substantially better than those of other methods using liquid-liquid extraction or headspace solid phase microextraction. The good recoveries (97 ± 14%) in blood samples were obtained and calibration curves over the range 0.05-20 mg/L have R2 values greater than 0.99. The developed method was applied to a fatal case of cartap intoxication of 74 years old woman who ingested cartap hydrochloride for suicide. Cartap and NTX were detected from postmortem specimens and the cause of the death was ruled to be nereistoxin intoxication. The concentrations of NTX were 2.58. mg/L, 3.36 mg/L and 1479.7 mg/L in heart, femoral blood and stomach liquid content, respectively. The heart blood/femoral blood ratio of NTX was 0.76.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113874141</affiliation-url><afid>113874141</afid><affilname>National Forensic Service</affilname><name-variant>Busan Institute of National Forensic Service</name-variant><affiliation-city>Yangsan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008783</affiliation-url><afid>60008783</afid><affilname>Pusan National University</affilname><name-variant>Pusan National University</name-variant><affiliation-city>Busan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010923</affiliation-url><afid>60010923</afid><affilname>Kyungsung University</affilname><name-variant>Kyungsung University</name-variant><affiliation-city>Busan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643418000</author-url><authid>56643418000</authid><authname>Park Y.</authname><surname>Park</surname><given-name>Yujin</given-name><initials>Y.</initials><afid>113874141</afid><afid>60008783</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643418000</author-url><authid>56643418000</authid><authname>Park Y.</authname><surname>Park</surname><given-name>Yujin</given-name><initials>Y.</initials><afid>113874141</afid><afid>60008783</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644101900</author-url><authid>56644101900</authid><authname>Choe S.</authname><surname>Choe</surname><given-name>Sanggil</given-name><initials>S.</initials><afid>113874141</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643520700</author-url><authid>56643520700</authid><authname>Lee H.</authname><surname>Lee</surname><given-name>Heesang</given-name><initials>H.</initials><afid>113874141</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55443585400</author-url><authid>55443585400</authid><authname>Jo J.</authname><surname>Jo</surname><given-name>Jiyeong</given-name><initials>J.</initials><afid>113874141</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643411700</author-url><authid>56643411700</authid><authname>Park Y.</authname><surname>Park</surname><given-name>Yonghoon</given-name><initials>Y.</initials><afid>113874141</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55705534500</author-url><authid>55705534500</authid><authname>Kim E.</authname><surname>Kim</surname><given-name>Eunmi</given-name><initials>E.</initials><afid>113874141</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:12801151700</author-url><authid>12801151700</authid><authname>Pyo J.</authname><surname>Pyo</surname><given-name>Jaesung</given-name><initials>J.</initials><afid>60010923</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24537466700</author-url><authid>24537466700</authid><authname>Jung J.</authname><surname>Jung</surname><given-name>Jee H.</given-name><initials>J.H.</initials><afid>60008783</afid></author><authkeywords>Cartap | GC/MS | MCX | Nereistoxin | Pesticide intoxication</authkeywords><intid>535947070</intid><source-id>27743</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928652627"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928652627?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928652627&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928652627&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S000334721500144X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928652627</prism:url><dc:identifier>SCOPUS_ID:84928652627</dc:identifier><eid>2-s2.0-84928652627</eid><dc:title>Social buffering in a bird</dc:title><dc:creator>Edgar J.</dc:creator><prism:publicationName>Animal Behaviour</prism:publicationName><prism:issn>00033472</prism:issn><prism:volume>105</prism:volume><prism:pageRange>11-19</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.anbehav.2015.04.007</prism:doi><pii>S000334721500144X</pii><dc:description>© 2015 The Association for the Study of Animal Behaviour. The presence of a conspecific can ameliorate an individual's stress response. This social buffering is known to be widespread in social mammals but the capacity of birds to act as social buffers has not yet been determined. We previously demonstrated that domestic hens, Gallus gallus domesticus, show socially mediated arousal when watching their chicks receiving an aversive air puff. Furthermore, the hens' expectation of the situation strongly influenced the chicks' behaviour. Here we examined whether hens act as a social buffer; reducing their chicks' stress response to an aversive stimulus. Pairs of chicks were exposed to an air puff treatment and a control, each with and without their mothers. Chicks showed a suite of responses to the air puff (including increased standing, reduced eye temperature, preening and ground pecking). Maternal absence exacerbated the chicks' preening and ground-pecking responses to this stressor. Individual hens varied in their effectiveness as a social buffer and this was associated with their socially mediated arousal when (matched pairs of) their chicks received an air puff. Specifically, the hens' heart rate increase was strongly negatively correlated with the degree to which chick preening and ground pecking increased with maternal presence. This is the first demonstration that avian mothers are able to reduce their chicks' stress responses to an aversive stimulus.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020650</affiliation-url><afid>60020650</afid><affilname>University of Bristol</affilname><name-variant>University of Bristol</name-variant><affiliation-city>Bristol</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000239</affiliation-url><afid>60000239</afid><affilname>Universitat Lausanne Schweiz</affilname><name-variant>University of Lausanne</name-variant><affiliation-city>Lausanne</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24447943300</author-url><authid>24447943300</authid><authname>Edgar J.</authname><surname>Edgar</surname><given-name>Joanne</given-name><initials>J.</initials><afid>60020650</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004238975</author-url><authid>7004238975</authid><authname>Held S.</authname><surname>Held</surname><given-name>Suzanne</given-name><initials>S.</initials><afid>60020650</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202850664</author-url><authid>7202850664</authid><authname>Paul E.</authname><surname>Paul</surname><given-name>Elizabeth</given-name><initials>E.</initials><afid>60020650</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56609979800</author-url><authid>56609979800</authid><authname>Pettersson I.</authname><surname>Pettersson</surname><given-name>Isabelle</given-name><initials>I.</initials><afid>60020650</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56610307400</author-url><authid>56610307400</authid><authname>I'Anson Price R.</authname><surname>I'Anson Price</surname><given-name>Robbie</given-name><initials>R.</initials><afid>60000239</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35448885300</author-url><authid>35448885300</authid><authname>Nicol C.</authname><surname>Nicol</surname><given-name>Christine</given-name><initials>C.</initials><afid>60020650</afid></author><authkeywords>Bird | Chicken | Empathy | Maternal | Social buffering | Socially mediated arousal</authkeywords><intid>535824005</intid><source-id>24580</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925134608"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925134608?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925134608&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925134608&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925753515000156"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925134608</prism:url><dc:identifier>SCOPUS_ID:84925134608</dc:identifier><eid>2-s2.0-84925134608</eid><dc:title>Preserving and improving the safety and health at work: Case of Hamma Bouziane cement plant (Algeria)</dc:title><dc:creator>Rachid C.</dc:creator><prism:publicationName>Safety Science</prism:publicationName><prism:issn>09257535</prism:issn><prism:eIssn>18791042</prism:eIssn><prism:volume>76</prism:volume><prism:pageRange>145-150</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ssci.2015.01.014</prism:doi><pii>S0925753515000156</pii><dc:description>© 2015 Elsevier Ltd. Safety and health at work (SHW) has become a public health priority in industrialized countries and a primary concern in the context of human resource management and in particular high risk-industries. Thus, developing a strong safety culture (SC) would be a mean to reduce the number of adverse events related to various activities in the company. Now, the laws and customs interact: when a people have good manners, laws become simple. Unfortunately, habits cannot be modified by setting example. Therefore, regardless of the size and activity of the entity, health and safety at work must be at the heart of its daily management. In the absence of effective management of health and safety at work, it is the entire company that is mismanaged. On the whole, risk management can be defined as a process of prevention and protection allowing a company or an entity, placed in a competitive context, to take all necessary decisions in order to optimize its activity, without affecting its customers as well as the environment. This work is an opportunity to initiate a global approach to prevention in cement plants whose purpose is to improve working conditions by technical, organizational and human solutions to improve the health and safety of employees while engaging in a process of continuous improvement.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114344224</affiliation-url><afid>114344224</afid><affilname>University of Constantine 1</affilname><name-variant>University of Constantine 1</name-variant><affiliation-city/><affiliation-country>Algeria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009915</affiliation-url><afid>60009915</afid><affilname>Universitatea Tehnica Gh. Asachi din IasI</affilname><name-variant>Gh. Asachi Technical University</name-variant><affiliation-city>Iasi</affiliation-city><affiliation-country>Romania</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56536751700</author-url><authid>56536751700</authid><authname>Rachid C.</authname><surname>Rachid</surname><given-name>Chaib</given-name><initials>C.</initials><afid>114344224</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56536552700</author-url><authid>56536552700</authid><authname>Ion V.</authname><surname>Ion</surname><given-name>Verzea</given-name><initials>V.</initials><afid>60009915</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56560231400</author-url><authid>56560231400</authid><authname>Irina C.</authname><surname>Irina</surname><given-name>Cozminca</given-name><initials>C.</initials><afid>60009915</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56559642700</author-url><authid>56559642700</authid><authname>Mohamed B.</authname><surname>Mohamed</surname><given-name>Benidir</given-name><initials>B.</initials><afid>114344224</afid></author><authkeywords>Deming wheel | Ishikawa diagram | Pareto diagram | Safety and health at work (SHW) | Safety culture (SC)</authkeywords><intid>35266473</intid><source-id>12332</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926504597"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926504597?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926504597&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926504597&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0145305X15000610"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926504597</prism:url><dc:identifier>SCOPUS_ID:84926504597</dc:identifier><eid>2-s2.0-84926504597</eid><dc:title>Cloning and primary immunological study of TGF-β1 and its receptors TβR I /TβR II in tilapia(Oreochromis niloticus)</dc:title><dc:creator>Zhan X.</dc:creator><prism:publicationName>Developmental and Comparative Immunology</prism:publicationName><prism:issn>0145305X</prism:issn><prism:eIssn>18790089</prism:eIssn><prism:volume>51</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>134-140</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.dci.2015.03.008</prism:doi><pii>S0145305X15000610</pii><dc:description>© 2015 Elsevier Ltd. The transforming growth factor β (TGF-β) superfamily plays critical roles in tumor suppression, cell proliferation and differentiation, tissue morphogenesis, lineage determination, cell migration and apoptosis. Recently, TGF-β1, one important member of TGF-β superfamily, is suggested as an immune regulator in the teleost. In this study, we cloned the cDNAs of TGF-β1 and its receptors, TβR I and TβR II (including three isoforms) from tilapia (Genbank accession numbers: KP754231- KP754235). A tissue distribution profile analysis indicated that TGF-β1 was highly expressed in the head kidney, gill, spleen, kidney and PBLs (peripheral blood leukocytes); TβR I only showed considerable expression in the liver; and TβR II-2 was highly expressed in the kidney, gill, liver, head kidney and heart. We determined that the mRNA expressions of TGF-β and TβR I /TβR II-2 were significantly increased in tilapia head kidney and spleen leukocytes by the stimulation of Lipopolysaccharide (LPS) or Poly I: C. We also examined their expressions in the spleen and head kidney of tilapia after IP injection of streptococcus agalactiae. The results showed that the mRNA expressions of these three genes all increased in the head kidney as early as 6 h post infection, and in the spleen 3 d post infection. In addition, the protein level of TGF-β1 was also up-regulated in the head kidney and the spleen after infection. Taken together, our data indicate that the TGF-β1-TβR I /TβR II-2 system functions potentially in tilapia immune system.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021182</affiliation-url><afid>60021182</afid><affilname>Sun Yat-Sen University</affilname><name-variant>Sun Yat-Sen University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56239252600</author-url><authid>56239252600</authid><authname>Zhan X.</authname><surname>Zhan</surname><given-name>Xu liang</given-name><initials>X.l.</initials><afid>60021182</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56239354200</author-url><authid>56239354200</authid><authname>Ma T.</authname><surname>Ma</surname><given-name>Tai yang</given-name><initials>T.y.</initials><afid>60021182</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56093924400</author-url><authid>56093924400</authid><authname>Wu J.</authname><surname>Wu</surname><given-name>Jin ying</given-name><initials>J.y.</initials><afid>60021182</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56583417400</author-url><authid>56583417400</authid><authname>Yi L.</authname><surname>Yi</surname><given-name>Li yuan</given-name><initials>L.y.</initials><afid>60021182</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56239915800</author-url><authid>56239915800</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jing yuan</given-name><initials>J.y.</initials><afid>60021182</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56239310300</author-url><authid>56239310300</authid><authname>Gao X.</authname><surname>Gao</surname><given-name>Xiao ke</given-name><initials>X.k.</initials><afid>60021182</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56239900500</author-url><authid>56239900500</authid><authname>Li W.</authname><surname>Li</surname><given-name>Wen sheng</given-name><initials>W.s.</initials><afid>60021182</afid></author><authkeywords>Immune response | Streptococcus agalactiae | TGF-β1 | TGF-β1 receptors | Tilapia</authkeywords><intid>1035450161</intid><source-id>20775</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929148533"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929148533?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929148533&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929148533&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008748"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929148533</prism:url><dc:identifier>SCOPUS_ID:84929148533</dc:identifier><eid>2-s2.0-84929148533</eid><dc:title>Treating and healing coronary artery ectasia disease with Bioresorbable Vascular Scaffold</dc:title><dc:creator>Yew K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>99-101</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.150</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009426</affiliation-url><afid>60009426</afid><affilname>Sarawak General Hospital</affilname><name-variant>Sarawak General Hospital</name-variant><affiliation-city>Kuching</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:42762568900</author-url><authid>42762568900</authid><authname>Yew K.</authname><surname>Yew</surname><given-name>Kuan Leong</given-name><initials>K.L.</initials><afid>60009426</afid></author><authkeywords>ABSORB | Bioresorbable vascular scaffold | Coronary artery aneurysm | Coronary artery ectasia | Fractional flow reserve | Negative remodeling</authkeywords><intid>35916500</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926501146"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926501146?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926501146&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926501146&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915000666"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926501146</prism:url><dc:identifier>SCOPUS_ID:84926501146</dc:identifier><eid>2-s2.0-84926501146</eid><dc:title>The flavo-oxidase QSOX1 supports vascular smooth muscle cell migration and proliferation: Evidence for a role in neointima growth</dc:title><dc:creator>Borges B.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1334-1346</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.03.002</prism:doi><pii>S0925443915000666</pii><dc:description>© 2015 Published by Elsevier B.V. Quiescin sulfhydryl oxidase 1 (QSOX1) is a flavoenzyme largely present in the extracellular milieu whose physiological functions and substrates are not known. QSOX1 has been implicated in the regulation of tumor cell survival, proliferation and migration, in addition to extracellular matrix (ECM) remodeling. However, data regarding other pathophysiological conditions are still lacking. Arterial injury by balloon catheter is an established model of post-angioplasty restenosis. This technique induces neointima formation due to migration and proliferation of vascular smooth muscle cells (VSMC), followed by ECM synthesis and remodeling. Here, we show that QSOX1 knockdown inhibited VSMC migration and proliferation in vitro. In contrast, QSOX1 overexpression stimulated these processes. While migration could be induced by the incubation of cells with the active recombinant QSOX1, proliferation was induced by addition of the active and also of an inactive mutant QSOX1 protein. The proliferation induced by both recombinants was independent of intracellular hydrogen peroxide and dependent of the MEK/ERK pathway. To recapitulate in vivo VSMC pathophysiology, balloon-induced arterial injury was performed. The expression of QSOX1 in the neointimal layer of balloon-injured rat carotids was high and peaked at 14. days post-injury. In vivo QSOX1 knockdown led to a significant decrease in PCNA expression at day 14 post-injury and a decreased intima/media area ratio at day 21 post-injury, compared with scrambled siRNA transfection. In summary, our findings demonstrate that QSOX1 induces VSMC migration and proliferation in vitro and contributes to neointima thickening in balloon-injured rat carotids.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015043</affiliation-url><afid>60015043</afid><affilname>Universidade Federal do Parana</affilname><name-variant>Universidade Federal do Paraná</name-variant><affiliation-city>Curitiba</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032530</affiliation-url><afid>60032530</afid><affilname>Universite Francois-Rabelais Tours</affilname><name-variant>Université de Tours</name-variant><affiliation-city>Tours</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008088</affiliation-url><afid>60008088</afid><affilname>Universidade de Sao Paulo - USP</affilname><name-variant>University of São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018034</affiliation-url><afid>60018034</afid><affilname>Universidade Estadual de Ponta Grossa</affilname><name-variant>State University of Ponta Grossa</name-variant><affiliation-city>Ponta Grossa</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55805790500</author-url><authid>55805790500</authid><authname>Borges B.</authname><surname>Borges</surname><given-name>Beatriz E.</given-name><initials>B.E.</initials><afid>60015043</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7101857443</author-url><authid>7101857443</authid><authname>Appel M.</authname><surname>Appel</surname><given-name>Márcia H.</given-name><initials>M.H.</initials><afid>60015043</afid><afid>60018034</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7101857443</author-url><authid>7101857443</authid><authname>Appel M.</authname><surname>Appel</surname><given-name>Márcia H.</given-name><initials>M.H.</initials><afid>60015043</afid><afid>60018034</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56162985200</author-url><authid>56162985200</authid><authname>Cofré A.</authname><surname>Cofré</surname><given-name>Axel R.</given-name><initials>A.R.</initials><afid>60015043</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56583690300</author-url><authid>56583690300</authid><authname>Prado M.</authname><surname>Prado</surname><given-name>Maiara L.</given-name><initials>M.L.</initials><afid>60015043</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55889736500</author-url><authid>55889736500</authid><authname>Steclan C.</authname><surname>Steclan</surname><given-name>Chelin A.</given-name><initials>C.A.</initials><afid>60015043</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701858065</author-url><authid>6701858065</authid><authname>Esnard F.</authname><surname>Esnard</surname><given-name>Frédéric</given-name><initials>F.</initials><afid>60032530</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602579505</author-url><authid>6602579505</authid><authname>Zanata S.</authname><surname>Zanata</surname><given-name>Silvio M.</given-name><initials>S.M.</initials><afid>60015043</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003930361</author-url><authid>7003930361</authid><authname>Laurindo F.</authname><surname>Laurindo</surname><given-name>Francisco R M</given-name><initials>F.R.M.</initials><afid>60008088</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7801520839</author-url><authid>7801520839</authid><authname>Nakao L.</authname><surname>Nakao</surname><given-name>Lia S.</given-name><initials>L.S.</initials><afid>60015043</afid></author><authkeywords>Cell migration | Cell proliferation | Neointima | Quiescin sulfhydryl oxidase | Vascular smooth muscle cell</authkeywords><intid>2035450032</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928319779"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928319779?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928319779&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928319779&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915001167"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928319779</prism:url><dc:identifier>SCOPUS_ID:84928319779</dc:identifier><eid>2-s2.0-84928319779</eid><dc:title>Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity</dc:title><dc:creator>Peng X.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1490-1497</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.04.010</prism:doi><pii>S0925443915001167</pii><dc:description>© 2015 Elsevier B.V. Myotonic dystrophy is a neuromuscular disease of RNA toxicity. The disease gene DMPK harbors expanded CTG trinucleotide repeats on its 3'-UTR. The transcripts of this mutant DMPK led to misregulation of RNA-binding proteins including MBNL1 and Celf1. In myoblasts, CUG-expansion impaired terminal differentiation. In this study, we formally tested how the abundance of Celf1 regulates normal myocyte differentiation, and how Celf1 expression level mediates CUG-expansion RNA toxicity-triggered impairment of myocyte differentiation. As the results, overexpression of Celf1 largely recapitulated the defects of myocytes with CUG-expansion, by increasing myocyte cycling. Knockdown of endogenous Celf1 level led to precocious myotube formation, supporting a negative connection between Celf1 abundance and myocyte terminal differentiation. Finally, knockdown of Celf1 in myocyte with CUG-expansion led to partial rescue, by promoting cell cycle exit. Our results suggest that Celf1 plays a distinctive and negative role in terminal myocyte differentiation, which partially contribute to DM1 RNA toxicity. Targeting Celf1 may be a valid strategy in correcting DM1 muscle phenotypes, especially for congenital cases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008332</affiliation-url><afid>60008332</afid><affilname>Nanchang University</affilname><name-variant>Nanchang University</name-variant><affiliation-city>Nanchang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005837</affiliation-url><afid>60005837</afid><affilname>University of Houston</affilname><name-variant>University of Houston</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023304</affiliation-url><afid>60023304</afid><affilname>Texas Heart Institute</affilname><name-variant>Texas Heart Institute</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56603516600</author-url><authid>56603516600</authid><authname>Peng X.</authname><surname>Peng</surname><given-name>Xiaoping</given-name><initials>X.</initials><afid>60008332</afid><afid>60005837</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56603516600</author-url><authid>56603516600</authid><authname>Peng X.</authname><surname>Peng</surname><given-name>Xiaoping</given-name><initials>X.</initials><afid>60008332</afid><afid>60005837</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56603499000</author-url><authid>56603499000</authid><authname>Shen X.</authname><surname>Shen</surname><given-name>Xiaopeng</given-name><initials>X.</initials><afid>60005837</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56603532200</author-url><authid>56603532200</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xuanying</given-name><initials>X.</initials><afid>60008332</afid><afid>60005837</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56603532200</author-url><authid>56603532200</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xuanying</given-name><initials>X.</initials><afid>60008332</afid><afid>60005837</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56603646400</author-url><authid>56603646400</authid><authname>Liang R.</authname><surname>Liang</surname><given-name>Rui</given-name><initials>R.</initials><afid>60005837</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56604174500</author-url><authid>56604174500</authid><authname>Azares A.</authname><surname>Azares</surname><given-name>Alon R.</given-name><initials>A.R.</initials><afid>60023304</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56603746300</author-url><authid>56603746300</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60005837</afid></author><authkeywords>Celf1 | CUGBP1 | Differentiation | Myoblast | Myotonic dystrophy</authkeywords><intid>1535766285</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928691504"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928691504?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928691504&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928691504&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515001115"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928691504</prism:url><dc:identifier>SCOPUS_ID:84928691504</dc:identifier><eid>2-s2.0-84928691504</eid><dc:title>Objectively measured sedentary time and associations with insulin sensitivity: Importance of reallocating sedentary time to physical activity</dc:title><dc:creator>Yates T.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>76</prism:volume><prism:pageRange>79-83</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.04.005</prism:doi><pii>S0091743515001115</pii><dc:description>© 2015 Published by Elsevier Inc. Objective: The aim of this study is to quantify associations between objectively measured sedentary time and markers of insulin sensitivity by considering allocation into light-intensity physical activity or moderate- to vigorous-intensity physical activity (MVPA). Methods: Participants with an increased risk of impaired glucose regulation (IGR) were recruited (Leicestershire, United Kingdom, 2010-2011). Sedentary, light-intensity physical activity and MVPA time were measured using accelerometers. Fasting and 2-hour post-challenge insulin and glucose were assessed; insulin sensitivity was calculated by HOMA-IS and Matsuda-ISI. Isotemporal substitution regression models were used. Data were analysed in 2014. Results: 508 participants were included (average age. =. 65. years, female. =. 34%). Reallocating 30. min of sedentary time into light-intensity physical activity was associated a 5% (95% CI 1, 9%; p. =. 0.024) difference in Matsuda-ISI after adjustment for measured confounding variables. Reallocation into MVPA was associated with a 15% (7, 25%; p. &lt;. 0.001) difference in HOMA-IS and 18% (8, 28%; p. &lt;. 0.001) difference in Matsuda-ISI. Results for light-intensity physical activity were modified by IGR status with stronger associations seen in those with IGR. Conclusions: Reallocating sedentary time into light-intensity physical activity or MVPA was associated with differences in insulin sensitivity, with stronger and more consistent associations seen for MVPA.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033125</affiliation-url><afid>60033125</afid><affilname>University of Leicester</affilname><name-variant>University of Leicester</name-variant><affiliation-city>Leicester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>and Physical Activity Biomedical Research Unit</affilname><name-variant>NIHR Leicester-Loughborough Diet</name-variant><name-variant>Lifestyle</name-variant><affiliation-city/><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033409</affiliation-url><afid>60033409</afid><affilname>Baker IDI Heart and Diabetes Institute</affilname><name-variant>Baker Heart Research Institute</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115199850</affiliation-url><afid>115199850</afid><affilname>NIHR Collaboration for Leadership in Applied Health Research and Care-East Midlands (NIHR CLAHRC-EM</affilname><name-variant>NIHR Collaboration for Leadership in Applied Health Research and Care-East Midlands (NIHR CLAHRC-EM</name-variant><affiliation-city/><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16302307500</author-url><authid>16302307500</authid><authname>Yates T.</authname><surname>Yates</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60033125</afid><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16302307500</author-url><authid>16302307500</authid><authname>Yates T.</authname><surname>Yates</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60033125</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35784360400</author-url><authid>35784360400</authid><authname>Henson J.</authname><surname>Henson</surname><given-name>Joseph</given-name><initials>J.</initials><afid>60033125</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35784360400</author-url><authid>35784360400</authid><authname>Henson J.</authname><surname>Henson</surname><given-name>Joseph</given-name><initials>J.</initials><afid>60033125</afid><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:31667536700</author-url><authid>31667536700</authid><authname>Edwardson C.</authname><surname>Edwardson</surname><given-name>Charlotte</given-name><initials>C.</initials><afid>60033125</afid><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:31667536700</author-url><authid>31667536700</authid><authname>Edwardson C.</authname><surname>Edwardson</surname><given-name>Charlotte</given-name><initials>C.</initials><afid>60033125</afid><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102907266</author-url><authid>7102907266</authid><authname>Dunstan D.</authname><surname>Dunstan</surname><given-name>David</given-name><initials>D.</initials><afid>60033409</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56020570900</author-url><authid>56020570900</authid><authname>Bodicoat D.</authname><surname>Bodicoat</surname><given-name>Danielle H.</given-name><initials>D.H.</initials><afid>60033125</afid><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56020570900</author-url><authid>56020570900</authid><authname>Bodicoat D.</authname><surname>Bodicoat</surname><given-name>Danielle H.</given-name><initials>D.H.</initials><afid>60033125</afid><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56601766100</author-url><authid>56601766100</authid><authname>Khunti K.</authname><surname>Khunti</surname><given-name>Kamlesh</given-name><initials>K.</initials><afid>60033125</afid><afid>115199850</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56601766100</author-url><authid>56601766100</authid><authname>Khunti K.</authname><surname>Khunti</surname><given-name>Kamlesh</given-name><initials>K.</initials><afid>60033125</afid><afid>115199850</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35477152800</author-url><authid>35477152800</authid><authname>Davies M.</authname><surname>Davies</surname><given-name>Melanie J.</given-name><initials>M.J.</initials><afid>60033125</afid><afid/></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35477152800</author-url><authid>35477152800</authid><authname>Davies M.</authname><surname>Davies</surname><given-name>Melanie J.</given-name><initials>M.J.</initials><afid>60033125</afid><afid/></author><authkeywords>Glucose | Insulin sensitivity | Isotemporal substitution | Physical activity | Sedentary behaviour</authkeywords><intid>1785824370</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927632795"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927632795?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927632795&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927632795&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S019697811500090X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927632795</prism:url><dc:identifier>SCOPUS_ID:84927632795</dc:identifier><eid>2-s2.0-84927632795</eid><dc:title>Prediction of all-cause mortality with copeptin in cardio-cerebrovascular patients: A meta-analysis of prospective studies</dc:title><dc:creator>Sun H.</dc:creator><prism:publicationName>Peptides</prism:publicationName><prism:issn>01969781</prism:issn><prism:eIssn>18735169</prism:eIssn><prism:volume>69</prism:volume><prism:pageRange>9-18</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.peptides.2015.03.023</prism:doi><pii>S019697811500090X</pii><dc:description>© 2015 Elsevier Inc. Background Measurement of the biomarker copeptin may help identify disease severity and risk of mortality for a various diseases. This study sought to determine the relationship between copeptin and all-cause mortality of patients with cardio-cerebrovascular disease. Methods Database of Medline and Web of Science were searched for studies with data involving the baseline copeptin levels and subsequent all-cause mortality outcomes. The pooled HRs of all-cause mortality were calculated and presented with 95%CIs. Subgroup analysis and sensitivity analysis were conducted to explore the possible sources of heterogeneity. Results Data from 14,395 participants were derived from 28 prospective studies. Higher copeptin significantly increased the risk of all-cause mortality (per unit copeptin: HR = 1.020, 95%CI = 1.004-1.036; log unit copeptin: HR = 2.884, 95%CI = 1.844-4.512; categorical copeptin: HR = 3.371, 95%CI = 2.077-5.472). Subgroup analysis indicated that the risk of all-cause death was higher in cerebrovascular patients (per unit copeptin: HR = 2.537, 95%CI = 0.956-6.731; log unit copeptin: HR = 3.419, 95%CI = 2.391-4.888) than cardiovascular patients (per unit copeptin: HR = 1.011, 95%CI = 1.002-1.020; log unit copeptin: HR = 2.009, 95%CI = 1.119-3.608). Conclusion Copeptin is associated with all-cause mortality of patients with cardiovascular and cerebrovascular disease. Our study suggests that copeptin seems to be a promising novel biomarker for prediction of mortality in cardio-cerebrovascular patients, especially for cerebrovascular patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008872</affiliation-url><afid>60008872</afid><affilname>China Medical University Shenyang</affilname><name-variant>China Medical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008872</affiliation-url><afid>60008872</afid><affilname>China Medical University Shenyang</affilname><name-variant>China Medical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115180205</affiliation-url><afid>115180205</afid><affilname>Liaoning Province and China Medical University</affilname><name-variant>Liaoning Province and China Medical University</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">21</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56590837800</author-url><authid>56590837800</authid><authname>Sun H.</authname><surname>Sun</surname><given-name>Hao</given-name><initials>H.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56590837800</author-url><authid>56590837800</authid><authname>Sun H.</authname><surname>Sun</surname><given-name>Hao</given-name><initials>H.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56590837800</author-url><authid>56590837800</authid><authname>Sun H.</authname><surname>Sun</surname><given-name>Hao</given-name><initials>H.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56591221300</author-url><authid>56591221300</authid><authname>Sun T.</authname><surname>Sun</surname><given-name>Ting</given-name><initials>T.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56591221300</author-url><authid>56591221300</authid><authname>Sun T.</authname><surname>Sun</surname><given-name>Ting</given-name><initials>T.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56591221300</author-url><authid>56591221300</authid><authname>Sun T.</authname><surname>Sun</surname><given-name>Ting</given-name><initials>T.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56591280500</author-url><authid>56591280500</authid><authname>Ma B.</authname><surname>Ma</surname><given-name>Bing</given-name><initials>B.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56591280500</author-url><authid>56591280500</authid><authname>Ma B.</authname><surname>Ma</surname><given-name>Bing</given-name><initials>B.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56591280500</author-url><authid>56591280500</authid><authname>Ma B.</authname><surname>Ma</surname><given-name>Bing</given-name><initials>B.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56049225700</author-url><authid>56049225700</authid><authname>Yang B.</authname><surname>Yang</surname><given-name>Bo Wen</given-name><initials>B.W.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56049225700</author-url><authid>56049225700</authid><authname>Yang B.</authname><surname>Yang</surname><given-name>Bo Wen</given-name><initials>B.W.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56049225700</author-url><authid>56049225700</authid><authname>Yang B.</authname><surname>Yang</surname><given-name>Bo Wen</given-name><initials>B.W.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56591305600</author-url><authid>56591305600</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yao</given-name><initials>Y.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56591305600</author-url><authid>56591305600</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yao</given-name><initials>Y.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56591305600</author-url><authid>56591305600</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yao</given-name><initials>Y.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56591027300</author-url><authid>56591027300</authid><authname>Huang D.</authname><surname>Huang</surname><given-name>Dong Hui</given-name><initials>D.H.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56591027300</author-url><authid>56591027300</authid><authname>Huang D.</authname><surname>Huang</surname><given-name>Dong Hui</given-name><initials>D.H.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56591027300</author-url><authid>56591027300</authid><authname>Huang D.</authname><surname>Huang</surname><given-name>Dong Hui</given-name><initials>D.H.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:13907004800</author-url><authid>13907004800</authid><authname>Shi J.</authname><surname>Shi</surname><given-name>Jing Pu</given-name><initials>J.P.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:13907004800</author-url><authid>13907004800</authid><authname>Shi J.</authname><surname>Shi</surname><given-name>Jing Pu</given-name><initials>J.P.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:13907004800</author-url><authid>13907004800</authid><authname>Shi J.</authname><surname>Shi</surname><given-name>Jing Pu</given-name><initials>J.P.</initials><afid>60008872</afid><afid>60008872</afid><afid>115180205</afid></author><authkeywords>All-cause mortality | Cardiovascular | Cerebrovascular | Copeptin | Meta-analysis</authkeywords><intid>1035641106</intid><source-id>14222</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928884489"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928884489?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928884489&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928884489&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010291"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928884489</prism:url><dc:identifier>SCOPUS_ID:84928884489</dc:identifier><eid>2-s2.0-84928884489</eid><dc:title>HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain</dc:title><dc:creator>Caselli C.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>55-61</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.811</prism:doi><pii>S0021915015010291</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objectives: Coronary computed tomography angiography (CTA) describes several features of coronary plaques, i.e. location, severity, and composition. Integrated CTA scores are able to identify individual patterns of higher risk. We sought to test whether circulating biomarkers related with metabolism and inflammation could predict high risk coronary anatomy at CTA in patients with stable chest pain. Methods: We evaluated a panel of 17 biomarkers in 429 patients (60.3±0.4 years, 268 males) with stable chest pain who underwent coronary CTA having been enrolled in the Evaluation of Integrated Cardiac Imaging (EVINCI) study. The individual CTA risk score was calculated combining plaque extent, severity, composition, and location. The presence and distribution of non-calcified, mixed and calcified plaques were analyzed in each patient. Results: After adjustment for age, sex and medical treatment, high-density lipoprotein (HDL) cholesterol, leptin, and interleukin-6 (IL-6) were independent predictors of CTA risk score at multivariate analysis (. P=0.050, 0.002, and 0.007, respectively). Integrating these biomarkers with common clinical variables, a model was developed which showed a better discriminating ability than the Framingham Risk Score and the Euro-SCORE in identifying the patients with higher CTA risk score (area under the receiver-operating characteristics curve=0.81, 0.63 and 0.71, respectively, P&lt;0.001). These three biomarkers were significantly altered in patients with mixed or non-calcified plaques. Conclusions: In patients with stable chest pain, low HDL cholesterol, low leptin and high IL-6 are independent predictors of high risk coronary anatomy as defined by an integrated CTA risk score.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009071</affiliation-url><afid>60009071</afid><affilname>Istituto di Fisiologia Clinica del CNR</affilname><name-variant>CNR</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028039</affiliation-url><afid>60028039</afid><affilname>Scuola Superiore Sant'Anna di Studi Universitari e di Perfezionamento</affilname><name-variant>Scuola Superiore Sant'Anna</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114308295</affiliation-url><afid>114308295</afid><affilname>Fondazione Toscana G. Monasterio</affilname><name-variant>Fondazione Toscana G. Monasterio</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603781747</author-url><authid>6603781747</authid><authname>Caselli C.</authname><surname>Caselli</surname><given-name>Chiara</given-name><initials>C.</initials><afid>60009071</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56588655000</author-url><authid>56588655000</authid><authname>De Graaf M.</authname><surname>De Graaf</surname><given-name>Michiel A.</given-name><initials>M.A.</initials><afid>60015618</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35798685400</author-url><authid>35798685400</authid><authname>Lorenzoni V.</authname><surname>Lorenzoni</surname><given-name>Valentina</given-name><initials>V.</initials><afid>60028039</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006175508</author-url><authid>7006175508</authid><authname>Rovai D.</authname><surname>Rovai</surname><given-name>Daniele</given-name><initials>D.</initials><afid>60009071</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23009287600</author-url><authid>23009287600</authid><authname>Marinelli M.</authname><surname>Marinelli</surname><given-name>Martina</given-name><initials>M.</initials><afid>60009071</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56521772100</author-url><authid>56521772100</authid><authname>Del Ry S.</authname><surname>Del Ry</surname><given-name>Silvia</given-name><initials>S.</initials><afid>60009071</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003672895</author-url><authid>7003672895</authid><authname>Giannessi D.</authname><surname>Giannessi</surname><given-name>Daniela</given-name><initials>D.</initials><afid>60009071</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35379683700</author-url><authid>35379683700</authid><authname>Bax J.</authname><surname>Bax</surname><given-name>Jeroen J.</given-name><initials>J.J.</initials><afid>60015618</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004525977</author-url><authid>7004525977</authid><authname>Neglia D.</authname><surname>Neglia</surname><given-name>Danilo</given-name><initials>D.</initials><afid>60009071</afid><afid>114308295</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004525977</author-url><authid>7004525977</authid><authname>Neglia D.</authname><surname>Neglia</surname><given-name>Danilo</given-name><initials>D.</initials><afid>60009071</afid><afid>114308295</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:8557383800</author-url><authid>8557383800</authid><authname>Scholte A.</authname><surname>Scholte</surname><given-name>Arthur J.</given-name><initials>A.J.</initials><afid>60015618</afid></author><authkeywords>Biomarkers | Coronary anatomy | Coronary computed tomography angiography | Risk scores | Stable angina</authkeywords><intid>2035856875</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928689716"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928689716?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928689716&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928689716&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010199"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928689716</prism:url><dc:identifier>SCOPUS_ID:84928689716</dc:identifier><eid>2-s2.0-84928689716</eid><dc:title>Obstructive sleep apnea and abdominal aortic calcification: Is there anassociation independent of comorbid risk factors?</dc:title><dc:creator>Tachikawa R.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>6-11</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.801</prism:doi><pii>S0021915015010199</pii><dc:description>© 2015 Elsevier Ireland Ltd. Background: No studies have addressed the relationship between obstructive sleep apnea (OSA) and abdominal aortic calcification (AAC), a marker for subclinical atherosclerosis and future cardiovascular events. Objectives: To investigate 1) the association between OSA severity and AAC, and 2) whether OSA can impact the extent of AAC independent of comorbid atherogenic risk factors. Methods: 390 participants aged 40-70 years underwent polysomnography and abdominal computed tomography. AAC was separately quantified in the upper and lower abdominal aorta using the modified Agatston scoring method, and the total AAC score was calculated as a sum of the two scores. OSA was defined as none/mild (apnea-hypopnea index [AHI] &lt;15, n=87), moderate (AHI 15-30, n=129), and severe (AHI ≥30, n=174). Results: Log-transformed total AAC score adjusted for age and body mass index (BMI) was greater in participants with an elevated AHI (3.4 for none/mild OSA, 3.7 for moderate OSA, and 4.2 for severe OSA, p=0.04). Multivariate linear regression analysis including age and BMI as covariates showed that severe OSA was associated with higher scores for the lower and total AAC (β=0.15 and 0.14, p=0.01 and 0.01, respectively). The association did not persist after additionally adjusting for traditional atherogenic risk factors including visceral fat, smoking, hypertension, dyslipidemia, and diabetes. Conclusions: Severe OSA was associated with a greater extent of AAC, which was dependent on coexisting atherogenic risk factors. Comorbid cardiometabolic disorders may largely mediate the association of OSA with subclinical atherosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011001</affiliation-url><afid>60011001</afid><affilname>Kyoto University</affilname><name-variant>Kyoto University</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011001</affiliation-url><afid>60011001</afid><affilname>Kyoto University</affilname><name-variant>Kyoto University</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011001</affiliation-url><afid>60011001</afid><affilname>Kyoto University</affilname><name-variant>Kyoto University</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23475989300</author-url><authid>23475989300</authid><authname>Tachikawa R.</authname><surname>Tachikawa</surname><given-name>Ryo</given-name><initials>R.</initials><afid>60011001</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56609932100</author-url><authid>56609932100</authid><authname>Koyasu S.</authname><surname>Koyasu</surname><given-name>Sho</given-name><initials>S.</initials><afid>60011001</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56609554100</author-url><authid>56609554100</authid><authname>Matsumoto T.</authname><surname>Matsumoto</surname><given-name>Takeshi</given-name><initials>T.</initials><afid>60011001</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36054503000</author-url><authid>36054503000</authid><authname>Hamada S.</authname><surname>Hamada</surname><given-name>Satoshi</given-name><initials>S.</initials><afid>60011001</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55556760100</author-url><authid>55556760100</authid><authname>Azuma M.</authname><surname>Azuma</surname><given-name>Masanori</given-name><initials>M.</initials><afid>60011001</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56385043600</author-url><authid>56385043600</authid><authname>Murase K.</authname><surname>Murase</surname><given-name>Kimihiko</given-name><initials>K.</initials><afid>60011001</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:13610867100</author-url><authid>13610867100</authid><authname>Tanizawa K.</authname><surname>Tanizawa</surname><given-name>Kiminobu</given-name><initials>K.</initials><afid>60011001</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35315763800</author-url><authid>35315763800</authid><authname>Inouchi M.</authname><surname>Inouchi</surname><given-name>Morito</given-name><initials>M.</initials><afid>60011001</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56609973100</author-url><authid>56609973100</authid><authname>Oga T.</authname><surname>Oga</surname><given-name>Toru</given-name><initials>T.</initials><afid>60011001</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56186955300</author-url><authid>56186955300</authid><authname>Mishima M.</authname><surname>Mishima</surname><given-name>Michiaki</given-name><initials>M.</initials><afid>60011001</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7101898163</author-url><authid>7101898163</authid><authname>Togashi K.</authname><surname>Togashi</surname><given-name>Kaori</given-name><initials>K.</initials><afid>60011001</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7202995572</author-url><authid>7202995572</authid><authname>Chin K.</authname><surname>Chin</surname><given-name>Kazuo</given-name><initials>K.</initials><afid>60011001</afid></author><authkeywords>Abdominal aorta | Arterial calcification | Atherosclerosis | Cardiovascular risk factors | Obstructive sleep apnea</authkeywords><intid>1535823802</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929397766"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929397766?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929397766&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929397766&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929397766</prism:url><dc:identifier>SCOPUS_ID:84929397766</dc:identifier><eid>2-s2.0-84929397766</eid><dc:title>Unified Data Model for Wireless Sensor Network</dc:title><dc:creator>Nachabe L.</dc:creator><prism:publicationName>IEEE Sensors Journal</prism:publicationName><prism:issn>1530437X</prism:issn><prism:volume>15</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>3657-3667</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1109/JSEN.2015.2393951</prism:doi><dc:description>© 2001-2012 IEEE. The constant evolution of technology in terms of inexpensive and embedded wireless interfaces and powerful chipsets has led to the massive usage and deployment of wireless sensors networks (WSNs). These networks are made of a growing number of small sensing devices and are used in multiple use cases, such as home automation (e.g., smart buildings), energy management and smart grids, crisis management and security, e-Health, entertainment, and so forth. Sensor devices, generally self-organized in clusters and domain dedicated, are provided by an increasing number of manufacturers, which leads to interoperability problems (e.g., heterogeneous interfaces and/or grounding, heterogeneous descriptions, profiles, models, and so forth). Furthermore, the data provided by these WSNs are very heterogeneous because they are coming from sensing nodes with various abilities (e.g., different sensing ranges, formats, coding schemes, and so forth). In this paper, we propose a solution for handling WSNs' heterogeneity, as well as easing interoperability management. The solution consists of a semantic open data model for sensor and sensor data generic description. This data model, designed for handling any kind of sensors/actuators and measured data (which is still not the case of existing WSNs data models), is fully detailed and formalized in an original ontology format called MyOntoSens and written using Ontology Web Language 2 description logic language. The proposed ontology has been implemented using Protégé 4.3, prevalidated with pellet reasoner, and is being standardized (A Body Area Network (BAN) dedicated instance of the proposed "MyOntoSens" ontology is being standardized as a Technical Specification (TS) within the SmartBAN Technical Committee of the ETSI (European Telecommunications Standards Institute) standardization body: ETSI SmartBAN Technical Committee website: portal.etsi.org/portal/server.pt/community/SmartBAN/368v). In addition, this original ontology has been prequalified through a runner's exercise monitoring application, using in particular SPARQL query language, within a small wireless body area network platform comprising heartbeat, GPS sensors, and Android mobile phones.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013161</affiliation-url><afid>60013161</afid><affilname>Institut National des Telecommunications</affilname><name-variant>GET/INT</name-variant><affiliation-city>Evry</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55229328700</author-url><authid>55229328700</authid><authname>Nachabe L.</authname><surname>Nachabe</surname><given-name>Lina</given-name><initials>L.</initials><afid>60013161</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55662904100</author-url><authid>55662904100</authid><authname>Girod-Genet M.</authname><surname>Girod-Genet</surname><given-name>Marc</given-name><initials>M.</initials><afid>60013161</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603225120</author-url><authid>6603225120</authid><authname>El Hassan B.</authname><surname>El Hassan</surname><given-name>Bachar</given-name><initials>B.</initials><afid>60013161</afid></author><authkeywords>BANs | heterogeneity management | ontology | open data model | OWL 2 DL | Pellet | Protégé | semantic | sensor | WSNs</authkeywords><intid>1035951558</intid><article-number>7014284</article-number><source-id>15047</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928644340"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928644340?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928644340&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928644340&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378874115002627"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928644340</prism:url><dc:identifier>SCOPUS_ID:84928644340</dc:identifier><eid>2-s2.0-84928644340</eid><dc:title>Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice</dc:title><dc:creator>Yang Y.</dc:creator><prism:publicationName>Journal of Ethnopharmacology</prism:publicationName><prism:issn>03788741</prism:issn><prism:eIssn>18727573</prism:eIssn><prism:volume>169</prism:volume><prism:pageRange>49-59</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jep.2015.04.011</prism:doi><pii>S0378874115002627</pii><dc:description>© 2015 Elsevier Ireland Ltd. Ethnopharmacological relevance Wuling San, a famous prescription in Chinese medicine, is composed of Polyporus, Poria, Alismatis rhizoma, Cinnamomi cortex and Atractylodis macrocephalae rhizoma, and promotes kidney function and diuresis. The main purpose of this study was to investigate its renal protective effect in high fructose-induced hyperuricemic mice. Materials and methods ICR mice were fed with 30% fructose in drinking water for 6 weeks to induce hyperuricemia and renal dysfunction. Then mice were orally administrated for other 6 weeks with Wuling San (987, 1316, 1755 and 2340 mg/kg), allopurinol (5 mg/kg) and water daily, respectively. Serum and urine levels of uric acid, creatinine and blood urea nitrogen (BUN) were measured. Hematoxylin and eosin staining was used to assess renal histological changes. Renal interleukin (IL)-1β concentrations were measured using ELISA kit. Renal protein levels of organic ion transporters, as well as toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) signaling and pyrin domain containing 3 (NLRP3) inflammasome were determined by Western blot assay. Results Wuling San significantly decreased serum uric acid, creatinine and BUN levels, increased fractional excretion of uric acid (FE&lt;inf&gt;UA&lt;/inf&gt;) in fructose-fed mice. It restored fructose-induced dysregulation of renal urate transporter 1 (URAT1), glucose transporter 9 (GLUT9), ATP-binding cassette subfamily G member 2 (ABCG2) and organic anion transporter 1 (OAT1), as well as organic cation transporter 1 (OCT1) and OCT2 in mice. Wuling San obviously alleviated infiltration of inflammation cells in kidney glomerulus of fructose-fed mice. Moreover, Wuling San suppressed the activation of TLR4/ MyD88 signaling to inhibit nuclear factor κB (NF-κB) signaling and mitogen-activated protein kinases (MAPKs) activation in fructose-fed mice. Additionally, Wuling San decreased NLRP3 inflammasome activation and IL-1β secretion in the kidney of fructose-fed mice. Conclusion Wuling San exerts renal protective effect by modulating renal organic ion transporters in fructose-induced hyperuricemic mice. The molecular mechanism of its action may be associated with the suppression of TLR4/MyD88 signaling and NLRP3 inflammasome activation to reduce IL-1β production in high fructose-induced hyperuricemic mice.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033100</affiliation-url><afid>60033100</afid><affilname>Nanjing University</affilname><name-variant>Nanjing University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115196711</affiliation-url><afid>115196711</afid><affilname>Zhejiang CONBA Pharmaceutical Co., LTD</affilname><name-variant>Zhejiang CONBA Pharmaceutical Co., LTD</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56452548100</author-url><authid>56452548100</authid><authname>Yang Y.</authname><surname>Yang</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60033100</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56451865700</author-url><authid>56451865700</authid><authname>Zhang D.</authname><surname>Zhang</surname><given-name>Dong Mei</given-name><initials>D.M.</initials><afid>60033100</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56609355200</author-url><authid>56609355200</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jia Hui</given-name><initials>J.H.</initials><afid>60033100</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12765910500</author-url><authid>12765910500</authid><authname>Hu L.</authname><surname>Hu</surname><given-name>Lin Shui</given-name><initials>L.S.</initials><afid>115196711</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56018983600</author-url><authid>56018983600</authid><authname>Xue Q.</authname><surname>Xue</surname><given-name>Qiao Chu</given-name><initials>Q.C.</initials><afid>60033100</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55207231400</author-url><authid>55207231400</authid><authname>Ding X.</authname><surname>Ding</surname><given-name>Xiao Qin</given-name><initials>X.Q.</initials><afid>60033100</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7201533047</author-url><authid>7201533047</authid><authname>Kong L.</authname><surname>Kong</surname><given-name>Ling Dong</given-name><initials>L.D.</initials><afid>60033100</afid></author><authkeywords>Fructose | Hyperuricemia | Renal dysfunction | Renal inflammation | Wuling San</authkeywords><intid>1785814873</intid><source-id>23015</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926388685"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926388685?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926388685&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926388685&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0265931X15000818"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926388685</prism:url><dc:identifier>SCOPUS_ID:84926388685</dc:identifier><eid>2-s2.0-84926388685</eid><dc:title>A GIS typology to locate sites of submarine groundwater discharge</dc:title><dc:creator>Rapaglia J.</dc:creator><prism:publicationName>Journal of Environmental Radioactivity</prism:publicationName><prism:issn>0265931X</prism:issn><prism:eIssn>18791700</prism:eIssn><prism:volume>145</prism:volume><prism:pageRange>10-18</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jenvrad.2015.03.016</prism:doi><pii>S0265931X15000818</pii><dc:description>© 2015 Elsevier Ltd. Although many researchers agree on the importance of submarine groundwater discharge (SGD), it remains difficult to locate and quantify this process. A groundwater typology was developed based on local digital elevation models and compared to concurrent radon mapping indicative of SGD in the Niantic River, CT USA. Areas of high radon activity were located near areas of high flow accumulation lending evidence to the utility of this approach to locate SGD. The benefits of this approach are three-fold: fresh terrestrial SGD may be quickly located through widely-available digital elevation models at little or no cost to the investigatorfresh SGD may also be quantified through the GIS approach by multiplying pixelated flow accumulation with the expected annual recharge and, as these data necessarily quantify only fresh SGD, a comparison of these data with SGD as calculated by Rn activity may allow for the separation of the fresh and circulated fractions of SGD. This exercise was completed for the Niantic River where SGD as calculated by the GIS model is 1.2m&lt;sup&gt;3&lt;/sup&gt;/s, SGD as calculated by Rn activity is 0.73-5.5m&lt;sup&gt;3&lt;/sup&gt;/s, and SGD as calculated via a theoretical approach is 1.8-4.3m&lt;sup&gt;3&lt;/sup&gt;/s. Therefore fresh, terrestrial SGD accounts for 22-100% of total SGD in the Niantic River.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022249</affiliation-url><afid>60022249</afid><affilname>Sacred Heart University Fairfield</affilname><name-variant>Sacred Heart University</name-variant><affiliation-city>Fairfield</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026415</affiliation-url><afid>60026415</afid><affilname>Stony Brook University State University of New York</affilname><name-variant>State University of New York at Stony Brook</name-variant><affiliation-city>Stony Brook</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012345</affiliation-url><afid>60012345</afid><affilname>Christian-Albrechts-Universitat zu Kiel</affilname><name-variant>University of Kiel</name-variant><affiliation-city>Kiel</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9740646200</author-url><authid>9740646200</authid><authname>Rapaglia J.</authname><surname>Rapaglia</surname><given-name>John</given-name><initials>J.</initials><afid>60022249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56581207200</author-url><authid>56581207200</authid><authname>Grant C.</authname><surname>Grant</surname><given-name>Carley</given-name><initials>C.</initials><afid>60022249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003920358</author-url><authid>7003920358</authid><authname>Bokuniewicz H.</authname><surname>Bokuniewicz</surname><given-name>Henry</given-name><initials>H.</initials><afid>60026415</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36337228800</author-url><authid>36337228800</authid><authname>Pick T.</authname><surname>Pick</surname><given-name>Tsvi</given-name><initials>T.</initials><afid>60026415</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56584887700</author-url><authid>56584887700</authid><authname>Scholten J.</authname><surname>Scholten</surname><given-name>Jan</given-name><initials>J.</initials><afid>60012345</afid></author><authkeywords>Digital elevation models | Geographic information systems | Radon mapping | Submarine groundwater discharge</authkeywords><intid>1535431279</intid><source-id>23388</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928341405"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928341405?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928341405&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928341405&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0141813015002160"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928341405</prism:url><dc:identifier>SCOPUS_ID:84928341405</dc:identifier><eid>2-s2.0-84928341405</eid><dc:title>Fabrication of 3D porous silk scaffolds by particulate (salt/sucrose) leaching for bone tissue reconstruction</dc:title><dc:creator>Park H.</dc:creator><prism:publicationName>International Journal of Biological Macromolecules</prism:publicationName><prism:issn>01418130</prism:issn><prism:eIssn>18790003</prism:eIssn><prism:volume>78</prism:volume><prism:pageRange>215-223</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijbiomac.2015.03.064</prism:doi><pii>S0141813015002160</pii><dc:description>© 2015 Elsevier B.V. Silk fibroin is a biomaterial being actively studied in the field of bone tissue engineering. In this study, we aimed to select the best strategy for bone reconstruction on scaffolds by changing various conditions. We compared the characteristics of each scaffold via structural analysis using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), the swelling ratio, water uptake, porosity, compressive strength, cell infiltration and cell viability (CCK-8). The scaffolds had high porosity with good inter pore connectivity and showed high compressive strength and modulus. In addition, to confirm bone reconstruction, animal studies were conducted in which samples were implanted in rat calvaria and investigated by micro-CT scans. In conclusion, the presented study indicates that using sucrose produces scaffolds showing better pore interconnectivity and cell infiltration than scaffolds made by using a salt process. In addition, in vivo experiments showed that hydroxyapatite accelerates bone reconstruction on implanted scaffolds. Accordingly, our scaffold will be expected to have a useful application in bone reconstruction.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018986</affiliation-url><afid>60018986</afid><affilname>Hallym University</affilname><name-variant>Hallym University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006034</affiliation-url><afid>60006034</afid><affilname>Hallym University, College of Medicine</affilname><name-variant>Hallym University College of Medicine</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55816278700</author-url><authid>55816278700</authid><authname>Park H.</authname><surname>Park</surname><given-name>Hyun Jung</given-name><initials>H.J.</initials><afid>60018986</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56494177000</author-url><authid>56494177000</authid><authname>Lee O.</authname><surname>Lee</surname><given-name>Ok Joo</given-name><initials>O.J.</initials><afid>60018986</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56245566600</author-url><authid>56245566600</authid><authname>Lee M.</authname><surname>Lee</surname><given-name>Min Chae</given-name><initials>M.C.</initials><afid>60018986</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55816127000</author-url><authid>55816127000</authid><authname>Moon B.</authname><surname>Moon</surname><given-name>Bo Mi</given-name><initials>B.M.</initials><afid>60018986</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55815474800</author-url><authid>55815474800</authid><authname>Ju H.</authname><surname>Ju</surname><given-name>Hyung Woo</given-name><initials>H.W.</initials><afid>60018986</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56127273500</author-url><authid>56127273500</authid><authname>Lee J.</authname><surname>Lee</surname><given-name>Jung min</given-name><initials>J.m.</initials><afid>60018986</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55815799300</author-url><authid>55815799300</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jung Ho</given-name><initials>J.H.</initials><afid>60018986</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56245763100</author-url><authid>56245763100</authid><authname>Kim D.</authname><surname>Kim</surname><given-name>Dong Wook</given-name><initials>D.W.</initials><afid>60018986</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56041884400</author-url><authid>56041884400</authid><authname>Park C.</authname><surname>Park</surname><given-name>Chan Hum</given-name><initials>C.H.</initials><afid>60018986</afid><afid>60006034</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56041884400</author-url><authid>56041884400</authid><authname>Park C.</authname><surname>Park</surname><given-name>Chan Hum</given-name><initials>C.H.</initials><afid>60018986</afid><afid>60006034</afid></author><authkeywords>Bone reconstruction | Hydroxyapatite | Particulate leaching | Silk fibroin</authkeywords><intid>1535765976</intid><source-id>17544</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925352879"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925352879?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925352879&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925352879&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306460315000994"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925352879</prism:url><dc:identifier>SCOPUS_ID:84925352879</dc:identifier><eid>2-s2.0-84925352879</eid><dc:title>Task and barrier self-efficacy among treatment-seeking smokers with current, past or no psychiatric diagnosis</dc:title><dc:creator>Clyde M.</dc:creator><prism:publicationName>Addictive Behaviors</prism:publicationName><prism:issn>03064603</prism:issn><prism:eIssn>18736327</prism:eIssn><prism:volume>46</prism:volume><prism:pageRange>65-69</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.addbeh.2015.03.002</prism:doi><pii>S0306460315000994</pii><dc:description>© 2015 Elsevier Ltd. Objective: Individuals with a lifetime diagnosis of mental illness smoke at rates greater than the general population, and have more difficultly quitting. Cessation self-efficacy has been linked with positive cessation outcomes and can be assessed as either task (confidence to quit) or barrier self-efficacy (confidence to quit in the face of obstacles). We investigated differences in self-efficacy among smokers with a current, past or no lifetime diagnosis of psychiatric illness. Methods: 737 treatment-seeking smokers provided demographic info and smoking history, and were assessed for nicotine dependence, motivation to quit, and task and barrier self-efficacy (Smoking Self-Efficacy Questionnaire; SEQ-12) for smoking cessation. Current and past psychiatric diagnoses were assessed with the Mini International Psychiatric Interview (M.I.N.I. 6.0). ANOVA, chi-square and correlations were calculated for the smoking-related variables across the psychiatric categories. Results: Those with a current diagnosis smoked more cigarettes and were highly nicotine dependent. These individuals had lower barrier self-efficacy compared to those with past or no diagnosis; no differences between groups were observed on task self-efficacy. Motivation to quit was significantly correlated with task self-efficacy in all 3 groups, but with barrier-self efficacy only among those with no lifetime diagnosis of psychiatric illness. Conclusion: Our results highlight the differences in task and barrier cessation self-efficacy in treatment-seeking smokers. Those with a current psychiatric diagnosis have less confidence in their ability to quit when confronting barriers, especially those reflecting internal states. These results highlight the need for targeted interventions to improve cessation self-efficacy, an important determinant of health behavior change.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011635</affiliation-url><afid>60011635</afid><affilname>University of Ottawa Heart Institute</affilname><name-variant>University of Ottawa Heart Institute</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030835</affiliation-url><afid>60030835</afid><affilname>University of Alberta</affilname><name-variant>University of Alberta</name-variant><affiliation-city>Edmonton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55536848400</author-url><authid>55536848400</authid><authname>Clyde M.</authname><surname>Clyde</surname><given-name>M.</given-name><initials>M.</initials><afid>60011635</afid><afid>60028897</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55536848400</author-url><authid>55536848400</authid><authname>Clyde M.</authname><surname>Clyde</surname><given-name>M.</given-name><initials>M.</initials><afid>60011635</afid><afid>60028897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603019268</author-url><authid>6603019268</authid><authname>Tulloch H.</authname><surname>Tulloch</surname><given-name>H.</given-name><initials>H.</initials><afid>60011635</afid><afid>60028897</afid><afid>60028897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603019268</author-url><authid>6603019268</authid><authname>Tulloch H.</authname><surname>Tulloch</surname><given-name>H.</given-name><initials>H.</initials><afid>60011635</afid><afid>60028897</afid><afid>60028897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603019268</author-url><authid>6603019268</authid><authname>Tulloch H.</authname><surname>Tulloch</surname><given-name>H.</given-name><initials>H.</initials><afid>60011635</afid><afid>60028897</afid><afid>60028897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401757570</author-url><authid>7401757570</authid><authname>Reid R.</authname><surname>Reid</surname><given-name>R.</given-name><initials>R.</initials><afid>60011635</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16309473600</author-url><authid>16309473600</authid><authname>Els C.</authname><surname>Els</surname><given-name>C.</given-name><initials>C.</initials><afid>60030835</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004462835</author-url><authid>7004462835</authid><authname>Pipe A.</authname><surname>Pipe</surname><given-name>A.</given-name><initials>A.</initials><afid>60011635</afid><afid>60028897</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004462835</author-url><authid>7004462835</authid><authname>Pipe A.</authname><surname>Pipe</surname><given-name>A.</given-name><initials>A.</initials><afid>60011635</afid><afid>60028897</afid></author><authkeywords>Psychiatric illness | Self-efficacy | Smoking cessation</authkeywords><intid>2035284588</intid><source-id>24763</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927132756"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927132756?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927132756&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927132756&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016786551500077X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927132756</prism:url><dc:identifier>SCOPUS_ID:84927132756</dc:identifier><eid>2-s2.0-84927132756</eid><dc:title>Self-affine snake for medical image segmentation</dc:title><dc:creator>Saadatmand-Tarzjan M.</dc:creator><prism:publicationName>Pattern Recognition Letters</prism:publicationName><prism:issn>01678655</prism:issn><prism:volume>59</prism:volume><prism:pageRange>1-10</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.patrec.2015.03.006</prism:doi><pii>S016786551500077X</pii><dc:description>© 2015 Elsevier B.V. In this paper, a new parametric active contour called self-affine snake is proposed for medical image segmentation. It integrates the wavelet transform, parametric active contour (or snake), and self-affine mapping system to keep their strengths and avoid the weak points. In more detail, it inherits wide capture range from wavelet transform and topological consistency from snake. Furthermore, it takes advantage of self-affine mapping system in several aspects including (i) convergence to weak boundaries, especially, next to strong edges, (ii) reconstruction of boundary openings, and (iii) progress into boundary concavities. The experimental results were performed using a number of synthetic and medical images given in five sets of experiments. Self-affine snake provided comparable/superior results in terms of both solution quality and CPU time compared to a number of frequently-used active contours including balloon, gradient vector flow (GVF), generalized GVF, and active contour without edges. However, its most important properties were the significant robustness against noise and reconstruction of boundary openings. Because of the valuable advantages, the proposed algorithm is an appropriate approach, particularly, for segmentation of medical images which usually suffers from noise corruption and edge uncertainty.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Ferdowsi University of Mashhad</affilname><name-variant>Medical Imaging Lab</name-variant><name-variant>Department of Electrical Engineering</name-variant><affiliation-city>Mashhad</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54966005700</author-url><authid>54966005700</authid><authname>Saadatmand-Tarzjan M.</authname><surname>Saadatmand-Tarzjan</surname><given-name>M.</given-name><initials>M.</initials><afid/></author><authkeywords>Medical image segmentation | Parametric active contours | Self-affine mapping system | Wavelet transform</authkeywords><intid>1535569394</intid><source-id>24825</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930221744"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930221744?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930221744&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930221744&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1570023215300106"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930221744</prism:url><dc:identifier>SCOPUS_ID:84930221744</dc:identifier><eid>2-s2.0-84930221744</eid><dc:title>Prediction of fetal lung maturity using the lecithin/sphingomyelin (L/S) ratio analysis with a simplified sample preparation, using a commercial microtip-column combined with mass spectrometric analysis</dc:title><dc:creator>Kwak H.</dc:creator><prism:publicationName>Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</prism:publicationName><prism:issn>15700232</prism:issn><prism:eIssn>1873376X</prism:eIssn><prism:volume>993-994</prism:volume><prism:pageRange>81-85</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jchromb.2015.05.012</prism:doi><pii>S1570023215300106</pii><dc:description>© 2015. Fetal lung maturity is estimated using the lecithin/sphingomyelin ratio (L/S ratio) in amniotic fluid and it is commonly measured with thin-layer chromatography (TLC). The TLC method is time consuming and technically difficult; however, it is widely used because there is no alternative. We evaluated a novel method for measuring the L/S ratio, which involves a tip-column with a cation-exchange resin and mass spectrometry. Phospholipids in the amniotic fluid were extracted using methanol and chloroform. Choline-containing phospholipids such as lecithin and sphingomyelin were purified by passing them through the tip-column. LC-MS/MS and MALDI-TOF were used to directly analyze the purified samples. The L/S ratio by mass spectrometry was calculated from the sum peak intensity of the six lecithin, and that of sphingomyelin 34:1. In 20 samples, the L/S ratio determined with TLC was significantly correlated with that obtained by LC-MS/MS and MALDI-TOF. There was a 100% concordance between the L/S ratio by TLC and that by LC-MS/MS (kappa value. =. 1.0). The concordance between the L/S ratio by TLC and that by MALDI-TOF was also 100% (kappa value. =. 1.0). Our method provides a faster, simpler, and more reliable assessment of fetal lung maturity. The L/S ratio measured by LC-MS/MS and MALDI-TOF offers a compelling alternative method to traditional TLC.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000304</affiliation-url><afid>60000304</afid><affilname>Dankook University, College of Medicine</affilname><name-variant>Dankook Univ. College of Medicine</name-variant><affiliation-city>Cheonan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028876</affiliation-url><afid>60028876</afid><affilname>Inha University, Incheon</affilname><name-variant>Inha University</name-variant><affiliation-city>Incheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006240</affiliation-url><afid>60006240</afid><affilname>University of Ulsan, College of Medicine</affilname><name-variant>University of Ulsan College of Medicine</name-variant><affiliation-city>Ulsan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018986</affiliation-url><afid>60018986</afid><affilname>Hallym University</affilname><name-variant>Hallym University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15029980500</author-url><authid>15029980500</authid><authname>Kwak H.</authname><surname>Kwak</surname><given-name>Ho Seok</given-name><initials>H.S.</initials><afid>60000304</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56529968200</author-url><authid>56529968200</authid><authname>Chung H.</authname><surname>Chung</surname><given-name>Hee Jung</given-name><initials>H.J.</initials><afid>60000304</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56565808500</author-url><authid>56565808500</authid><authname>Choi Y.</authname><surname>Choi</surname><given-name>Young Sik</given-name><initials>Y.S.</initials><afid>60028876</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102353483</author-url><authid>7102353483</authid><authname>Min W.</authname><surname>Min</surname><given-name>Won Ki</given-name><initials>W.K.</initials><afid>60006240</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56565906400</author-url><authid>56565906400</authid><authname>Jung S.</authname><surname>Jung</surname><given-name>So Young</given-name><initials>S.Y.</initials><afid>60018986</afid></author><authkeywords>Cation-exchange resin | ESI-MS/MS | Fetal lung maturity | Lecithin/sphingomyelin ratio | MALDI-TOF</authkeywords><intid>36086097</intid><source-id>24172</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928658822"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928658822?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928658822&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928658822&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014483515001359"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928658822</prism:url><dc:identifier>SCOPUS_ID:84928658822</dc:identifier><eid>2-s2.0-84928658822</eid><dc:title>Ebselen by modulating oxidative stress improves hypoxia-induced macroglial müller cell and vascular injury in the retina</dc:title><dc:creator>Tan S.</dc:creator><prism:publicationName>Experimental Eye Research</prism:publicationName><prism:issn>00144835</prism:issn><prism:eIssn>10960007</prism:eIssn><prism:volume>136</prism:volume><prism:pageRange>1-8</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.exer.2015.04.015</prism:doi><pii>S0014483515001359</pii><dc:description>© 2015 Elsevier Ltd. Oxidative stress is an important contributor to glial and vascular cell damage in ischemic retinopathies. We hypothesized that ebselen via its ability to reduce reactive oxygen species (ROS) and augment nuclear factor-like 2 (Nrf2) anti-oxidants would attenuate hypoxia-induced damage to macroglial Müller cells and also lessen retinal vasculopathy. Primary cultures of rat Müller cells were exposed to normoxia (21% O&lt;inf&gt;2&lt;/inf&gt;), hypoxia (0.5% O&lt;inf&gt;2&lt;/inf&gt;) and ebselen (2.5μM) for up to 72h. Oxygen-induced retinopathy (OIR) was induced in C57BL/6J mice while control mice were housed in room air. Mice received vehicle (saline, 5% dimethyl sulfoxide) or ebselen (10mg/kg) each day between postnatal days 6-18. In cultured Müller cells, flow cytometry for dihydroethidium revealed that ebselen reduced the hypoxia-induced increase in ROS levels, whilst increasing the expression of Nrf2-regulated anti-oxidant genes, heme oxygenase 1, glutathione peroxidase-1, NAD(P)H dehydrogenase quinone oxidoreductase 1 and glutamate-cysteine ligase. Moreover, in Müller cells, ebselen reduced the hypoxia-induced increase in protein levels of pro-angiogenic and pro-inflammatory factors including vascular endothelial growth factor, interleukin-6, monocyte chemoattractant-protein 1 and intercellular adhesion molecule-1, and the mRNA levels of glial fibrillary acidic protein (GFAP), a marker of Müller cell injury. Ebselen improved OIR by attenuating capillary vaso-obliteration and neovascularization and a concomitant reduction in Müller cell gliosis and GFAP. We conclude that ebselen protects against hypoxia-induced injury of retinal Müller cells and the microvasculature, which is linked to its ability to reduce oxidative stress, vascular damaging factors and inflammation. Agents such as ebselen may be potential treatments for retinopathies that feature oxidative stress-mediated damage to glia and the microvasculature.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033409</affiliation-url><afid>60033409</afid><affilname>Baker IDI Heart and Diabetes Institute</affilname><name-variant>Baker Heart Research Institute</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019578</affiliation-url><afid>60019578</afid><affilname>Monash University</affilname><name-variant>Monash University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26531955000</author-url><authid>26531955000</authid><authname>Tan S.</authname><surname>Tan</surname><given-name>Sih Min</given-name><initials>S.M.</initials><afid>60033409</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54415561900</author-url><authid>54415561900</authid><authname>Deliyanti D.</authname><surname>Deliyanti</surname><given-name>Devy</given-name><initials>D.</initials><afid>60019578</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36439588600</author-url><authid>36439588600</authid><authname>Figgett W.</authname><surname>Figgett</surname><given-name>William A.</given-name><initials>W.A.</initials><afid>60019578</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56609972000</author-url><authid>56609972000</authid><authname>Talia D.</authname><surname>Talia</surname><given-name>Dean M.</given-name><initials>D.M.</initials><afid>60019578</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103156664</author-url><authid>7103156664</authid><authname>de Haan J.</authname><surname>de Haan</surname><given-name>Judy B.</given-name><initials>J.B.</initials><afid>60033409</afid><afid>60019578</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103156664</author-url><authid>7103156664</authid><authname>de Haan J.</authname><surname>de Haan</surname><given-name>Judy B.</given-name><initials>J.B.</initials><afid>60033409</afid><afid>60019578</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701322653</author-url><authid>6701322653</authid><authname>Wilkinson-Berka J.</authname><surname>Wilkinson-Berka</surname><given-name>Jennifer L.</given-name><initials>J.L.</initials><afid>60033409</afid><afid>60019578</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701322653</author-url><authid>6701322653</authid><authname>Wilkinson-Berka J.</authname><surname>Wilkinson-Berka</surname><given-name>Jennifer L.</given-name><initials>J.L.</initials><afid>60033409</afid><afid>60019578</afid></author><authkeywords>Ebselen | Glia | Oxidative stress | Reactive oxygen species | Retinopathy | Vasculature</authkeywords><intid>2035818656</intid><source-id>13866</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929621222"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929621222?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929621222&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929621222&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0028393215300142"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929621222</prism:url><dc:identifier>SCOPUS_ID:84929621222</dc:identifier><eid>2-s2.0-84929621222</eid><dc:title>Relations between social-perceptual ability in multi- and unisensory contexts, autonomic reactivity, and social functioning in individuals with Williams syndrome</dc:title><dc:creator>Järvinen A.</dc:creator><prism:publicationName>Neuropsychologia</prism:publicationName><prism:issn>00283932</prism:issn><prism:eIssn>18733514</prism:eIssn><prism:volume>73</prism:volume><prism:pageRange>127-140</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuropsychologia.2015.04.035</prism:doi><pii>S0028393215300142</pii><dc:description>© 2015 Elsevier Ltd. Compromised social-perceptual ability has been proposed to contribute to social dysfunction in neurodevelopmental disorders. While such impairments have been identified in Williams syndrome (WS), little is known about emotion processing in auditory and multisensory contexts. Employing a multidimensional approach, individuals with WS and typical development (TD) were tested for emotion identification across fearful, happy, and angry multisensory and unisensory face and voice stimuli. Autonomic responses were monitored in response to unimodal emotion. The WS group was administered an inventory of social functioning. Behaviorally, individuals with WS relative to TD demonstrated impaired processing of unimodal vocalizations and emotionally incongruent audiovisual compounds, reflecting a generalized deficit in social-auditory processing in WS. The TD group outperformed their counterparts with WS in identifying negative (fearful and angry) emotion, with similar between-group performance with happy stimuli. Mirroring this pattern, electrodermal activity (EDA) responses to the emotional content of the stimuli indicated that whereas those with WS showed the highest arousal to happy, and lowest arousal to fearful stimuli, the TD participants demonstrated the contrasting pattern. In WS, more normal social functioning was related to higher autonomic arousal to facial expressions. Implications for underlying neural architecture and emotional functions are discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032445</affiliation-url><afid>60032445</afid><affilname>Salk Institute for Biological Studies</affilname><name-variant>Salk Institute for Biological Studies</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024053</affiliation-url><afid>60024053</afid><affilname>Universita Cattolica del Sacro Cuore</affilname><name-variant>Università Cattolica del Sacro Cuore</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55376459500</author-url><authid>55376459500</authid><authname>Järvinen A.</authname><surname>Järvinen</surname><given-name>Anna</given-name><initials>A.</initials><afid>60032445</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:50462077200</author-url><authid>50462077200</authid><authname>Ng R.</authname><surname>Ng</surname><given-name>Rowena</given-name><initials>R.</initials><afid>60032445</afid><afid>60005745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:50462077200</author-url><authid>50462077200</authid><authname>Ng R.</authname><surname>Ng</surname><given-name>Rowena</given-name><initials>R.</initials><afid>60032445</afid><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35087864600</author-url><authid>35087864600</authid><authname>Crivelli D.</authname><surname>Crivelli</surname><given-name>Davide</given-name><initials>D.</initials><afid>60024053</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56567394100</author-url><authid>56567394100</authid><authname>Arnold A.</authname><surname>Arnold</surname><given-name>Andrew J.</given-name><initials>A.J.</initials><afid>60032445</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56652161800</author-url><authid>56652161800</authid><authname>Woo-VonHoogenstyn N.</authname><surname>Woo-VonHoogenstyn</surname><given-name>Nicholas</given-name><initials>N.</initials><afid>60032445</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006708089</author-url><authid>7006708089</authid><authname>Bellugi U.</authname><surname>Bellugi</surname><given-name>Ursula</given-name><initials>U.</initials><afid>60032445</afid></author><authkeywords>Autonomic nervous system | Electrodermal activity | Emotion | Facial expression | Multisensory integration | Social functioning | Vocalization | Williams syndrome</authkeywords><intid>535990991</intid><source-id>18009</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929119891"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929119891?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929119891&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929119891&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929119891</prism:url><dc:identifier>SCOPUS_ID:84929119891</dc:identifier><eid>2-s2.0-84929119891</eid><dc:title>HIF-2 inhibition supresses inflammatory responses and osteoclastic differentiation in human periodontal ligament cells</dc:title><dc:creator>Bae W.</dc:creator><prism:publicationName>Journal of Cellular Biochemistry</prism:publicationName><prism:issn>07302312</prism:issn><prism:eIssn>10974644</prism:eIssn><prism:volume>116</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1241-1255</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1002/jcb.25078</prism:doi><dc:description>© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc. Recent reports suggest that hypoxia inducible factor-2α (HIF-2α) is a key regulator of osteoarthritis cartilage destruction. However, the precise role of HIF-2α in the inflammatory response and osteoclast differentiation remains unclear. The purpose of this study was to investigate the effect of HIF-2α on inflammatory cytokines, extracellular matrix (ECM) destruction enzymes, and osteoclastic differentiation in nicotine and lipopolysaccharide (LPS)-stimulated human periodontal ligament cells (PDLCs). HIF-2α was upregulated in chronically inflamed PDLCs of periodontitis patients, and in nicotine- and LPS-exposed PDLC in dose- and time-dependent manners. HIF-2α inhibitor and HIF-2α siRNA attenuated the nicotine- and LPS- induced production of NO and PGE&lt;inf&gt;2&lt;/inf&gt;, upregulation of iNOS, COX-2, pro-inflammatory cytokines (IL-1β, TNF-α, IL-1β, IL-6, IL-8, IL-10, IL-11, and IL-17), and matrix metalloproteinases (MMPs; MMP-1, -8, -13, -2 and -9), and reversed the effect on TIMPs (TIMP-1 and -2) in PDLCs. The conditioned medium produced by nicotine and LPS-treated PDLCs increased the number of TRAP-stained osteoclasts, TRAP activity and osteoclast-specific genes, which has been blocked by HIF-2α inhibition and silencing. HIF-2α inhibitor and HIF-2α siRNA inhibited the effects of nicotine and LPS on the activation of Akt, JAK2 and STAT3, ERK and JNK MAPK, nuclear factor-κB, c-Jun, and c-Fos. Taken together, this study is the first to demonstrate that HIF-2α inhibition exhibits anti-inflammatory activity through the inhibition of inflammatory cytokines and impairment of ECM destruction, as well as blocking of osteoclastic differentiation in a nicotine- and periodontopathogen-stimulated PDLCs model. Thus, HIF-2α inhibition may be a novel molecular target for therapeutic approaches in periodontitis. J. Cell. Biochem. 116: 1241-1255, 2015.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001873</affiliation-url><afid>60001873</afid><affilname>Kyung Hee University</affilname><name-variant>Kyung Hee University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018986</affiliation-url><afid>60018986</afid><affilname>Hallym University</affilname><name-variant>Hallym University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001873</affiliation-url><afid>60001873</afid><affilname>Kyung Hee University</affilname><name-variant>Kyung Hee University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001873</affiliation-url><afid>60001873</afid><affilname>Kyung Hee University</affilname><name-variant>Kyung Hee University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34874475000</author-url><authid>34874475000</authid><authname>Bae W.</authname><surname>Bae</surname><given-name>Won Jung</given-name><initials>W.J.</initials><afid>60001873</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56222451000</author-url><authid>56222451000</authid><authname>Shin M.</authname><surname>Shin</surname><given-name>Mee Ran</given-name><initials>M.R.</initials><afid>60018986</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56183054000</author-url><authid>56183054000</authid><authname>Kang S.</authname><surname>Kang</surname><given-name>Soo Kyung</given-name><initials>S.K.</initials><afid>60001873</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56638411500</author-url><authid>56638411500</authid><authname>Zhang-Jun </authname><surname>Zhang-Jun</surname><given-name/><initials/><afid>60001873</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55746526200</author-url><authid>55746526200</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jun Yeol</given-name><initials>J.Y.</initials><afid>60001873</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56465431800</author-url><authid>56465431800</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Cheon</given-name><initials>S.C.</initials><afid>60001873</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:49861387900</author-url><authid>49861387900</authid><authname>Kim E.</authname><surname>Kim</surname><given-name>Eun Cheol</given-name><initials>E.C.</initials><afid>60001873</afid></author><authkeywords>HIF-2α | INFLAMMATORY CYTOKINE | OSTEOCLAST | PERIODONTAL LIGAMENT CELLS | PERIODONTITIS</authkeywords><intid>1535900292</intid><source-id>17598</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923060637"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923060637?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923060637&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923060637&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0739724015000041"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923060637</prism:url><dc:identifier>SCOPUS_ID:84923060637</dc:identifier><eid>2-s2.0-84923060637</eid><dc:title>Effects of season, age, sex, and housing on salivary cortisol concentrations in horses</dc:title><dc:creator>Aurich J.</dc:creator><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:issn>07397240</prism:issn><prism:volume>52</prism:volume><prism:pageRange>11-16</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.domaniend.2015.01.003</prism:doi><pii>S0739724015000041</pii><dc:description>© 2015 Elsevier Inc. Analysis of salivary cortisol is increasingly used to assess stress responses in horses. Because spontaneous or experimentally induced increases in cortisol concentrations are often relatively small for stress studies, proper controls are needed. This requires an understanding of the factors affecting salivary cortisol over longer times. In this study, we have analyzed salivary cortisol concentration for 6mo in horses (n = 94) differing in age, sex, reproductive state, and housing. Salivary cortisol followed a diurnal rhythm with the highest concentrations in the morning and a decrease throughout the day (P &lt; 0.001). This rhythm was disrupted in individual groups on individual days; however, alterations remained within the range of diurnal changes. Comparison between months showed highest cortisol concentrations in December (P &lt; 0.001). Cortisol concentrations increased in breeding stallions during the breeding season (P &lt; 0.001). No differences in salivary cortisol concentrations between nonpregnant mares with and without a corpus luteum existed. In stallions, mean daily salivary cortisol and plasma testosterone concentrations were weakly correlated (r = 0.251, P &lt; 0.01). No differences in salivary cortisol between female and male young horses and no consistent differences between horses of different age existed. Group housing and individual stabling did not affect salivary cortisol. In conclusion, salivary cortisol concentrations in horses follow a diurnal rhythm and are increased in active breeding sires. Time of the day and reproductive state of the horses are thus important for experiments that include analysis of cortisol in saliva.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:102039428</affiliation-url><afid>102039428</afid><affilname>University of Veterinary Sciences</affilname><name-variant>University Veterinary Sciences</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105809280</affiliation-url><afid>105809280</afid><affilname>Graf Lehndorff Institute for Equine Science</affilname><name-variant>Graf Lehndorff Institute for Equine Science</name-variant><affiliation-city>Neustadt (Dosse)</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:102039428</affiliation-url><afid>102039428</afid><affilname>University of Veterinary Sciences</affilname><name-variant>University Veterinary Sciences</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:102039428</affiliation-url><afid>102039428</afid><affilname>University of Veterinary Sciences</affilname><name-variant>University Veterinary Sciences</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005485987</author-url><authid>7005485987</authid><authname>Aurich J.</authname><surname>Aurich</surname><given-name>J.</given-name><initials>J.</initials><afid>102039428</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37102868200</author-url><authid>37102868200</authid><authname>Wulf M.</authname><surname>Wulf</surname><given-name>M.</given-name><initials>M.</initials><afid>105809280</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55573482400</author-url><authid>55573482400</authid><authname>Ille N.</authname><surname>Ille</surname><given-name>N.</given-name><initials>N.</initials><afid>102039428</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:49961351200</author-url><authid>49961351200</authid><authname>Erber R.</authname><surname>Erber</surname><given-name>R.</given-name><initials>R.</initials><afid>102039428</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55572758200</author-url><authid>55572758200</authid><authname>von Lewinski M.</authname><surname>von Lewinski</surname><given-name>M.</given-name><initials>M.</initials><afid>105809280</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55119967900</author-url><authid>55119967900</authid><authname>Palme R.</authname><surname>Palme</surname><given-name>R.</given-name><initials>R.</initials><afid>102039428</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006283802</author-url><authid>7006283802</authid><authname>Aurich C.</authname><surname>Aurich</surname><given-name>C.</given-name><initials>C.</initials><afid>102039428</afid></author><authkeywords>Cortisol | Diurnal rhythm | Horse | Housing | Reproduction</authkeywords><intid>1784909875</intid><source-id>17755</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928810840"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928810840?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928810840&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928810840&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001029"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928810840</prism:url><dc:identifier>SCOPUS_ID:84928810840</dc:identifier><eid>2-s2.0-84928810840</eid><dc:title>Wilms' tumor 1 (re)activation in evidence for both epicardial progenitor and endothelial cells for cardiovascular regeneration</dc:title><dc:creator>Aguiar C.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>112-115</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.001</prism:doi><pii>S0022282815001029</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113110278</affiliation-url><afid>113110278</afid><affilname>Dalhousie Medicine New Brunswick</affilname><name-variant>Dalhousie Medical Program in New Brunswick</name-variant><affiliation-city>St John</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55238220200</author-url><authid>55238220200</authid><authname>Aguiar C.</authname><surname>Aguiar</surname><given-name>Christie</given-name><initials>C.</initials><afid>113110278</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14070021300</author-url><authid>14070021300</authid><authname>Brunt K.</authname><surname>Brunt</surname><given-name>Keith R.</given-name><initials>K.R.</initials><afid>113110278</afid></author><intid>1035846359</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928884892"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928884892?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928884892&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928884892&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002191501501028X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928884892</prism:url><dc:identifier>SCOPUS_ID:84928884892</dc:identifier><eid>2-s2.0-84928884892</eid><dc:title>Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals inHungary</dc:title><dc:creator>Mark L.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>62-68</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.810</prism:doi><pii>S002191501501028X</pii><dc:description>© 2015 . Aims: Non-HDL cholesterol represents the pro-atherogenic, apo-B-containing lipoprotein fraction of circulating lipids, and represents a secondary target for CVD prevention in people with diabetes. We therefore assessed the proportion of individuals with diabetes and CVD who attain a non-HDL-C goal of &lt;2.6mmol/L, the extent to which triglycerides influence this goal attainment, and their relationship with HDL-C and triglyceride-rich lipoproteins (TRL). Methods and results: Of 2674 diabetic subjects with baseline CVD in the Hungarian MULTI-GAP programme (mean age 64.8 years, mean HbA1c 7.2%), an LDL-C goal &lt;1.8 and non-HDL-C goal &lt;2.6mmol/L was attained in 13.5% and 17.7% individuals, respectively. Non-HDL-C goal attainment declined at higher triglyceride concentrations; and graphically this relationship appeared to be continuously and inversely associated with triglyceride concentrations. In contrast, the relationship between LDL-C goal attainment was inversely and continuously associated with triglyceride levels up to about 2.5mmol/L, after which the graphical appearance plateaued such that no further difference in LDL-C were observed beyond triglyceride levels of 2.5mmol/L. With increasing triglyceride concentrations, non-HDL-C increased continuously, HDL-C decreased initially but later plateaued (at 1.5-2.0 [men] or 2.0-2.5mmol/L [women]), LDL-C levels plateaued at about 2.0-2.5mmol/L, and TRL-cholesterol (non-HDL-C minus LDL-C) rose continuously. In multivariable-adjusted models, elevated triglyceride concentrations, non-specialist care and uncontrolled blood pressure were inversely associated with non-HDL-C goal attainment. Triglyceride levels were more strongly associated with non-HDL-C than with LDL-C goal attainment (ORs per 1-SD increase in log-triglycerides was 0.74, 95% CI 0.61-0.89, for LDL-C goal attainment, and 0.49, 95% CI 0.38-0.61, for non-HDL-C goal attainment). Conclusion: Non-HDL-C goal attainment was suboptimal in people with diabetes and co-existing CVD. This was most marked at higher triglyceride levels, possibly due to higher levels of TRL.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100390854</affiliation-url><afid>100390854</afid><affilname>Pandy Kalman Bekes County Hospital</affilname><name-variant>Pándy Kálmán Békés County Hospital</name-variant><affiliation-city>Gyula</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033387</affiliation-url><afid>60033387</afid><affilname>University of London</affilname><name-variant>University of London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112617414</affiliation-url><afid>112617414</afid><affilname>St George Fejer County Hospital</affilname><name-variant>St George Fejer County Hospital</name-variant><affiliation-city>Szekesfehervar</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007822</affiliation-url><afid>60007822</afid><affilname>University of Debrecen Medical and Health Science Center</affilname><name-variant>University Medical School</name-variant><affiliation-city>Debrecen</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015150</affiliation-url><afid>60015150</afid><affilname>Imperial College London</affilname><name-variant>Imperial College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16747226900</author-url><authid>16747226900</authid><authname>Mark L.</authname><surname>Mark</surname><given-name>Laszlo</given-name><initials>L.</initials><afid>100390854</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26027650300</author-url><authid>26027650300</authid><authname>Vallejo-Vaz A.</authname><surname>Vallejo-Vaz</surname><given-name>Antonio J.</given-name><initials>A.J.</initials><afid>60033387</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507640538</author-url><authid>6507640538</authid><authname>Reiber I.</authname><surname>Reiber</surname><given-name>Istvan</given-name><initials>I.</initials><afid>112617414</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650214900</author-url><authid>56650214900</authid><authname>Paragh G.</authname><surname>Paragh</surname><given-name>György</given-name><initials>G.</initials><afid>60007822</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56077522400</author-url><authid>56077522400</authid><authname>Kondapally Seshasai S.</authname><surname>Kondapally Seshasai</surname><given-name>Sreenivasa Rao</given-name><initials>S.R.</initials><afid>60033387</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35303190300</author-url><authid>35303190300</authid><authname>Ray K.</authname><surname>Ray</surname><given-name>Kausik K.</given-name><initials>K.K.</initials><afid>60015150</afid></author><authkeywords>Cardiovascular disease | Diabetes mellitus | LDL cholesterol | Non-HDL cholesterol | Remnants | Triglyceride-rich lipoproteins | Triglycerides</authkeywords><intid>535863179</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928683715"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928683715?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928683715&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928683715&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1877750315000630"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928683715</prism:url><dc:identifier>SCOPUS_ID:84928683715</dc:identifier><eid>2-s2.0-84928683715</eid><dc:title>The CardioRisk project: Improvement of cardiovascular risk assessment</dc:title><dc:creator>Paredes S.</dc:creator><prism:publicationName>Journal of Computational Science</prism:publicationName><prism:issn>18777503</prism:issn><prism:volume>9</prism:volume><prism:pageRange>39-44</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jocs.2015.04.025</prism:doi><pii>S1877750315000630</pii><dc:description>© 2015 Elsevier B.V. The CardioRisk project addresses the coronary artery disease (CAD), namely, the management of myocardial infarction (MI) patients. The main goal is the development of personalized clinical models for cardiovascular (CV) risk assessment of acute events (e.g., death and new hospitalization), in order to stratify patients according to their care needs. This paper presents an overview of the scientific and technological issues that are under research and development.Three major scientific challenges can be identified: (i) the development of fusion approaches to merge CV risk assessment tools; (ii) strategies for the grouping (clustering) of patients; (iii) biosignal processing techniques to achieve personalized diagnosis. At the end of the project, a set of algorithms/models must properly address these three challenges.Additionally, a clinical platform was implemented, integrating the developed models and algorithms. This platform supports a clinical observational study (100 patients) that is being carried out in Leiria Hospital Centre to validate the developed approach. Inputs from the hospital information system (demographics, biomarkers, clinical exams) are considered as well as an ECG signal acquired based on a Holter device. A real patient dataset provided by Santa Cruz Hospital, Portugal, comprising N = 460 ACS-NSTEMI patients is also applied to perform initial validations (individual algorithms).The CardioRisk team is composed by two research institutions, the University of Coimbra (Portugal), Politecnico di Milano (Italy) and Leiria Hospital Centre (a Portuguese public hospital).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027898</affiliation-url><afid>60027898</afid><affilname>Instituto Superior de Engenharia de Coimbra</affilname><name-variant>Instituto Superior de Engenharia de Coimbra</name-variant><affiliation-city>Coimbra</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020985</affiliation-url><afid>60020985</afid><affilname>Universidade de Coimbra</affilname><name-variant>Universidade de Coimbra</name-variant><affiliation-city>Coimbra</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023256</affiliation-url><afid>60023256</afid><affilname>Politecnico di Milano</affilname><name-variant>Politecnico di Milano</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115200115</affiliation-url><afid>115200115</afid><affilname>Centro Hospitalar de Leiria</affilname><name-variant>Centro Hospitalar de Leiria</name-variant><affiliation-city/><affiliation-country>Portugal</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55959932800</author-url><authid>55959932800</authid><authname>Paredes S.</authname><surname>Paredes</surname><given-name>Simão</given-name><initials>S.</initials><afid>60027898</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23980930400</author-url><authid>23980930400</authid><authname>Rocha T.</authname><surname>Rocha</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60027898</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26535630100</author-url><authid>26535630100</authid><authname>de Carvalho P.</authname><surname>de Carvalho</surname><given-name>Paulo</given-name><initials>P.</initials><afid>60020985</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:14010018700</author-url><authid>14010018700</authid><authname>Henriques J.</authname><surname>Henriques</surname><given-name>Jorge</given-name><initials>J.</initials><afid>60020985</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56609920600</author-url><authid>56609920600</authid><authname>Mendes D.</authname><surname>Mendes</surname><given-name>Diana</given-name><initials>D.</initials><afid>60020985</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56610381600</author-url><authid>56610381600</authid><authname>Cabete R.</authname><surname>Cabete</surname><given-name>Ricardo</given-name><initials>R.</initials><afid>60027898</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55193127000</author-url><authid>55193127000</authid><authname>Cabiddu R.</authname><surname>Cabiddu</surname><given-name>Ramona</given-name><initials>R.</initials><afid>60023256</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7401727981</author-url><authid>7401727981</authid><authname>Bianchi A.</authname><surname>Bianchi</surname><given-name>Anna</given-name><initials>A.</initials><afid>60023256</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35916716800</author-url><authid>35916716800</authid><authname>Morais J.</authname><surname>Morais</surname><given-name>João</given-name><initials>J.</initials><afid>115200115</afid></author><authkeywords>Cardiovascular risk assessment | Clinical applications | Myocardial infarction | Personalization</authkeywords><intid>2035818346</intid><source-id>19700174607</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929012145"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929012145?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929012145&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929012145&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002191501501014X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929012145</prism:url><dc:identifier>SCOPUS_ID:84929012145</dc:identifier><eid>2-s2.0-84929012145</eid><dc:title>Animal models of surgically manipulated flow velocities to study shear stress-induced atherosclerosis</dc:title><dc:creator>Winkel L.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>100-110</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.796</prism:doi><pii>S002191501501014X</pii><dc:description>© 2015 Elsevier Ireland Ltd. Atherosclerosis is a chronic inflammatory disease of the arterial tree that develops at predisposed sites, coinciding with locations that are exposed to low or oscillating shear stress. Manipulating flow velocity, and concomitantly shear stress, has proven adequate to promote endothelial activation and subsequent plaque formation in animals. In this article, we will give an overview of the animal models that have been designed to study the causal relationship between shear stress and atherosclerosis by surgically manipulating blood flow velocity profiles. These surgically manipulated models include arteriovenous fistulas, vascular grafts, arterial ligation, and perivascular devices. We review these models of manipulated blood flow velocity from an engineering and biological perspective, focusing on the shear stress profiles they induce and the vascular pathology that is observed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54399648200</author-url><authid>54399648200</authid><authname>Winkel L.</authname><surname>Winkel</surname><given-name>Leah C.</given-name><initials>L.C.</initials><afid>60032114</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55382786900</author-url><authid>55382786900</authid><authname>Hoogendoorn A.</authname><surname>Hoogendoorn</surname><given-name>Ayla</given-name><initials>A.</initials><afid>60032114</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56625621500</author-url><authid>56625621500</authid><authname>Xing R.</authname><surname>Xing</surname><given-name>Ruoyu</given-name><initials>R.</initials><afid>60032114</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003548849</author-url><authid>7003548849</authid><authname>Wentzel J.</authname><surname>Wentzel</surname><given-name>Jolanda J.</given-name><initials>J.J.</initials><afid>60032114</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56030728900</author-url><authid>56030728900</authid><authname>Van der Heiden K.</authname><surname>Van der Heiden</surname><given-name>Kim</given-name><initials>K.</initials><afid>60032114</afid></author><authkeywords>Animal models | Atherosclerosis | Endothelium | Fluid dynamics | Shear stress | Vulnerable plaque</authkeywords><intid>1035879514</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928123232"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928123232?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928123232&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928123232&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515001000"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928123232</prism:url><dc:identifier>SCOPUS_ID:84928123232</dc:identifier><eid>2-s2.0-84928123232</eid><dc:title>Disparities in long-term cardiovascular disease risk by sexual identity: The National Longitudinal Study of Adolescent to Adult Health</dc:title><dc:creator>Clark C.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>76</prism:volume><prism:pageRange>26-30</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.022</prism:doi><pii>S0091743515001000</pii><dc:description>© 2015 Elsevier Inc. Objective: To examine long-term cardiovascular disease (CVD) risk disparities by sexual identity using a nationally representative sample of young adults in the United States. Methods: Data include participants in wave 4 (2008/09; ages 24-34. years) of the National Longitudinal Study of Adolescent to Adult Health (7087 females; 6340 males). Sexual identity was self-reported (heterosexual, mostly heterosexual, bisexual, mostly homosexual, homosexual) and a Framingham-based prediction model was used to estimate participants' risk of a CVD event over 30. years. Differences in CVD risk by sexual identity, relative to heterosexuals, were calculated with linear regression models adjusted for age, race/ethnicity, education, and financial distress. Results: Average 30-year CVD risk was 17.2% (95% CI: 16.7, 17.7) in males and 9.0% (95% CI: 8.6, 9.3) in females. Compared to heterosexual females, mostly heterosexual (0.8%; 95% CI: 0.2, 1.4) and mostly homosexual females (2.8%; 95% CI: 0.8, 4.9) had higher CVD risk. Bisexual and homosexual females had higher but not statistically significant CVD risk compared to heterosexuals. Among males, differences in CVD risk by sexual identity were not statistically significant. Conclusion: Sexual identity was associated with CVD risk in sexual minority subgroups. Population- and clinic-based prevention strategies are needed to minimize disparities in subsequent disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113137722</affiliation-url><afid>113137722</afid><affilname>Rainbow Health Initiative</affilname><name-variant>Rainbow Health Initiative</name-variant><affiliation-city>Minneapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Independent Researcher</affilname><affiliation-city>Atlanta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100628660</affiliation-url><afid>100628660</afid><affilname>Division Health Policy and Management</affilname><name-variant>Division Health Policy and Management</name-variant><affiliation-city>Berkeley</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113601313</affiliation-url><afid>113601313</afid><affilname>Program in Health Disparities Research</affilname><name-variant>Program in Health Disparities Research</name-variant><affiliation-city>Minneapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55311601500</author-url><authid>55311601500</authid><authname>Clark C.</authname><surname>Clark</surname><given-name>Cari Jo</given-name><initials>C.J.</initials><afid>60005745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701472623</author-url><authid>6701472623</authid><authname>Borowsky I.</authname><surname>Borowsky</surname><given-name>Iris W.</given-name><initials>I.W.</initials><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56600016900</author-url><authid>56600016900</authid><authname>Salisbury J.</authname><surname>Salisbury</surname><given-name>John</given-name><initials>J.</initials><afid>113137722</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56600126100</author-url><authid>56600126100</authid><authname>Usher J.</authname><surname>Usher</surname><given-name>Joann</given-name><initials>J.</initials><afid>113137722</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55225847700</author-url><authid>55225847700</authid><authname>Spencer R.</authname><surname>Spencer</surname><given-name>Rachael A.</given-name><initials>R.A.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56167687100</author-url><authid>56167687100</authid><authname>Przedworski J.</authname><surname>Przedworski</surname><given-name>Julia M.</given-name><initials>J.M.</initials><afid>100628660</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:33267854900</author-url><authid>33267854900</authid><authname>Renner L.</authname><surname>Renner</surname><given-name>Lynette M.</given-name><initials>L.M.</initials><afid>60005745</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7402131171</author-url><authid>7402131171</authid><authname>Fisher C.</authname><surname>Fisher</surname><given-name>Colleen</given-name><initials>C.</initials><afid>60005745</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602905729</author-url><authid>6602905729</authid><authname>Everson-Rose S.</authname><surname>Everson-Rose</surname><given-name>Susan A.</given-name><initials>S.A.</initials><afid>113601313</afid></author><authkeywords>Cardiovascular diseases | Health status disparities | Homosexuality</authkeywords><intid>1535733709</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929179438"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929179438?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929179438&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929179438&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1551714415000853"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929179438</prism:url><dc:identifier>SCOPUS_ID:84929179438</dc:identifier><eid>2-s2.0-84929179438</eid><dc:title>A centralized cardiovascular risk service to improve guideline adherence in private primary care offices</dc:title><dc:creator>Carter B.</dc:creator><prism:publicationName>Contemporary Clinical Trials</prism:publicationName><prism:issn>15517144</prism:issn><prism:eIssn>15592030</prism:eIssn><prism:volume>43</prism:volume><prism:pageRange>25-32</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cct.2015.04.014</prism:doi><pii>S1551714415000853</pii><dc:description>© 2015 Elsevier Inc. Background: Many large health systems now employ clinical pharmacists in team-based care to assist patients and physicians with management of cardiovascular (CV) diseases. However, small private offices often lack the resources to hire a clinical pharmacist for their office. The purpose of this study is to evaluate whether a centralized, web-based CV risk service (CVRS) managed by clinical pharmacists will improve guideline adherence in primary care medical offices in rural and small communities. Methods: This study is a cluster randomized prospective trial in 12 primary care offices. Medical offices were randomized to either the CVRS intervention or usual care. The intervention will last for 12. months and all subjects will have research visits at baseline and 12. months. Primary outcomes will include adherence to treatment guidelines and control of key CV risk factors. Data will also be abstracted from the medical record at 30. months to determine if the intervention effect is sustained after it is discontinued. Conclusions: This study will enroll subjects through 2015 and results will be available in 2018. This study will provide information on whether a distant, centralized CV risk service can improve guideline adherence in medical offices that lack the resources to employ clinical pharmacists.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107076887</affiliation-url><afid>107076887</afid><affilname>College of Pharmacy</affilname><name-variant>College of Pharmacy</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106456470</affiliation-url><afid>106456470</afid><affilname>Roy J. and Lucille A. Carver College of Medicine</affilname><name-variant>Roy and Lucille Carver School of Medicine</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106442652</affiliation-url><afid>106442652</afid><affilname>College of Public Health</affilname><name-variant>College of Public Health</name-variant><affiliation-city>Little Rock</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018615</affiliation-url><afid>60018615</afid><affilname>Veterans Administration</affilname><name-variant>Veterans Administration</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106448241</affiliation-url><afid>106448241</afid><affilname>Carver College of Medicine</affilname><name-variant>Carver College of Medicine</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:111165220</affiliation-url><afid>111165220</afid><affilname>College of Liberal Arts</affilname><name-variant>College of Liberal Arts</name-variant><affiliation-city>Tahlequah</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024324</affiliation-url><afid>60024324</afid><affilname>University of Iowa</affilname><name-variant>University of Iowa</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35414941300</author-url><authid>35414941300</authid><authname>Carter B.</authname><surname>Carter</surname><given-name>Barry L.</given-name><initials>B.L.</initials><afid>107076887</afid><afid>106456470</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35414941300</author-url><authid>35414941300</authid><authname>Carter B.</authname><surname>Carter</surname><given-name>Barry L.</given-name><initials>B.L.</initials><afid>107076887</afid><afid>106456470</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35511214000</author-url><authid>35511214000</authid><authname>Levy B.</authname><surname>Levy</surname><given-name>Barcey T.</given-name><initials>B.T.</initials><afid>106456470</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507325087</author-url><authid>6507325087</authid><authname>Gryzlak B.</authname><surname>Gryzlak</surname><given-name>Brian</given-name><initials>B.</initials><afid>107076887</afid><afid>106442652</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507325087</author-url><authid>6507325087</authid><authname>Gryzlak B.</authname><surname>Gryzlak</surname><given-name>Brian</given-name><initials>B.</initials><afid>107076887</afid><afid>106442652</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004472256</author-url><authid>7004472256</authid><authname>Chrischilles E.</authname><surname>Chrischilles</surname><given-name>Elizabeth A.</given-name><initials>E.A.</initials><afid>106442652</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55191139500</author-url><authid>55191139500</authid><authname>Vander Weg M.</authname><surname>Vander Weg</surname><given-name>Mark W.</given-name><initials>M.W.</initials><afid>60018615</afid><afid>106448241</afid><afid>111165220</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55191139500</author-url><authid>55191139500</authid><authname>Vander Weg M.</authname><surname>Vander Weg</surname><given-name>Mark W.</given-name><initials>M.W.</initials><afid>60018615</afid><afid>106448241</afid><afid>111165220</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55191139500</author-url><authid>55191139500</authid><authname>Vander Weg M.</authname><surname>Vander Weg</surname><given-name>Mark W.</given-name><initials>M.W.</initials><afid>60018615</afid><afid>106448241</afid><afid>111165220</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640674700</author-url><authid>56640674700</authid><authname>Christensen A.</authname><surname>Christensen</surname><given-name>Alan J.</given-name><initials>A.J.</initials><afid>106448241</afid><afid>111165220</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640674700</author-url><authid>56640674700</authid><authname>Christensen A.</authname><surname>Christensen</surname><given-name>Alan J.</given-name><initials>A.J.</initials><afid>106448241</afid><afid>111165220</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:34975060200</author-url><authid>34975060200</authid><authname>James P.</authname><surname>James</surname><given-name>Paul A.</given-name><initials>P.A.</initials><afid>106456470</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56401580100</author-url><authid>56401580100</authid><authname>Moss C.</authname><surname>Moss</surname><given-name>Carol A.</given-name><initials>C.A.</initials><afid>106456470</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56033849200</author-url><authid>56033849200</authid><authname>Parker C.</authname><surname>Parker</surname><given-name>Christopher P.</given-name><initials>C.P.</initials><afid>107076887</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56324620300</author-url><authid>56324620300</authid><authname>Gums T.</authname><surname>Gums</surname><given-name>Tyler</given-name><initials>T.</initials><afid>107076887</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56640890600</author-url><authid>56640890600</authid><authname>Finkelstein R.</authname><surname>Finkelstein</surname><given-name>Rachel J.</given-name><initials>R.J.</initials><afid>107076887</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:23013338100</author-url><authid>23013338100</authid><authname>Xu Y.</authname><surname>Xu</surname><given-name>Yinghui</given-name><initials>Y.</initials><afid>106456470</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56454744900</author-url><authid>56454744900</authid><authname>Dawson J.</authname><surname>Dawson</surname><given-name>Jeffrey D.</given-name><initials>J.D.</initials><afid>60024324</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:12766972000</author-url><authid>12766972000</authid><authname>Polgreen L.</authname><surname>Polgreen</surname><given-name>Linnea A.</given-name><initials>L.A.</initials><afid>107076887</afid></author><authkeywords>Cardiovascular disease | Clinical trial | Diabetes | Guideline adherence | Pharmacist management</authkeywords><intid>1785917457</intid><source-id>130115</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929584490"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929584490?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929584490&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929584490&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009898115002430"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929584490</prism:url><dc:identifier>SCOPUS_ID:84929584490</dc:identifier><eid>2-s2.0-84929584490</eid><dc:title>Biological variation of established and novel biomarkers for atherosclerosis: Results from a prospective, parallel-group cohort study</dc:title><dc:creator>Engelberger R.</dc:creator><prism:publicationName>Clinica Chimica Acta</prism:publicationName><prism:issn>00098981</prism:issn><prism:eIssn>18733492</prism:eIssn><prism:volume>447</prism:volume><prism:pageRange>16-22</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cca.2015.05.003</prism:doi><pii>S0009898115002430</pii><dc:description>© 2015 Elsevier B.V. Background: Biomarkers are a promising tool for the management of patients with atherosclerosis, but their variation is largely unknown. We assessed within-subject and between-subject biological variation of biomarkers in peripheral artery disease (PAD) patients and healthy controls, and defined which biomarkers have a favorable variation profile for future studies. Methods: Prospective, parallel-group cohort study, including 62 patients with stable PAD (79% men, 65±7years) and 18 healthy control subjects (44% men, 57±7years). Blood samples were taken at baseline, and after 3-, 6-, and 12-months. We calculated within-subject (CV&lt;inf&gt;I&lt;/inf&gt;) and between-subject (CV&lt;inf&gt;G&lt;/inf&gt;) coefficients of variation and intra-class correlation coefficient (ICC). Results: Mean levels of D-dimer, hs-CRP, IL-6, IL-8, MMP-9, MMP-3, S100A8/A9, PAI-1, sICAM-1, and sP-selectin levels were higher in PAD patients than in healthy controls (P≤.05 for all). CV&lt;inf&gt;I&lt;/inf&gt; and CV&lt;inf&gt;G&lt;/inf&gt; of the different biomarkers varied considerably in both groups. An ICC≥0.5 (indicating moderate-to-good reliability) was found for hs-CRP, D-Dimer, E-selectin, IL-10, MCP-1, MMP-3, oxLDL, sICAM-1 and sP-selectin in both groups, for sVCAM in healthy controls and for MMP-9, PAI-1 and sCD40L in PAD patients. Conclusions: Single biomarker measurements are of limited utility due to large within-subject variation, both in PAD patients and healthy subjects. D-dimer, hs-CRP, MMP-9, MMP-3, PAI-1, sP-selectin and sICAM-1 are biomarkers with both higher mean levels in PAD patients and a favorable variation profile making them most suitable for future studies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023561</affiliation-url><afid>60023561</afid><affilname>Centre Hospitalier Universitaire Vaudois</affilname><name-variant>CHUV</name-variant><affiliation-city>Lausanne</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020486</affiliation-url><afid>60020486</afid><affilname>Universitat Bern</affilname><name-variant>University of Berne</name-variant><affiliation-city>Bern</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015322</affiliation-url><afid>60015322</afid><affilname>Institut fur Sozial- und Praventivmedizin</affilname><name-variant>University of Geneva</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008201</affiliation-url><afid>60008201</afid><affilname>F. Hoffmann-La Roche AG</affilname><name-variant>F. Hoffmann-La Roche Ltd.</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24503123900</author-url><authid>24503123900</authid><authname>Engelberger R.</authname><surname>Engelberger</surname><given-name>Rolf P.</given-name><initials>R.P.</initials><afid>60023561</afid><afid>60020486</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24503123900</author-url><authid>24503123900</authid><authname>Engelberger R.</authname><surname>Engelberger</surname><given-name>Rolf P.</given-name><initials>R.P.</initials><afid>60023561</afid><afid>60020486</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12143180000</author-url><authid>12143180000</authid><authname>Limacher A.</authname><surname>Limacher</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60015322</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006281296</author-url><authid>7006281296</authid><authname>Kucher N.</authname><surname>Kucher</surname><given-name>Nils</given-name><initials>N.</initials><afid>60020486</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37080093600</author-url><authid>37080093600</authid><authname>Baumann F.</authname><surname>Baumann</surname><given-name>Frédéric</given-name><initials>F.</initials><afid>60020486</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24779993900</author-url><authid>24779993900</authid><authname>Silbernagel G.</authname><surname>Silbernagel</surname><given-name>Günther</given-name><initials>G.</initials><afid>60020486</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603192836</author-url><authid>6603192836</authid><authname>Benghozi R.</authname><surname>Benghozi</surname><given-name>Renée</given-name><initials>R.</initials><afid>60008201</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56376843600</author-url><authid>56376843600</authid><authname>Do D.</authname><surname>Do</surname><given-name>Dai Do</given-name><initials>D.D.</initials><afid>60020486</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:14020935700</author-url><authid>14020935700</authid><authname>Willenberg T.</authname><surname>Willenberg</surname><given-name>Torsten</given-name><initials>T.</initials><afid>60020486</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005347057</author-url><authid>7005347057</authid><authname>Baumgartner I.</authname><surname>Baumgartner</surname><given-name>Iris</given-name><initials>I.</initials><afid>60020486</afid></author><authkeywords>Atherosclerosis | Biological variation | Biomarkers | Inflammation | Peripheral vascular disease</authkeywords><intid>2035975743</intid><source-id>29286</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929306852"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929306852?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929306852&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929306852&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010126"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929306852</prism:url><dc:identifier>SCOPUS_ID:84929306852</dc:identifier><eid>2-s2.0-84929306852</eid><dc:title>Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy</dc:title><dc:creator>Bugiardini R.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>151-156</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.794</prism:doi><pii>S0021915015010126</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objective: We sought explore the relative benefits of unfractionated heparin (UFH) compared with enoxaparin, alone or in combination with clopidogrel, in ST-segment elevation myocardial infarction (STEMI) patients not undergoing reperfusion therapy. Methods: This is a propensity score study from The International Survey on Acute Coronary Syndromes in Transition Countries (ISACS-TC/NCT01218776) on patients admitted between October 2010-June 2013. There were a total of 1175 STEMI patients who did not receive mechanical or pharmacological reperfusion. Of these, 1063 were eligible for the aim of the study, being treated with UFH (522/1175; 44.4%) or enoxaparin (541/1175; 46%). Clopidogrel in combination with UFH or enoxaparin was given to 751 (63.9%) patients. The primary endpoint was in-hospital mortality. Secondary endpoints were intracranial hemorrhages, and clinically relevant bleedings. Results: After adjustment for any confounders, UFH was associated with a lower risk of in-hospital mortality in clopidogrel users (multivariate adjusted regression analysis: odds ratio [OR]: 0.62, 95% Confidence Interval [CI] 0.41-0.94) as compared with clopidogrel non-users (OR: 0.94, 95% CI 0.55-1.60). The observed effect was not associated with combined enoxaparin and clopidogrel therapy. Major bleeding events were comparable in the enoxaparin group and UFH group (0.4% and 1.5% respectively, p=0.06). The risk of major hemorrhage was nearly similar with combined UFH-clopidogrel therapy (1.4%) as compared with UFH alone (1.9%), p=0.67. Conclusion: UFH - Clopidogrel combination was associated with a large mortality reduction in STEMI patients not undergoing reperfusion therapy and did not significantly increase the risk of major bleeding.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028218</affiliation-url><afid>60028218</afid><affilname>Alma Mater Studiorum Universita di Bologna</affilname><name-variant>University of Bologna</name-variant><affiliation-city>Bologna</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113167296</affiliation-url><afid>113167296</afid><affilname>Floreasca Emergency Hospital</affilname><name-variant>Emergency Hospital Floreasca</name-variant><affiliation-city>Bucharest</affiliation-city><affiliation-country>Romania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068815</affiliation-url><afid>60068815</afid><affilname>University of Belgrade</affilname><name-variant>University of Belgrade</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072629</affiliation-url><afid>60072629</afid><affilname>SS Cyril and Methodius University</affilname><name-variant>Ss. Cyril and Methodius University</name-variant><affiliation-city>Skopje</affiliation-city><affiliation-country>Macedonia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107123770</affiliation-url><afid>107123770</afid><affilname>Center of Cardiology</affilname><name-variant>Center of Cardiology</name-variant><affiliation-city>Podgorica</affiliation-city><affiliation-country>Montenegro</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006461</affiliation-url><afid>60006461</afid><affilname>University of Zagreb School of Medicine</affilname><name-variant>University of Zagreb Medical School</name-variant><affiliation-city>Zagreb</affiliation-city><affiliation-country>Croatia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112981826</affiliation-url><afid>112981826</afid><affilname>Clinical Center of Banja Luka</affilname><name-variant>Clinical Center of Banja Luka</name-variant><affiliation-city/><affiliation-country>Bosnia and Herzegovina</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107034151</affiliation-url><afid>107034151</afid><affilname>University Clinical Centre of Kosovo</affilname><name-variant>University Clinical Centre of Kosovo</name-variant><affiliation-city/><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027871</affiliation-url><afid>60027871</afid><affilname>Testnevelesi es Sporttudomanyi Kar Semmelweis Egyetem</affilname><name-variant>Hung. Univ. of Physical Education</name-variant><affiliation-city>Budapest</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029961</affiliation-url><afid>60029961</afid><affilname>New York Medical College</affilname><name-variant>New York Medical College</name-variant><affiliation-city>Valhalla</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023020</affiliation-url><afid>60023020</afid><affilname>Universidad Autonoma de Barcelona</affilname><name-variant>Universitat Autonoma de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26541113500</author-url><authid>26541113500</authid><authname>Bugiardini R.</authname><surname>Bugiardini</surname><given-name>Raffaele</given-name><initials>R.</initials><afid>60028218</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6604055561</author-url><authid>6604055561</authid><authname>Dorobantu M.</authname><surname>Dorobantu</surname><given-name>Maria</given-name><initials>M.</initials><afid>113167296</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602641182</author-url><authid>6602641182</authid><authname>Vasiljevic Z.</authname><surname>Vasiljevic</surname><given-name>Zorana</given-name><initials>Z.</initials><afid>60068815</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23970691700</author-url><authid>23970691700</authid><authname>Kedev S.</authname><surname>Kedev</surname><given-name>Sasko</given-name><initials>S.</initials><afid>60072629</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23474019600</author-url><authid>23474019600</authid><authname>Knežević B.</authname><surname>Knežević</surname><given-name>Božidarka</given-name><initials>B.</initials><afid>107123770</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003530479</author-url><authid>7003530479</authid><authname>Miličić D.</authname><surname>Miličić</surname><given-name>Davor</given-name><initials>D.</initials><afid>60006461</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56010202500</author-url><authid>56010202500</authid><authname>Calmac L.</authname><surname>Calmac</surname><given-name>Lucian</given-name><initials>L.</initials><afid>113167296</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56009277500</author-url><authid>56009277500</authid><authname>Trninic D.</authname><surname>Trninic</surname><given-name>Dijana</given-name><initials>D.</initials><afid>112981826</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:26027859400</author-url><authid>26027859400</authid><authname>Daullxhiu I.</authname><surname>Daullxhiu</surname><given-name>Irfan</given-name><initials>I.</initials><afid>107034151</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55651505300</author-url><authid>55651505300</authid><authname>Cenko E.</authname><surname>Cenko</surname><given-name>Edina</given-name><initials>E.</initials><afid>60028218</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56011398600</author-url><authid>56011398600</authid><authname>Ricci B.</authname><surname>Ricci</surname><given-name>Beatrice</given-name><initials>B.</initials><afid>60028218</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7101784080</author-url><authid>7101784080</authid><authname>Puddu P.</authname><surname>Puddu</surname><given-name>Paolo Emilio</given-name><initials>P.E.</initials><afid>60032350</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6505860414</author-url><authid>6505860414</authid><authname>Manfrini O.</authname><surname>Manfrini</surname><given-name>Olivia</given-name><initials>O.</initials><afid>60028218</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7102499922</author-url><authid>7102499922</authid><authname>Koller A.</authname><surname>Koller</surname><given-name>Akos</given-name><initials>A.</initials><afid>60027871</afid><afid>60029961</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7102499922</author-url><authid>7102499922</authid><authname>Koller A.</authname><surname>Koller</surname><given-name>Akos</given-name><initials>A.</initials><afid>60027871</afid><afid>60029961</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7102141956</author-url><authid>7102141956</authid><authname>Badimon L.</authname><surname>Badimon</surname><given-name>Lina</given-name><initials>L.</initials><afid>60023020</afid></author><authkeywords>Clopidogrel | Enoxaparin | No-reperfusion therapy | Outcomes | ST-segment elevation myocardial infarction | Unfractionated heparin</authkeywords><intid>1535945551</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928747131"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928747131?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928747131&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928747131&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0278691515001131"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928747131</prism:url><dc:identifier>SCOPUS_ID:84928747131</dc:identifier><eid>2-s2.0-84928747131</eid><dc:title>Modulating effect of synthetic statins against damage induced by doxorubicin in somatic cells of Drosophila melanogaster</dc:title><dc:creator>Orsolin P.</dc:creator><prism:publicationName>Food and Chemical Toxicology</prism:publicationName><prism:issn>02786915</prism:issn><prism:eIssn>18736351</prism:eIssn><prism:volume>81</prism:volume><prism:pageRange>111-119</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fct.2015.04.004</prism:doi><pii>S0278691515001131</pii><dc:description>© 2015. The competitive inhibitors of HMG-CoA reductase, popularly known as statins, exert pleiotropic effects, which result from the ability of statins to inhibit the synthesis of isoprenoids, which are fundamental for the functioning of proteins responsible for intracellular signaling. Some recent studies suggest an important role associated with the use of antineoplastic atorvastatin and rosuvastatin, the statins most widely used today. In this study, the Drosophila wing spot test was used to evaluate possible protective effects of atorvastatin and rosuvastatin against damage induced by DXR. Larvae were chronically treated with negative control (ethanol 5%), positive control (DXR 0.125 mg/mL) and five different concentrations of atorvastatin and rosuvastatin. The results demonstrated absence of a mutagenic effect for the two statins tested. The analysis of the descendants co-treated with DXR and atorvastatin/rosuvastatin revealed a modulatory effect of these statins on damage induced by DXR. This effect was verified in all concentrations tested in the descendants of the ST and HB crosses treated with rosuvastatin, and only in descendants of the HB cross treated with atorvastatin. Induction of apoptosis and antioxidant activity appear to be the main mechanisms involved in reducing the frequency of mutant spots and consequent modulation of the damage induced by DXR.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015104</affiliation-url><afid>60015104</afid><affilname>Universidade Federal de Uberlandia</affilname><name-variant>Federal University of Uberlândia</name-variant><affiliation-city>Uberlandia</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100816958</affiliation-url><afid>100816958</afid><affilname>Centro Universitário de Patos de Minas</affilname><name-variant>Centro Universitário de Patos de Minas</name-variant><affiliation-city/><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55253719200</author-url><authid>55253719200</authid><authname>Orsolin P.</authname><surname>Orsolin</surname><given-name>P. C.</given-name><initials>P.C.</initials><afid>60015104</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55253516400</author-url><authid>55253516400</authid><authname>Silva-Oliveira R.</authname><surname>Silva-Oliveira</surname><given-name>R. G.</given-name><initials>R.G.</initials><afid>60015104</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6508255027</author-url><authid>6508255027</authid><authname>Nepomuceno J.</authname><surname>Nepomuceno</surname><given-name>J. C.</given-name><initials>J.C.</initials><afid>60015104</afid><afid>100816958</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6508255027</author-url><authid>6508255027</authid><authname>Nepomuceno J.</authname><surname>Nepomuceno</surname><given-name>J. C.</given-name><initials>J.C.</initials><afid>60015104</afid><afid>100816958</afid></author><authkeywords>Atorvastatin | Drosophila melanogaster | Modulatory effect | Rosuvastatin | Smart</authkeywords><intid>1035834842</intid><source-id>25096</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929144042"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929144042?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929144042&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929144042&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915000654"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929144042</prism:url><dc:identifier>SCOPUS_ID:84929144042</dc:identifier><eid>2-s2.0-84929144042</eid><dc:title>Sirtuins in vascular diseases: Emerging roles and therapeutic potential</dc:title><dc:creator>D'Onofrio N.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1311-1322</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.03.001</prism:doi><pii>S0925443915000654</pii><dc:description>© 2015. Silent information regulator-2 (Sir-2) proteins, or sirtuins, are a highly conserved protein family of histone deacetylases that promote longevity by mediating many of the beneficial effects of calorie restriction which extends life span and reduces the incidence of cancer, cardiovascular disease (CVD), and diabetes. Here, we review the role of sirtuins (SIRT1-7) in vascular homeostasis and diseases by providing an update on the latest knowledge about their roles in endothelial damage and vascular repair mechanisms. Among all sirtuins, in the light of the numerous functions reported on SIRT1 in the vascular system, herein we discuss its roles not only in the control of endothelial cells (EC) functionality but also in other cell types beyond EC, including endothelial progenitor cells (EPC), smooth muscle cells (SMC), and immune cells. Furthermore, we also provide an update on the growing field of compounds under clinical evaluation for the modulation of SIRT1 which, at the state of the art, represents the most promising target for the development of novel drugs against CVD, especially when concomitant with type 2 diabetes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026777</affiliation-url><afid>60026777</afid><affilname>Seconda Universita degli Studi di Napoli</affilname><name-variant>Second University of Naples</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55386273200</author-url><authid>55386273200</authid><authname>D'Onofrio N.</authname><surname>D'Onofrio</surname><given-name>Nunzia</given-name><initials>N.</initials><afid>60026777</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56639947200</author-url><authid>56639947200</authid><authname>Vitiello M.</authname><surname>Vitiello</surname><given-name>Milena</given-name><initials>M.</initials><afid>60026777</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55385644500</author-url><authid>55385644500</authid><authname>Casale R.</authname><surname>Casale</surname><given-name>Rosario</given-name><initials>R.</initials><afid>60026777</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004337310</author-url><authid>7004337310</authid><authname>Servillo L.</authname><surname>Servillo</surname><given-name>Luigi</given-name><initials>L.</initials><afid>60026777</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003525296</author-url><authid>7003525296</authid><authname>Giovane A.</authname><surname>Giovane</surname><given-name>Alfonso</given-name><initials>A.</initials><afid>60026777</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006679321</author-url><authid>7006679321</authid><authname>Balestrieri M.</authname><surname>Balestrieri</surname><given-name>Maria Luisa</given-name><initials>M.L.</initials><afid>60026777</afid></author><authkeywords>Cardiovascular disease | Endothelial progenitor cell | Endothelium | Sirtuins | Vascular dysfunction</authkeywords><intid>535906424</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928580489"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928580489?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928580489&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928580489&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001173"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928580489</prism:url><dc:identifier>SCOPUS_ID:84928580489</dc:identifier><eid>2-s2.0-84928580489</eid><dc:title>Associations between flavan-3-ol intake and CVD risk in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk)</dc:title><dc:creator>Vogiatzoglou A.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>1-10</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.03.005</prism:doi><pii>S0891584915001173</pii><dc:description>© 2015 The Authors. Dietary intervention studies suggest that flavan-3-ol intake can improve vascular function and reduce the risk of cardiovascular diseases (CVD). However, results from prospective studies failed to show a consistent beneficial effect. Associations between flavan-3-ol intake and CVD risk in the Norfolk arm of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) were investigated. Data were available from 24,885 (11,252 men; 13,633 women) participants, recruited between 1993 and 1997 into the EPIC-Norfolk study. Flavan-3-ol intake was assessed using 7-day food diaries and the FLAVIOLA Flavanol Food Composition database. Missing data for plasma cholesterol and vitamin C were imputed using multiple imputation. Associations between flavan-3-ol intake and blood pressure at baseline were determined using linear regression models. Associations with CVD risk were estimated using Cox regression analyses. Median intake of total flavan-3-ols was 1034 mg/d (range: 0-8531 mg/d) for men and 970 mg/d (0-6695 mg/d) for women, median intake of flavan-3-ol monomers was 233 mg/d (0-3248 mg/d) for men and 217 (0-2712 mg/d) for women. There were no consistent associations between flavan-3-ol monomer intake and baseline systolic and diastolic blood pressure (BP). After 286,147 person-years of follow-up, there were 8463 cardiovascular events and 1987 CVD related deaths; no consistent association between flavan-3-ol intake and CVD risk (HR 0.93, 95% CI: 0.87; 1.00; Q1 vs Q5) or mortality was observed (HR 0.93, 95% CI: 0.84; 1.04). Flavan-3-ol intake in EPIC-Norfolk is not sufficient to achieve a statistically significant reduction in CVD risk.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012197</affiliation-url><afid>60012197</afid><affilname>University of Reading</affilname><name-variant>University of Reading</name-variant><affiliation-city>Reading</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031101</affiliation-url><afid>60031101</afid><affilname>University of Cambridge</affilname><name-variant>University of Cambridge</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025310</affiliation-url><afid>60025310</afid><affilname>Heinrich Heine Universitat</affilname><affiliation-city>Dusseldorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002182</affiliation-url><afid>60002182</afid><affilname>Mars Incorporated</affilname><name-variant>Mars Incorporated</name-variant><affiliation-city>Hackettstown</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031101</affiliation-url><afid>60031101</afid><affilname>University of Cambridge</affilname><name-variant>University of Cambridge</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25121715200</author-url><authid>25121715200</authid><authname>Vogiatzoglou A.</authname><surname>Vogiatzoglou</surname><given-name>Anna</given-name><initials>A.</initials><afid>60012197</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004246941</author-url><authid>7004246941</authid><authname>Mulligan A.</authname><surname>Mulligan</surname><given-name>Angela A.</given-name><initials>A.A.</initials><afid>60031101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16506441300</author-url><authid>16506441300</authid><authname>Bhaniani A.</authname><surname>Bhaniani</surname><given-name>Amit</given-name><initials>A.</initials><afid>60031101</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35261917400</author-url><authid>35261917400</authid><authname>Lentjes M.</authname><surname>Lentjes</surname><given-name>Marleen A H</given-name><initials>M.A.H.</initials><afid>60031101</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603540130</author-url><authid>6603540130</authid><authname>McTaggart A.</authname><surname>McTaggart</surname><given-name>Alison</given-name><initials>A.</initials><afid>60031101</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004585179</author-url><authid>7004585179</authid><authname>Luben R.</authname><surname>Luben</surname><given-name>Robert N.</given-name><initials>R.N.</initials><afid>60031101</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35272137800</author-url><authid>35272137800</authid><authname>Heiss C.</authname><surname>Heiss</surname><given-name>Christian</given-name><initials>C.</initials><afid>60025310</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24794775000</author-url><authid>24794775000</authid><authname>Kelm M.</authname><surname>Kelm</surname><given-name>Malte</given-name><initials>M.</initials><afid>60025310</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602823946</author-url><authid>6602823946</authid><authname>Merx M.</authname><surname>Merx</surname><given-name>Marc W.</given-name><initials>M.W.</initials><afid>60025310</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35449673700</author-url><authid>35449673700</authid><authname>Spencer J.</authname><surname>Spencer</surname><given-name>Jeremy P E</given-name><initials>J.P.E.</initials><afid>60025310</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004322659</author-url><authid>7004322659</authid><authname>Schroeter H.</authname><surname>Schroeter</surname><given-name>Hagen</given-name><initials>H.</initials><afid>60002182</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35354760500</author-url><authid>35354760500</authid><authname>Khaw K.</authname><surname>Khaw</surname><given-name>Kay Tee</given-name><initials>K.T.</initials><afid>60031101</afid><afid>60031101</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35354760500</author-url><authid>35354760500</authid><authname>Khaw K.</authname><surname>Khaw</surname><given-name>Kay Tee</given-name><initials>K.T.</initials><afid>60031101</afid><afid>60031101</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7003769113</author-url><authid>7003769113</authid><authname>Kuhnle G.</authname><surname>Kuhnle</surname><given-name>Gunter G C</given-name><initials>G.G.C.</initials><afid>60012197</afid><afid>60031101</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7003769113</author-url><authid>7003769113</authid><authname>Kuhnle G.</authname><surname>Kuhnle</surname><given-name>Gunter G C</given-name><initials>G.G.C.</initials><afid>60012197</afid><afid>60031101</afid></author><authkeywords>Cardio-vascular diseases | EPIC Norfolk | Flavan-3-ols | Nutritional epidemiology</authkeywords><intid>1785803645</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930002637"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930002637?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930002637&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930002637&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S009174351500105X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930002637</prism:url><dc:identifier>SCOPUS_ID:84930002637</dc:identifier><eid>2-s2.0-84930002637</eid><dc:title>Lost in translation: Dietary management of cardiovascular risk factors is seldom implemented</dc:title><dc:creator>Grange M.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>76</prism:volume><prism:pageRange>68-73</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.024</prism:doi><pii>S009174351500105X</pii><dc:description>© 2015 Elsevier Inc. Objective: To assess dietary management of cardiovascular risk factors (CVRFs) in the general population. Method: Cross-sectional study conducted between 2009 and 2012 on 4811 participants (2567 women, 58 ± 11 years) living in Lausanne, Switzerland. Results: Sixteen percent of participants diagnosed with overweight/obesity reported a slimming diet. Slimming diet was associated with diagnosis of hypertension: Odds ratio and (95% confidence interval): 0.61 (0.40-0.93); older age [0.84 (0.58-1.21), 0.79 (0.53-1.18) and 0.47 (0.27-0.81) for [50-60[, [60-70[and [70. + years, respectively]; female gender [1.84 (1.36-2.48)] and diagnosis of diabetes [2.16 (1.13-4.12)]. Only 8% of participants diagnosed with hypertension reported a low-salt diet. Low-salt diet was associated with antihypertensive drug treatment [2.17 (1.28-3.68)] and diagnosis of diabetes [2.72 (1.26-5.86)]. One-third of participants diagnosed with dyslipidemia reported a low-fat diet. Low-fat diet was associated with female gender [1.47 (1.17-1.86)]; older age [1.29 (0.89-1.87), 1.71 (1.18-2.48) and 2.01 (1.33-3.03) for [50-60[, [60-70[and [70 + years, respectively]; hypolipidemic drug treatment [OR = 1.68 (1.29-2.18)]; current smoking [0.70 (0.51-0.96)] and obesity [0.67 (0.45-1.00)]. Approximately half of participants diagnosed with diabetes reported an antidiabetic diet. Antidiabetic diet was associated with current smoking [0.44 (0.22-0.88)] and antidiabetic drug treatment [OR = 3.26 (1.81-5.86)]. Conclusion: Dietary management of CVRFs is seldom implemented in Switzerland.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023561</affiliation-url><afid>60023561</afid><affilname>Centre Hospitalier Universitaire Vaudois</affilname><name-variant>CHUV</name-variant><affiliation-city>Lausanne</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009963</affiliation-url><afid>60009963</afid><affilname>Hopitaux universitaires de Geneve</affilname><name-variant>Geneva University Hospital</name-variant><affiliation-city>Geneve</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023561</affiliation-url><afid>60023561</afid><affilname>Centre Hospitalier Universitaire Vaudois</affilname><name-variant>CHUV</name-variant><affiliation-city>Lausanne</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658433900</author-url><authid>56658433900</authid><authname>Grange M.</authname><surname>Grange</surname><given-name>Matthieu</given-name><initials>M.</initials><afid>60023561</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55303652700</author-url><authid>55303652700</authid><authname>Mayén A.</authname><surname>Mayén</surname><given-name>Ana Lucia</given-name><initials>A.L.</initials><afid>60023561</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14826822100</author-url><authid>14826822100</authid><authname>Guessous I.</authname><surname>Guessous</surname><given-name>Idris</given-name><initials>I.</initials><afid>60023561</afid><afid>60009963</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14826822100</author-url><authid>14826822100</authid><authname>Guessous I.</authname><surname>Guessous</surname><given-name>Idris</given-name><initials>I.</initials><afid>60023561</afid><afid>60009963</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006946995</author-url><authid>7006946995</authid><authname>Waeber G.</authname><surname>Waeber</surname><given-name>Gérard</given-name><initials>G.</initials><afid>60023561</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003669072</author-url><authid>7003669072</authid><authname>Vollenweider P.</authname><surname>Vollenweider</surname><given-name>Peter</given-name><initials>P.</initials><afid>60023561</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004465818</author-url><authid>7004465818</authid><authname>Marques-Vidal P.</authname><surname>Marques-Vidal</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60023561</afid></author><authkeywords>Diabetes | Dietary prevention | Dyslipidemia | Epidemiology | Hypertension | Switzerland</authkeywords><intid>1036044779</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929155377"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929155377?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929155377&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929155377&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010321"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929155377</prism:url><dc:identifier>SCOPUS_ID:84929155377</dc:identifier><eid>2-s2.0-84929155377</eid><dc:title>Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome</dc:title><dc:creator>Jialal I.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>130-137</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.814</prism:doi><pii>S0021915015010321</pii><dc:description>© 2015. Objective: Adipose Tissue (AT) dysregulation contributes to the pro-inflammatory state and insulin resistance of Metabolic Syndrome (MetS). We examined AT secretion of the hepatokine, Fetuin-A, LBP, sCD14 and HMGB-1, and toll-like receptor 2 and 4 protein levels in MetS and controls. Design and methods: Secreted levels of Fetuin-A, LBP, HMGB-1 and sCD14 and TLR2 and TLR4 protein in AT of controls and MetS patients were assayed. Also mRNA and protein for Fetuin-A, LBP, sCD14 and HMGB-1 were studied in subcutaneous fat depot of mice and during adipocyte differentiation. Results: Secretion of Fetuin-A, LBP and HMGB-1 from AT were significantly increased in MetS (n=28) compared to controls (n=25), even after adjustment for adiposity. There were no significant differences in sCD14. Both LBP and Fetuin-A correlated significantly with HOMA-IR and increased significantly with increasing features of MetS. There was a significant increase in AT TLR2 and TLR4 protein in MetS compared to controls. Expression of Fetuin-A and LBP were significantly higher in subcutaneous white adipose tissue of HFD fed mice as well as in ob/ob mice compared to C57BL6/J control mice (n=6 per group). Additionally mRNA and protein levels of FetA, LBP and HMGB-1 increased during differentiation of 3T3-L1 adipocytes. Conclusions: We make the novel observation of increased secretion of Fetuin A, LBP and HMGB-1 from AT and hypothesize that these engage TLRs in AT and other tissues contributing to the pro-inflammatory state and insulin resistance of MetS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003160</affiliation-url><afid>60003160</afid><affilname>UC Davis Medical Center</affilname><name-variant>University of California Davis Medical Center</name-variant><affiliation-city>Sacramento</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014232</affiliation-url><afid>60014232</afid><affilname>VA Medical Center</affilname><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002441</affiliation-url><afid>60002441</afid><affilname>Baylor College of Medicine</affilname><name-variant>Baylor College of Medicine</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014439</affiliation-url><afid>60014439</afid><affilname>UC Davis</affilname><name-variant>University of California</name-variant><affiliation-city>Davis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026695</affiliation-url><afid>60026695</afid><affilname>UT Southwestern Medical Center</affilname><name-variant>University of Texas Southwestern Medical Center</name-variant><affiliation-city>Dallas</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26643018400</author-url><authid>26643018400</authid><authname>Jialal I.</authname><surname>Jialal</surname><given-name>Ishwarlal</given-name><initials>I.</initials><afid>60003160</afid><afid>60014232</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26643018400</author-url><authid>26643018400</authid><authname>Jialal I.</authname><surname>Jialal</surname><given-name>Ishwarlal</given-name><initials>I.</initials><afid>60003160</afid><afid>60014232</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004533440</author-url><authid>7004533440</authid><authname>Devaraj S.</authname><surname>Devaraj</surname><given-name>Sridevi</given-name><initials>S.</initials><afid>60002441</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36715962200</author-url><authid>36715962200</authid><authname>Bettaieb A.</authname><surname>Bettaieb</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>60014439</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6506043265</author-url><authid>6506043265</authid><authname>Haj F.</authname><surname>Haj</surname><given-name>Fawaz</given-name><initials>F.</initials><afid>60014439</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701708992</author-url><authid>6701708992</authid><authname>Adams-Huet B.</authname><surname>Adams-Huet</surname><given-name>Beverley</given-name><initials>B.</initials><afid>60026695</afid></author><authkeywords>Adipose tissue | Fetuin A | Lipopolysaccharide binding protein | Metabolic syndrome | TLR</authkeywords><intid>1035913067</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926479945"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926479945?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926479945&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926479945&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715001809"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926479945</prism:url><dc:identifier>SCOPUS_ID:84926479945</dc:identifier><eid>2-s2.0-84926479945</eid><dc:title>Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder</dc:title><dc:creator>Bortolasci C.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>179</prism:volume><prism:pageRange>148-155</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.03.041</prism:doi><pii>S0165032715001809</pii><dc:description>© 2015 Published by Elsevier B.V. Objective This study examines the effects of malondialdehyde (MDA) and uric acid on insulin resistance and atherogenicity in subjects with and without mood disorders, the metabolic syndrome (MetS) and tobacco use disorder (TUD). Methods We included 314 subjects with depression and bipolar depression, with and without the MetS and TUD and computed insulin resistance using the updated homeostasis model assessment (HOMA2IR) and atherogenicity using the atherogenic index of plasma (AIP), that is log10 (triglycerides/high density lipoprotein (HDL) cholesterol. Results HOMA2IR is correlated with body mass index (BMI) and uric acid levels, but not with mood disorders and TUD, while the AIP is positively associated with BMI, mood disorders, TUD, uric acid, MDA and male sex. Uric acid is positively associated with insulin and triglycerides and negatively with HDL cholesterol. MDA is positively associated with triglyceride levels. Comorbid mood disorders and TUD further increase AIP but not insulin resistance. Glucose is positively associated with increasing age, male gender and BMI. Discussion The results show that mood disorders, TUD and BMI together with elevated levels of uric acid and MDA independently contribute to increased atherogenic potential, while BMI and uric acid are risk factors for insulin resistance. The findings show that mood disorders and TUD are closely related to an increased atherogenic potential but not to insulin resistance or the MetS. Increased uric acid is a highly significant risk factor for insulin resistance and increased atherogenic potential. MDA, a marker of lipid peroxidation, further contributes to different aspects of the atherogenic potential. Mood disorders and TUD increase triglyceride levels, lower HDL cholesterol and are strongly associated with the atherogenic, but not insulin resistance, component of the MetS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027866</affiliation-url><afid>60027866</afid><affilname>Universidade Estadual de Londrina</affilname><name-variant>Universidade Estadual de Londrina</name-variant><affiliation-city>Londrina</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018805</affiliation-url><afid>60018805</afid><affilname>Deakin University</affilname><name-variant>Deakin University</name-variant><affiliation-city>Geelong</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027866</affiliation-url><afid>60027866</afid><affilname>Universidade Estadual de Londrina</affilname><name-variant>Universidade Estadual de Londrina</name-variant><affiliation-city>Londrina</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027866</affiliation-url><afid>60027866</afid><affilname>Universidade Estadual de Londrina</affilname><name-variant>Universidade Estadual de Londrina</name-variant><affiliation-city>Londrina</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027866</affiliation-url><afid>60027866</afid><affilname>Universidade Estadual de Londrina</affilname><name-variant>Universidade Estadual de Londrina</name-variant><affiliation-city>Londrina</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027866</affiliation-url><afid>60027866</afid><affilname>Universidade Estadual de Londrina</affilname><name-variant>Universidade Estadual de Londrina</name-variant><affiliation-city>Londrina</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026553</affiliation-url><afid>60026553</afid><affilname>University of Melbourne</affilname><name-variant>University of Melbourne</name-variant><affiliation-city>Parkville</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114353065</affiliation-url><afid>114353065</afid><affilname>Florey Institute of Neuroscience and Mental Health</affilname><name-variant>The Florey Institute of Neuroscience and Mental Health</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114503863</affiliation-url><afid>114503863</afid><affilname>Orygen</affilname><name-variant>Orygen</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028190</affiliation-url><afid>60028190</afid><affilname>Chulalongkorn University</affilname><name-variant>Chulalongkorn University</name-variant><affiliation-city>Bangkok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55344767200</author-url><authid>55344767200</authid><authname>Bortolasci C.</authname><surname>Bortolasci</surname><given-name>Chiara Cristina</given-name><initials>C.C.</initials><afid>60027866</afid><afid>60018805</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55344767200</author-url><authid>55344767200</authid><authname>Bortolasci C.</authname><surname>Bortolasci</surname><given-name>Chiara Cristina</given-name><initials>C.C.</initials><afid>60027866</afid><afid>60018805</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:34574038700</author-url><authid>34574038700</authid><authname>Vargas H.</authname><surname>Vargas</surname><given-name>Heber Odebrecht</given-name><initials>H.O.</initials><afid>60027866</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6505757258</author-url><authid>6505757258</authid><authname>Vargas Nunes S.</authname><surname>Vargas Nunes</surname><given-name>Sandra Odebrecht</given-name><initials>S.O.</initials><afid>60027866</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56297175200</author-url><authid>56297175200</authid><authname>De Melo L.</authname><surname>De Melo</surname><given-name>Luiz Gustavo Piccoli</given-name><initials>L.G.P.</initials><afid>60027866</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35730999100</author-url><authid>35730999100</authid><authname>De Castro M.</authname><surname>De Castro</surname><given-name>Márcia Regina Pizzo</given-name><initials>M.R.P.</initials><afid>60027866</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35885141000</author-url><authid>35885141000</authid><authname>Moreira E.</authname><surname>Moreira</surname><given-name>Estefania Gastaldello</given-name><initials>E.G.</initials><afid>60027866</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56247578100</author-url><authid>56247578100</authid><authname>Dodd S.</authname><surname>Dodd</surname><given-name>Seetal</given-name><initials>S.</initials><afid>60018805</afid><afid>60026553</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56247578100</author-url><authid>56247578100</authid><authname>Dodd S.</authname><surname>Dodd</surname><given-name>Seetal</given-name><initials>S.</initials><afid>60018805</afid><afid>60026553</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005331429</author-url><authid>7005331429</authid><authname>Barbosa D.</authname><surname>Barbosa</surname><given-name>Décio Sabbatini</given-name><initials>D.S.</initials><afid>60027866</afid><afid>60027866</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005331429</author-url><authid>7005331429</authid><authname>Barbosa D.</authname><surname>Barbosa</surname><given-name>Décio Sabbatini</given-name><initials>D.S.</initials><afid>60027866</afid><afid>60027866</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35323887600</author-url><authid>35323887600</authid><authname>Berk M.</authname><surname>Berk</surname><given-name>Michael</given-name><initials>M.</initials><afid>60018805</afid><afid>60026553</afid><afid>114353065</afid><afid>114503863</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35323887600</author-url><authid>35323887600</authid><authname>Berk M.</authname><surname>Berk</surname><given-name>Michael</given-name><initials>M.</initials><afid>60018805</afid><afid>60026553</afid><afid>114353065</afid><afid>114503863</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35323887600</author-url><authid>35323887600</authid><authname>Berk M.</authname><surname>Berk</surname><given-name>Michael</given-name><initials>M.</initials><afid>60018805</afid><afid>60026553</afid><afid>114353065</afid><afid>114503863</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35323887600</author-url><authid>35323887600</authid><authname>Berk M.</authname><surname>Berk</surname><given-name>Michael</given-name><initials>M.</initials><afid>60018805</afid><afid>60026553</afid><afid>114353065</afid><afid>114503863</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201782377</author-url><authid>7201782377</authid><authname>Maes M.</authname><surname>Maes</surname><given-name>Michael</given-name><initials>M.</initials><afid>60027866</afid><afid>60018805</afid><afid>60028190</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201782377</author-url><authid>7201782377</authid><authname>Maes M.</authname><surname>Maes</surname><given-name>Michael</given-name><initials>M.</initials><afid>60027866</afid><afid>60018805</afid><afid>60028190</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7201782377</author-url><authid>7201782377</authid><authname>Maes M.</authname><surname>Maes</surname><given-name>Michael</given-name><initials>M.</initials><afid>60027866</afid><afid>60018805</afid><afid>60028190</afid></author><intid>35453882</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928786965"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928786965?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928786965&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928786965&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001483"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928786965</prism:url><dc:identifier>SCOPUS_ID:84928786965</dc:identifier><eid>2-s2.0-84928786965</eid><dc:title>COX-2 is involved in vascular oxidative stress and endothelial dysfunction of renal interlobar arteries from obese Zucker rats</dc:title><dc:creator>Muñoz M.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>77-90</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.03.024</prism:doi><pii>S0891584915001483</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Abstract Obesity is related to vascular dysfunction through inflammation and oxidative stress and it has been identified as a risk factor for chronic renal disease. In the present study, we assessed the specific relationships among reactive oxygen species (ROS), cyclooxygenase 2 (COX-2), and endothelial dysfunction in renal interlobar arteries from a genetic model of obesity/insulin resistance, the obese Zucker rats (OZR). Relaxations to acetylcholine (ACh) were significantly reduced in renal arteries from OZR compared to their counterpart, the lean Zucker rat (LZR), suggesting endothelial dysfunction. Blockade of COX with indomethacin and with the selective blocker of COX-2 restored the relaxations to ACh in obese rats. Selective blockade of the TXA&lt;inf&gt;2&lt;/inf&gt;/PGH&lt;inf&gt;2&lt;/inf&gt; (TP) receptor enhanced ACh relaxations only in OZR, while inhibition of the prostacyclin (PGI&lt;inf&gt;2&lt;/inf&gt;) receptor (IP) enhanced basal tone and inhibited ACh vasodilator responses only in LZR. Basal production of superoxide was increased in arteries of OZR and involved NADPH and xanthine oxidase activation and NOS uncoupling. Under conditions of NOS blockade, ACh induced vasoconstriction and increased ROS generation that were augmented in arteries from OZR and blunted by COX-2 inhibition and by the ROS scavenger tempol. Hydrogen peroxide (H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;) evoked both endothelium- and vascular smooth muscle (VSM)-dependent contractions, as well as ROS generation that was reduced by COX-2 inhibition. In addition, COX-2 expression was enhanced in both VSM and endothelium of renal arteries from OZR. These results suggest that increased COX-2-dependent vasoconstriction contributes to renal endothelial dysfunction through enhanced (ROS) generation in obesity. COX-2 activity is in turn upregulated by ROS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027282</affiliation-url><afid>60027282</afid><affilname>Universidad Complutense de Madrid</affilname><name-variant>Universidad Complutense</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027282</affiliation-url><afid>60027282</afid><affilname>Universidad Complutense de Madrid</affilname><name-variant>Universidad Complutense</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56091302200</author-url><authid>56091302200</authid><authname>Muñoz M.</authname><surname>Muñoz</surname><given-name>Mercedes</given-name><initials>M.</initials><afid>60027282</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7401887023</author-url><authid>7401887023</authid><authname>Sánchez A.</authname><surname>Sánchez</surname><given-name>Ana</given-name><initials>A.</initials><afid>60027282</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:39863425800</author-url><authid>39863425800</authid><authname>Pilar Martínez M.</authname><surname>Pilar Martínez</surname><given-name>María</given-name><initials>M.</initials><afid>60027282</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603951771</author-url><authid>6603951771</authid><authname>Benedito S.</authname><surname>Benedito</surname><given-name>Sara</given-name><initials>S.</initials><afid>60027282</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56613513900</author-url><authid>56613513900</authid><authname>López-Oliva M.</authname><surname>López-Oliva</surname><given-name>Maria Elvira</given-name><initials>M.E.</initials><afid>60027282</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004161520</author-url><authid>7004161520</authid><authname>García-Sacristán A.</authname><surname>García-Sacristán</surname><given-name>Albino</given-name><initials>A.</initials><afid>60027282</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56408870400</author-url><authid>56408870400</authid><authname>Hernández M.</authname><surname>Hernández</surname><given-name>Medardo</given-name><initials>M.</initials><afid>60027282</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004590869</author-url><authid>7004590869</authid><authname>Prieto D.</authname><surname>Prieto</surname><given-name>Dolores</given-name><initials>D.</initials><afid>60027282</afid></author><authkeywords>COX-2 | Endothelial dysfunction | Obesity | Oxidative stress | Renal arteries</authkeywords><intid>1035846149</intid><article-number>12364</article-number><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924546768"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924546768?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924546768&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924546768&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0957417415001116"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924546768</prism:url><dc:identifier>SCOPUS_ID:84924546768</dc:identifier><eid>2-s2.0-84924546768</eid><dc:title>QRS detection algorithm based on the quadratic filter</dc:title><dc:creator>Phukpattaranont P.</dc:creator><prism:publicationName>Expert Systems with Applications</prism:publicationName><prism:issn>09574174</prism:issn><prism:volume>42</prism:volume><prism:issueIdentifier>11</prism:issueIdentifier><prism:pageRange>4867-4877</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.eswa.2015.02.012</prism:doi><pii>S0957417415001116</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. QRS detection in the electrocardiogram signal is very crucial as a preliminary step for obtaining QRS complex, beat segmentation, and beat-to-beat intervals. Two main problems in QRS detection are a variety of noise types and various types of abnormal morphologies. We propose a QRS detection algorithm consisting of the quadratic filter for enhancing QRS signal to noise ratio. Results show that significant improvement in QRS signal to noise ratio can be obtained from challenging situations including low amplitude QRS complexes corrupted by baseline drift and abnormal morphologies such as an aberrated atrial premature beat, a premature ventricular contraction beat, a fusion of ventricular and normal beat, and a fusion of paced and normal beat. The enhancements in QRS signal to noise ratio allow us to use a single fixed threshold without any additional post-processing techniques in beat detection step. The performance of proposed algorithm was evaluated with the electrocardiogram data from MIT-BIH arrhythmia database. Results show that the quadratic filter is capable of enhancing QRS signal to noise very well leading to the average detection error rate of 0.38% from 48 records.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006314</affiliation-url><afid>60006314</afid><affilname>Prince of Songkla University</affilname><name-variant>Prince of Songkla University</name-variant><affiliation-city>Hatyai</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602493030</author-url><authid>6602493030</authid><authname>Phukpattaranont P.</authname><surname>Phukpattaranont</surname><given-name>Pornchai</given-name><initials>P.</initials><afid>60006314</afid></author><authkeywords>ECG beat detection | Electrocardiography (ECG) | QRS detection | Quadratic filter | Signal processing | Volterra filter</authkeywords><intid>535170611</intid><source-id>24201</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926455682"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926455682?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926455682&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926455682&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213158215000637"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926455682</prism:url><dc:identifier>SCOPUS_ID:84926455682</dc:identifier><eid>2-s2.0-84926455682</eid><dc:title>The associations of depression and hypertension with brain volumes: Independent or interactive?</dc:title><dc:creator>Meurs M.</dc:creator><prism:publicationName>NeuroImage: Clinical</prism:publicationName><prism:eIssn>22131582</prism:eIssn><prism:volume>8</prism:volume><prism:pageRange>79-86</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.nicl.2015.03.020</prism:doi><pii>S2213158215000637</pii><dc:description>© 2015 The Authors. Abstract Independent studies on major depressive disorder (MDD) and hypertension, suggest overlapping abnormalities in brain regions associated with emotional and autonomic processing. However, the unique and interactive effects of MDD and hypertension have never been studied in a single sample. Brain volume in these areas may be an explanatory link in the comorbidity between MDD and hypertension. Voxel-based morphometry was used to test for main effects of MDD (N = 152) and hypertension (N = 82) and their interactions on gray and white matter volumes. Voxel-wise results are reported at p &lt;.05 FWE corrected for the spatial extent of the whole brain and a-priori regions of interest (ROIs: hippocampus, anterior cingulate cortex (ACC) and inferior frontal gyrus (IFG)). In addition, analyses on the extracted total volumes of our ROIs were performed. Interactive effects in the mid-cingulate cortex (MCC) (p&lt;inf&gt;FWE&lt;/inf&gt; =.01), cerebellum (p&lt;inf&gt;FWE&lt;/inf&gt; =.01) and in the ACC total ROI volume (p =.02) were found. MDD in the presence, but not in the absence of hypertension was associated with lower volumes in the ACC and MCC, and with a trend towards larger gray matter volume in the cerebellum. No associations with white matter volumes were observed. Results suggest that the combination of MDD and hypertension has a unique effect on brain volumes in areas implicated in the regulation of emotional and autonomic functions. Brain volume in these regulatory areas may be an explanatory link in the comorbidity between hypertension and MDD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010023</affiliation-url><afid>60010023</afid><affilname>Rijksuniversiteit Groningen</affilname><name-variant>University of Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002483</affiliation-url><afid>60002483</afid><affilname>University of Amsterdam</affilname><name-variant>University of Amsterdam</name-variant><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55369555900</author-url><authid>55369555900</authid><authname>Meurs M.</authname><surname>Meurs</surname><given-name>Maaike</given-name><initials>M.</initials><afid>60010023</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36550270700</author-url><authid>36550270700</authid><authname>Groenewold N.</authname><surname>Groenewold</surname><given-name>Nynke A.</given-name><initials>N.A.</initials><afid>60010023</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36865688500</author-url><authid>36865688500</authid><authname>Roest A.</authname><surname>Roest</surname><given-name>Annelieke M.</given-name><initials>A.M.</initials><afid>60010023</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603371837</author-url><authid>6603371837</authid><authname>Van Der Wee N.</authname><surname>Van Der Wee</surname><given-name>Nic J A</given-name><initials>N.J.A.</initials><afid>60015618</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003711554</author-url><authid>7003711554</authid><authname>Veltman D.</authname><surname>Veltman</surname><given-name>Dick J.</given-name><initials>D.J.</initials><afid>60002483</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15048810700</author-url><authid>15048810700</authid><authname>Van Tol M.</authname><surname>Van Tol</surname><given-name>Marie José</given-name><initials>M.J.</initials><afid>60006027</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006567237</author-url><authid>7006567237</authid><authname>De Jonge P.</authname><surname>De Jonge</surname><given-name>Peter</given-name><initials>P.</initials><afid>60010023</afid></author><authkeywords>Blood pressure | Comorbidity | Depression | Gray matter | Hypertension | MRI</authkeywords><intid>1785457177</intid><article-number>478</article-number><source-id>21100222534</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929430494"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929430494?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929430494&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929430494&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1551714415300021"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929430494</prism:url><dc:identifier>SCOPUS_ID:84929430494</dc:identifier><eid>2-s2.0-84929430494</eid><dc:title>A randomized controlled exercise training trial on insulin sensitivity in African American men: The ARTIIS study: Major category: Study design, statistical design, study protocols</dc:title><dc:creator>Newton R.</dc:creator><prism:publicationName>Contemporary Clinical Trials</prism:publicationName><prism:issn>15517144</prism:issn><prism:eIssn>15592030</prism:eIssn><prism:volume>43</prism:volume><prism:pageRange>75-82</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cct.2015.05.004</prism:doi><pii>S1551714415300021</pii><dc:description>© 2015 Elsevier Inc. Background: Lack of regular physical activity at prescribed intensity levels is a modifiable risk factor for insulin resistance and the development of diabetes. African American men are at increased risk for developing diabetes and most African American men are not meeting the current recommended levels of physical activity. The primary objective of the Aerobic Plus Resistance Training and Insulin Resistance in African American Men (ARTIIS) study is to determine the effectiveness of an exercise training intervention aimed at reducing diabetes risk factors in African American men at risk for developing diabetes. Methods: Insufficiently active 35-70. year old African American men with a family history of diabetes were eligible for the study. The 5-month randomized controlled trial assigns 116 men to an exercise training or healthy living control arm. The exercise training arm combines aerobic and resistance training according to the current national physical activity recommendations and is conducted in community (YMCA) facilities. The healthy living arm receives information promoting healthy lifestyle changes. Outcomes: Insulin response to an oral glucose load is the primary outcome measure, and changes in physiological parameters, cardiorespiratory fitness, strength, body composition, and psychological well-being comprise the secondary outcomes. Conclusions: The ARTIIS study is one of the first adequately powered, rigorously designed studies to investigate the effects of an aerobic plus resistance exercise training program and to assess adherence to exercise training in community facilities, in African American men.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021235</affiliation-url><afid>60021235</afid><affilname>Pennington Biomedical Research Center</affilname><name-variant>Pennington Biomed. Research Center</name-variant><affiliation-city>Baton Rouge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007566</affiliation-url><afid>60007566</afid><affilname>Louisiana State University</affilname><name-variant>Louisiana State University</name-variant><affiliation-city>Baton Rouge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115246153</affiliation-url><afid>115246153</afid><affilname>ACAP Health</affilname><name-variant>ACAP Health</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7401830997</author-url><authid>7401830997</authid><authname>Newton R.</authname><surname>Newton</surname><given-name>Robert L.</given-name><initials>R.L.</initials><afid>60021235</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35431196500</author-url><authid>35431196500</authid><authname>Johnson W.</authname><surname>Johnson</surname><given-name>William D.</given-name><initials>W.D.</initials><afid>60021235</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56379892400</author-url><authid>56379892400</authid><authname>Hendrick C.</authname><surname>Hendrick</surname><given-name>Chelsea</given-name><initials>C.</initials><afid>60021235</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55192587000</author-url><authid>55192587000</authid><authname>Harris M.</authname><surname>Harris</surname><given-name>Melissa</given-name><initials>M.</initials><afid>60021235</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645934600</author-url><authid>56645934600</authid><authname>Andrews E.</authname><surname>Andrews</surname><given-name>Emanuel</given-name><initials>E.</initials><afid>60021235</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507870763</author-url><authid>6507870763</authid><authname>Johannsen N.</authname><surname>Johannsen</surname><given-name>Neil</given-name><initials>N.</initials><afid>60021235</afid><afid>60007566</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507870763</author-url><authid>6507870763</authid><authname>Johannsen N.</authname><surname>Johannsen</surname><given-name>Neil</given-name><initials>N.</initials><afid>60021235</afid><afid>60007566</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:15756640800</author-url><authid>15756640800</authid><authname>Rodarte R.</authname><surname>Rodarte</surname><given-name>Ruben Q.</given-name><initials>R.Q.</initials><afid>60021235</afid><afid>115246153</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:15756640800</author-url><authid>15756640800</authid><authname>Rodarte R.</authname><surname>Rodarte</surname><given-name>Ruben Q.</given-name><initials>R.Q.</initials><afid>60021235</afid><afid>115246153</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56646088100</author-url><authid>56646088100</authid><authname>Hsia D.</authname><surname>Hsia</surname><given-name>Daniel S.</given-name><initials>D.S.</initials><afid>60007566</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7102848510</author-url><authid>7102848510</authid><authname>Church T.</authname><surname>Church</surname><given-name>Timothy S.</given-name><initials>T.S.</initials><afid>60021235</afid><afid>115246153</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7102848510</author-url><authid>7102848510</authid><authname>Church T.</authname><surname>Church</surname><given-name>Timothy S.</given-name><initials>T.S.</initials><afid>60021235</afid><afid>115246153</afid></author><authkeywords>African american | Community | Diabetes risk | Exercise training | Male</authkeywords><intid>1535954888</intid><source-id>130115</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929175438"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929175438?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929175438&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929175438&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008499"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929175438</prism:url><dc:identifier>SCOPUS_ID:84929175438</dc:identifier><eid>2-s2.0-84929175438</eid><dc:title>Glycosylated hemoglobin levels and clinical outcomes in diabetic patients receiving percutaneous coronary interventions: A meta-analysis of cohort studies</dc:title><dc:creator>Xu X.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>143-147</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.126</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030434</affiliation-url><afid>60030434</afid><affilname>Qingdao University</affilname><name-variant>Qingdao University</name-variant><affiliation-city>Qingdao</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030434</affiliation-url><afid>60030434</afid><affilname>Qingdao University</affilname><name-variant>Qingdao University</name-variant><affiliation-city>Qingdao</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640016800</author-url><authid>56640016800</authid><authname>Xu X.</authname><surname>Xu</surname><given-name>Xiang</given-name><initials>X.</initials><afid>60030434</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56395666600</author-url><authid>56395666600</authid><authname>Wang R.</authname><surname>Wang</surname><given-name>Robin</given-name><initials>R.</initials><afid>60030434</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56174616900</author-url><authid>56174616900</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yangang</given-name><initials>Y.</initials><afid>60030434</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56421202900</author-url><authid>56421202900</authid><authname>Cai S.</authname><surname>Cai</surname><given-name>Shanglang</given-name><initials>S.</initials><afid>60030434</afid></author><authkeywords>Diabetes mellitus | Glycosylated hemoglobin | Major advance cardiovascular events | Percutaneous coronary interventions</authkeywords><intid>535917826</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928555600"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928555600?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928555600&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928555600&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915001179"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928555600</prism:url><dc:identifier>SCOPUS_ID:84928555600</dc:identifier><eid>2-s2.0-84928555600</eid><dc:title>The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis</dc:title><dc:creator>Buckley M.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1498-1510</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.04.011</prism:doi><pii>S0925443915001179</pii><dc:description>© 2015. Atherosclerosis, the underlying cause of myocardial infarction and thrombotic cerebrovascular events, is responsible for the majority of deaths in westernized societies. Mortality from this disease is also increasing at a marked rate in developing countries due to the acquisition of a westernized lifestyle accompanied with elevated rates of obesity and diabetes. Atherosclerosis is recognized as a chronic inflammatory disorder associated with lipid accumulation and the development of fibrotic plaques within the walls of medium and large arteries. A range of immune cells, such as macrophages and T-lymphocytes, through the action of various cytokines, such as interleukins-1 and -33, transforming growth factor-β and interferon-γ, orchestrates the inflammatory response in this disease. The disease is also characterized by marked dysfunction in lipid homeostasis and signaling pathways that control the inflammatory response. This review will discuss the molecular basis of atherosclerosis with particular emphasis on the roles of the immune cells and cytokines along with the dysfunctional lipid homeostasis and cell signaling associated with this disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023998</affiliation-url><afid>60023998</afid><affilname>Cardiff University</affilname><name-variant>University of Wales</name-variant><affiliation-city>Cardiff</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:47460941900</author-url><authid>47460941900</authid><authname>Buckley M.</authname><surname>Buckley</surname><given-name>Melanie L.</given-name><initials>M.L.</initials><afid>60023998</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003825007</author-url><authid>7003825007</authid><authname>Ramji D.</authname><surname>Ramji</surname><given-name>Dipak P.</given-name><initials>D.P.</initials><afid>60023998</afid></author><authkeywords>Atherosclerosis | Cytokines | Immune cells | Inflammation | Lipoproteins | Signaling</authkeywords><intid>2035798271</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929208505"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929208505?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929208505&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929208505&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500861X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929208505</prism:url><dc:identifier>SCOPUS_ID:84929208505</dc:identifier><eid>2-s2.0-84929208505</eid><dc:title>Hypertrophic cardiomyopathy and left ventricular non-compaction: Different manifestations of the same cardiomyopathy spectrum?</dc:title><dc:creator>Lorca R.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>26-28</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.138</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016862</affiliation-url><afid>60016862</afid><affilname>Hospital Universitario Central de Asturias</affilname><name-variant>Hospital Central de Asturias</name-variant><affiliation-city>Oviedo</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641464000</author-url><authid>56641464000</authid><authname>Lorca R.</authname><surname>Lorca</surname><given-name>Rebeca</given-name><initials>R.</initials><afid>60016862</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7406970558</author-url><authid>7406970558</authid><authname>Martín M.</authname><surname>Martín</surname><given-name>María</given-name><initials>M.</initials><afid>60016862</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35498351600</author-url><authid>35498351600</authid><authname>Gómez J.</authname><surname>Gómez</surname><given-name>Juan</given-name><initials>J.</initials><afid>60016862</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:13402686300</author-url><authid>13402686300</authid><authname>Santamarta E.</authname><surname>Santamarta</surname><given-name>Elena</given-name><initials>E.</initials><afid>60016862</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004564191</author-url><authid>7004564191</authid><authname>Morís C.</authname><surname>Morís</surname><given-name>César</given-name><initials>C.</initials><afid>60016862</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56483007100</author-url><authid>56483007100</authid><authname>Reguero J.</authname><surname>Reguero</surname><given-name>José Julián R</given-name><initials>J.J.R.</initials><afid>60016862</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006206106</author-url><authid>7006206106</authid><authname>Coto E.</authname><surname>Coto</surname><given-name>Eliecer</given-name><initials>E.</initials><afid>60016862</afid></author><authkeywords>Cardiomyopathies | Genetics | Hypertrophic cardiomyopathy (HCM) | Left ventricular non-compaction (LVNC) | Magnetic resonance imaging (MRI)</authkeywords><intid>1035913396</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929452481"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929452481?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929452481&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929452481&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1568163715000471"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929452481</prism:url><dc:identifier>SCOPUS_ID:84929452481</dc:identifier><eid>2-s2.0-84929452481</eid><dc:title>Sarcopenia - The search for emerging biomarkers</dc:title><dc:creator>Kalinkovich A.</dc:creator><prism:publicationName>Ageing Research Reviews</prism:publicationName><prism:issn>15681637</prism:issn><prism:eIssn>18729649</prism:eIssn><prism:volume>22</prism:volume><prism:pageRange>58-71</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.arr.2015.05.001</prism:doi><pii>S1568163715000471</pii><dc:description>© 2015 Elsevier B.V. Sarcopenia, an age-related decline in skeletal muscle mass and function, dramatically affects the life quality of elder people. In view of increasing life expectancy, sarcopenia renders a heavy burden on the health care system. However, although there is a consensus that sarcopenia is a multifactorial syndrome, its etiology, underlying mechanisms, and even definition remain poorly delineated, thus, preventing development of a precise treatment strategy. The main aim of our review is to critically analyze potential sarcopenia biomarkers in light of the molecular mechanisms of their involvement in sarcopenia pathogenesis. Normal muscle mass and function maintenance are proposed to be dependent on the dynamic balance between the positive regulators of muscle growth such as bone morphogenetic proteins (BMPs), brain-derived neurotrophic factor (BDNF), follistatin (FST) and irisin, and negative regulators including TGFβ, myostatin, activins A and B, and growth and differentiation factor-15 (GDF-15). We hypothesize that the shift in this balance to muscle growth inhibitors, along with increased expression of the C- terminal agrin fragment (CAF) associated with age-dependent neuromuscular junction (NMJ) dysfunction, as well as skeletal muscle-specific troponin T (sTnT), a key component of contractile machinery, is a main mechanism underlying sarcopenia pathogenesis. Thus, this review proposes and emphasizes that these molecules are the emerging sarcopenia biomarkers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005037</affiliation-url><afid>60005037</afid><affilname>Tel Aviv University, Sackler Faculty of Medicine</affilname><name-variant>Tel Aviv University</name-variant><affiliation-city>Ramal Aviv</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003805795</author-url><authid>7003805795</authid><authname>Kalinkovich A.</authname><surname>Kalinkovich</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60005037</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004831571</author-url><authid>7004831571</authid><authname>Livshits G.</authname><surname>Livshits</surname><given-name>Gregory</given-name><initials>G.</initials><afid>60005037</afid></author><authkeywords>Biomarker | Inflamm-aging | Muscle mass deterioration | Neuromuscular junction | Sarcopenia</authkeywords><intid>35964100</intid><source-id>28475</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929000506"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929000506?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929000506&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929000506&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929000506</prism:url><dc:identifier>SCOPUS_ID:84929000506</dc:identifier><eid>2-s2.0-84929000506</eid><dc:title>The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney Disease</dc:title><dc:creator>Stadler K.</dc:creator><prism:publicationName>Current Diabetes Reports</prism:publicationName><prism:issn>15344827</prism:issn><prism:eIssn>15390829</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1007/s11892-015-0611-8</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Although diabetes is mainly diagnosed based on elevated glucose levels, dyslipidemia is also observed in these patients. Chronic kidney disease (CKD), a frequent occurrence in patients with diabetes, is associated with major abnormalities in circulating lipoproteins and renal lipid metabolism. At baseline, most renal epithelial cells rely on fatty acids as their energy source. CKD, including that which occurs in diabetes, is characterized by tubule epithelial lipid accumulation. Whether this is due to increased uptake or greater local fatty acid synthesis is unknown. We have recently shown that CKD also leads to decreased fatty acid oxidation, which might be an additional mechanism leading to lipid accumulation. Defective fatty acid utilization causes energy depletion resulting in increased apoptosis and dedifferentiation, which in turn contributes to fibrosis and CKD progression. Enhanced fatty acid oxidation in the kidney induced by fenofibrate, a peroxisomal proliferator-activated receptor (PPAR)-α agonist, showed benefit in mouse models of CKD. Fenofibrate treatment also reduced albuminuria in patients with diabetes in multiple clinical trials. Taken together, these findings suggest that further understanding of lipid metabolism in diabetic kidney disease may lead to novel therapeutic approaches.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021235</affiliation-url><afid>60021235</afid><affilname>Pennington Biomedical Research Center</affilname><name-variant>Pennington Biomed. Research Center</name-variant><affiliation-city>Baton Rouge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024541</affiliation-url><afid>60024541</afid><affilname>New York University School of Medicine</affilname><name-variant>New York Univ. School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006297</affiliation-url><afid>60006297</afid><affilname>University of Pennsylvania</affilname><name-variant>University of Pennsylvania</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003816841</author-url><authid>7003816841</authid><authname>Stadler K.</authname><surname>Stadler</surname><given-name>Krisztian</given-name><initials>K.</initials><afid>60021235</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402471623</author-url><authid>7402471623</authid><authname>Goldberg I.</authname><surname>Goldberg</surname><given-name>Ira J.</given-name><initials>I.J.</initials><afid>60024541</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602464922</author-url><authid>6602464922</authid><authname>Susztak K.</authname><surname>Susztak</surname><given-name>Katalin</given-name><initials>K.</initials><afid>60006297</afid></author><authkeywords>Chronic renal failure | Diabetes | Fatty acid metabolism | Triglyceride</authkeywords><intid>1035879537</intid><source-id>25465</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928995249"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928995249?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928995249&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928995249&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010369"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928995249</prism:url><dc:identifier>SCOPUS_ID:84928995249</dc:identifier><eid>2-s2.0-84928995249</eid><dc:title>Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids</dc:title><dc:creator>Castle J.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>92-99</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.817</prism:doi><pii>S0021915015010369</pii><dc:description>© 2015 Elsevier Ireland Ltd. Background: Low levels of HDL-C are an independent cardiovascular risk factor associated with increased premature cardiovascular death. However, HDL-C therapies historically have been limited by issues relating to immunogenicity, hepatotoxicity and scalability, and have been ineffective in clinical trials. Objective: We examined the feasibility of using injectable acoustic microspheres to locally deliver human ApoA-I DNA plasmids in a pre-clinical model and quantify increased production of HDL-C invivo. Methods: Our novel site-specific gene delivery system was examined in naïve rat model and comprised the following steps: (1) intravenous co-administration of a solution containing acoustically active microspheres (Optison™, GE Healthcare, Princeton, New Jersey) and human ApoA-I plasmids; (2) ultrasound verification of the presence of the microspheres within the liver vasculature; (3) External application of locally-directed acoustic energy, (4) induction of microsphere disruption and in situ sonoporation; (4) ApoA-I plasmid hepatic uptake; (5) transcription and expression of human ApoA-I protein; and (6) elevation of serum HDL-C. Results: Co-administration of ApoA-I plasmids and acoustic microspheres, activated by external ultrasound energy, resulted in transcription and production of human ApoA-I protein and elevated serum HDL-C in rats (up to 61%; p-value&lt;0.05). Conclusions: HDL-C was increased in rats following ultrasound directed delivery of human ApoA-I plasmids by microsphere sonoporation. The present method provides a novel approach to promote ApoA-I synthesis and nascent HDL-C elevation, potentially permitting the use of a minimally-invasive ultrasound-based, gene delivery system for treating individuals with low HDL-C.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021211</affiliation-url><afid>60021211</afid><affilname>GE Global Research</affilname><name-variant>General Electric Research and Development Center</name-variant><affiliation-city>Niskayuna</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021211</affiliation-url><afid>60021211</afid><affilname>GE Global Research</affilname><name-variant>General Electric Research and Development Center</name-variant><affiliation-city>Niskayuna</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113378894</affiliation-url><afid>113378894</afid><affilname>SonoGene LLC</affilname><name-variant>SonoGene LLC</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007541</affiliation-url><afid>60007541</afid><affilname>University of Chicago Pritzker School of Medicine</affilname><name-variant>University of Chicago Pritzker School of Medicine</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018691</affiliation-url><afid>60018691</afid><affilname>Rush University Medical Center</affilname><name-variant>Rush University Medical Center</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55578227200</author-url><authid>55578227200</authid><authname>Castle J.</authname><surname>Castle</surname><given-name>Jason W.</given-name><initials>J.W.</initials><afid>60021211</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55578182400</author-url><authid>55578182400</authid><authname>Kent K.</authname><surname>Kent</surname><given-name>Kevin P.</given-name><initials>K.P.</initials><afid>60021211</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36726654800</author-url><authid>36726654800</authid><authname>Fan Y.</authname><surname>Fan</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60021211</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102664931</author-url><authid>7102664931</authid><authname>Wallace K.</authname><surname>Wallace</surname><given-name>Kirk D.</given-name><initials>K.D.</initials><afid>60021211</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56625453300</author-url><authid>56625453300</authid><authname>Davis C.</authname><surname>Davis</surname><given-name>Cynthia E L</given-name><initials>C.E.L.</initials><afid>60021211</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56625403600</author-url><authid>56625403600</authid><authname>Roberts J.</authname><surname>Roberts</surname><given-name>Jeannette C.</given-name><initials>J.C.</initials><afid>60021211</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56625552200</author-url><authid>56625552200</authid><authname>Marino M.</authname><surname>Marino</surname><given-name>Michael E.</given-name><initials>M.E.</initials><afid>60021211</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602994510</author-url><authid>6602994510</authid><authname>Thomenius K.</authname><surname>Thomenius</surname><given-name>Kai E.</given-name><initials>K.E.</initials><afid>60021211</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56625439800</author-url><authid>56625439800</authid><authname>Lim H.</authname><surname>Lim</surname><given-name>Hae W.</given-name><initials>H.W.</initials><afid>60021211</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56625691200</author-url><authid>56625691200</authid><authname>Coles E.</authname><surname>Coles</surname><given-name>Eric</given-name><initials>E.</initials><afid>113378894</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7401857573</author-url><authid>7401857573</authid><authname>Davidson M.</authname><surname>Davidson</surname><given-name>Michael H.</given-name><initials>M.H.</initials><afid>113378894</afid><afid>60007541</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7401857573</author-url><authid>7401857573</authid><authname>Davidson M.</authname><surname>Davidson</surname><given-name>Michael H.</given-name><initials>M.H.</initials><afid>113378894</afid><afid>60007541</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7102073956</author-url><authid>7102073956</authid><authname>Feinstein S.</authname><surname>Feinstein</surname><given-name>Steven B.</given-name><initials>S.B.</initials><afid>113378894</afid><afid>60018691</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7102073956</author-url><authid>7102073956</authid><authname>Feinstein S.</authname><surname>Feinstein</surname><given-name>Steven B.</given-name><initials>S.B.</initials><afid>113378894</afid><afid>60018691</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:36046565000</author-url><authid>36046565000</authid><authname>DeMaria A.</authname><surname>DeMaria</surname><given-name>Anthony</given-name><initials>A.</initials><afid>60030612</afid></author><authkeywords>Acoustic microspheres | ApoA-I | Drug delivery | HDL-C | Hypo-alphalipoproteinemia | Optison™ | Ultrasound</authkeywords><intid>1785884341</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925341464"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925341464?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925341464&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925341464&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925753515000600"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925341464</prism:url><dc:identifier>SCOPUS_ID:84925341464</dc:identifier><eid>2-s2.0-84925341464</eid><dc:title>Risk assessment of occupational injuries using Accident Severity Grade</dc:title><dc:creator>Azadeh-Fard N.</dc:creator><prism:publicationName>Safety Science</prism:publicationName><prism:issn>09257535</prism:issn><prism:eIssn>18791042</prism:eIssn><prism:volume>76</prism:volume><prism:pageRange>160-167</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ssci.2015.03.002</prism:doi><pii>S0925753515000600</pii><dc:description>© 2015 Elsevier Ltd. Problem: In spite of recent efforts to improve occupational health and safety, many occupational accidents result in serious injury and death every year. Continued efforts are therefore necessary to improve current safety initiatives and reduce the frequency and severity of these incidents. To identify workplace hazards, many safety surveillance techniques have been used, including severity metrics to determine the significance of an accident. These techniques involve risk assessment to identify potential hazards and the expected severity of injuries which may result from these hazards, usually based on the severity of similar past injuries. However, these severity metrics do not consider important employee and workplace risk factors, such as age, gender, and weather, which may have significant impacts on accident severity. Method: A new severity scoring system is introduced which considers multiple injury severity factors, and is used as part of a novel three-dimensional risk assessment matrix which includes an incident's severity, frequency, and preventability. A case study using the proposed methodology with real data is presented. Discussion: The consideration of additional severity factors improves risk assessment and the estimation of injury severity. A three dimensional risk assessment matrix allows for the analysis of an incident's degree of preventability, frequency, and severity all at once. Practical Applications: This study demonstrates that organizations, industries, and regulatory bodies can improve workplace safety surveillance tools by incorporating this new severity metric in a three-dimensional risk assessment matrix.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027090</affiliation-url><afid>60027090</afid><affilname>Virginia Polytechnic Institute and State University</affilname><name-variant>Virginia Polytechnic Institute and State University</name-variant><affiliation-city>Blacksburg</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112447274</affiliation-url><afid>112447274</afid><affilname>U.S. Army Institute of Public Health</affilname><name-variant>U.S. Army Institute of Public Health</name-variant><affiliation-city>Aberdeen Proving Ground</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56255082100</author-url><authid>56255082100</authid><authname>Azadeh-Fard N.</authname><surname>Azadeh-Fard</surname><given-name>Nasibeh</given-name><initials>N.</initials><afid>60027090</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54392285800</author-url><authid>54392285800</authid><authname>Schuh A.</authname><surname>Schuh</surname><given-name>Anna</given-name><initials>A.</initials><afid>112447274</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55576306200</author-url><authid>55576306200</authid><authname>Rashedi E.</authname><surname>Rashedi</surname><given-name>Ehsan</given-name><initials>E.</initials><afid>60027090</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603341254</author-url><authid>6603341254</authid><authname>Camelio J.</authname><surname>Camelio</surname><given-name>Jaime A.</given-name><initials>J.A.</initials><afid>60027090</afid></author><authkeywords>Injury severity | Occupational safety | Preventability | Risk assessment | Surveillance</authkeywords><intid>535283021</intid><source-id>12332</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925294330"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925294330?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925294330&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925294330&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1095643315000604"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925294330</prism:url><dc:identifier>SCOPUS_ID:84925294330</dc:identifier><eid>2-s2.0-84925294330</eid><dc:title>Variations in temperature acclimation effects on glycogen storage, hypoxia tolerance and swimming performance with seasonal acclimatization in juvenile Chinese crucian carp</dc:title><dc:creator>Yang Y.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology -Part A : Molecular and Integrative Physiology</prism:publicationName><prism:issn>10956433</prism:issn><prism:eIssn>15314332</prism:eIssn><prism:volume>185</prism:volume><prism:pageRange>16-23</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpa.2015.03.009</prism:doi><pii>S1095643315000604</pii><dc:description>© 2015 Elsevier Inc. The aim of this study was to test whether temperature acclimation (10 vs 20°C) effects on tissue glycogen content, hypoxia tolerance, and swimming performance of Chinese crucian carp (Carassius auratus) varied with seasonal acclimatization (winter vs spring) and potential combined interactions. Both the routine metabolic rate (M·O2rout) and critical oxygen tension (Pcrit) of the M·O2rout increased significantly with temperature, whereas the seasonal acclimatization showed no significant effect. Only the high temperature group that acclimatized in spring showed a significantly higher aquatic surface respiration (ASRcrit) value compared with the other three groups. Fish in spring tended to show ASR behavior at higher oxygen tension compared with those in winter, which might have been caused by a more active lifestyle. Time to show LOE prolonged by 25-34% under low temperature. Spring fish showed 20% shorter LOE duration at 10°C, whereas the difference tended to vanish at 20°C. Glycogen contents in both liver and muscle were higher in winter than spring. The liver and muscle glycogen content decreased by 5-42% after exposure to anoxic conditions, whereas the magnitude was much smaller in spring. When fish swam in normoxic conditions, fish in higher temperatures showed higher critical swimming speed (Ucrit) than low temperature (5.49 vs 3.74BLs-1 in winter and 4.27 vs 3.21BLs-1 in spring), whereas fish in winter also showed higher Ucrit than fish in spring for each temperature. However, when fish swam in hypoxic waters, fish in higher temperatures showed a more profound decrease (52-61%) in Ucrit compared to those in lower temperature (25-27%). Fish in lower temperatures that had acclimatized in winter showed the highest Ucrit, which might have been caused by higher glycogen storage. The present study suggested that both glycogen storage and alterations in lifestyle had profound effects on hypoxia tolerance and swimming performance, which resulted in a profound difference between seasons and acclimation temperatures.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010752</affiliation-url><afid>60010752</afid><affilname>Chongqing Normal University</affilname><name-variant>Chongqing Normal University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56564486600</author-url><authid>56564486600</authid><authname>Yang Y.</authname><surname>Yang</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60010752</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8929417200</author-url><authid>8929417200</authid><authname>Cao Z.</authname><surname>Cao</surname><given-name>Zhen Dong</given-name><initials>Z.D.</initials><afid>60010752</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55545112500</author-url><authid>55545112500</authid><authname>Fu S.</authname><surname>Fu</surname><given-name>Shi Jian</given-name><initials>S.J.</initials><afid>60010752</afid></author><authkeywords>Carassius auratus | Hypoxia tolerance | Season acclimatization | Swimming performance | Temperature acclimation</authkeywords><intid>35280829</intid><source-id>3500148021</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929470146"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929470146?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929470146&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929470146&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1568163715000252"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929470146</prism:url><dc:identifier>SCOPUS_ID:84929470146</dc:identifier><eid>2-s2.0-84929470146</eid><dc:title>Effects of physical activity in telomere length: Systematic review and meta-analysis</dc:title><dc:creator>Mundstock E.</dc:creator><prism:publicationName>Ageing Research Reviews</prism:publicationName><prism:issn>15681637</prism:issn><prism:eIssn>18729649</prism:eIssn><prism:volume>22</prism:volume><prism:pageRange>72-80</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.arr.2015.02.004</prism:doi><pii>S1568163715000252</pii><dc:description>© 2015 Elsevier B.V. The aim of this systematic review is to assess the effects of exercise on telomeres length. We searched the following databases: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), Scopus, LILACS, SPORTDiscus and Web of Science from inception to August 2014. All articles that assessed the effects of exercise in telomere length were included in this review. The search strategy used the following combinations of terms: telomere AND "motor activity" OR exercise OR "physical activity". Two reviewers, working independently, screened all titles and abstracts to identify studies that could meet inclusion criteria. Whenever possible, and if appropriate, we performed a random-effect meta-analysis of study outcomes. Thirty-seven original studies were included in this systematic review, including 41,230 participants. Twenty articles did not find statistically significant association, whereas 15 described a positive association. Two papers found an inverted "U" correlation. There is a tendency toward demonstrating an effect of exercise on telomere length. Few prospective studies were found, many studies did not reach statistical significance and there was an important methodological diversity. For this reason, a possible significant association between physical activity and telomere length remains an open question.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015760</affiliation-url><afid>60015760</afid><affilname>Pontificia Universidade Catolica do Rio Grande do Sul</affilname><name-variant>Pontifícia Universidade Católica do Rio Grande do Sul</name-variant><affiliation-city>Porto Alegre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006726</affiliation-url><afid>60006726</afid><affilname>Universidade Federal do Rio Grande do Sul</affilname><name-variant>Universidade Federal do Rio Grande do Sul</name-variant><affiliation-city>Porto Alegre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019654</affiliation-url><afid>60019654</afid><affilname>Universidade de Santa Cruz do Sul</affilname><name-variant>Universidade de Santa Cruz do Sul</name-variant><affiliation-city>Santa Cruz do Sul</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56648008300</author-url><authid>56648008300</authid><authname>Mundstock E.</authname><surname>Mundstock</surname><given-name>Eduardo</given-name><initials>E.</initials><afid>60015760</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14625810700</author-url><authid>14625810700</authid><authname>Zatti H.</authname><surname>Zatti</surname><given-name>Helen</given-name><initials>H.</initials><afid>60015760</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647866300</author-url><authid>56647866300</authid><authname>Louzada F.</authname><surname>Louzada</surname><given-name>Fernanda Mattos</given-name><initials>F.M.</initials><afid>60015760</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56647549600</author-url><authid>56647549600</authid><authname>Oliveira S.</authname><surname>Oliveira</surname><given-name>Suelen Goecks</given-name><initials>S.G.</initials><afid>60015760</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602855983</author-url><authid>6602855983</authid><authname>Guma F.</authname><surname>Guma</surname><given-name>Fátima T C R</given-name><initials>F.T.C.R.</initials><afid>60006726</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56647665200</author-url><authid>56647665200</authid><authname>Paris M.</authname><surname>Paris</surname><given-name>Mariana Migliorini</given-name><initials>M.M.</initials><afid>60006726</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56647738100</author-url><authid>56647738100</authid><authname>Rueda A.</authname><surname>Rueda</surname><given-name>Angélica Barba</given-name><initials>A.B.</initials><afid>60015760</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56647736300</author-url><authid>56647736300</authid><authname>Machado D.</authname><surname>Machado</surname><given-name>Denise Greff</given-name><initials>D.G.</initials><afid>60015760</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7402952293</author-url><authid>7402952293</authid><authname>Stein R.</authname><surname>Stein</surname><given-name>Renato T.</given-name><initials>R.T.</initials><afid>60015760</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7501845934</author-url><authid>7501845934</authid><authname>Jones M.</authname><surname>Jones</surname><given-name>Marcus Herbert</given-name><initials>M.H.</initials><afid>60015760</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7801405648</author-url><authid>7801405648</authid><authname>Sarria E.</authname><surname>Sarria</surname><given-name>Edgar E.</given-name><initials>E.E.</initials><afid>60019654</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:8588076800</author-url><authid>8588076800</authid><authname>Barbé-Tuana F.</authname><surname>Barbé-Tuana</surname><given-name>Florencia M.</given-name><initials>F.M.</initials><afid>60006726</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:25223467700</author-url><authid>25223467700</authid><authname>Mattiello R.</authname><surname>Mattiello</surname><given-name>Rita</given-name><initials>R.</initials><afid>60015760</afid></author><authkeywords>Aging | Physical activity | Physical exercise | Telomere length</authkeywords><intid>535964198</intid><source-id>28475</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925825871"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925825871?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925825871&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925825871&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1388198115000633"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925825871</prism:url><dc:identifier>SCOPUS_ID:84925825871</dc:identifier><eid>2-s2.0-84925825871</eid><dc:title>Human FABP1 T94A variant enhances cholesterol uptake</dc:title><dc:creator>Huang H.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids</prism:publicationName><prism:issn>13881981</prism:issn><prism:eIssn>18792618</prism:eIssn><prism:volume>1851</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>946-955</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbalip.2015.02.015</prism:doi><pii>S1388198115000633</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Although expression of the human liver fatty acid binding protein (FABP1) T94A variant alters serum lipoprotein cholesterol levels in human subjects, nothing is known whereby the variant elicits these effects. This issue was addressed by in vitro cholesterol binding assays using purified recombinant wild-type (WT) FABP1 T94T and T94A variant proteins and in cultured primary human hepatocytes expressing the FABP1 T94T (genotyped as TT) or T94A (genotyped as CC) proteins. The human FABP1 T94A variant protein had 3-fold higher cholesterol-binding affinity than the WT FABP1 T94T as shown by NBD-cholesterol fluorescence binding assays and by cholesterol isothermal titration microcalorimetry (ITC) binding assays. CC variant hepatocytes also exhibited 30% higher total FABP1 protein. HDL- and LDL-mediated NBD-cholesterol uptake was faster in CC variant than TT WT human hepatocytes. VLDL-mediated uptake of NBD-cholesterol did not differ between CC and TT human hepatocytes. The increased HDL- and LDL-mediated NBD-cholesterol uptake was not associated with any significant change in mRNA levels of SCARB1, LDLR, CETP, and LCAT encoding the key proteins in lipoprotein cholesterol uptake. Thus, the increased HDL- and LDL-mediated NBD-cholesterol uptake by CC hepatocytes may be associated with higher affinity of T94A protein for cholesterol and/or increased total T94A protein level.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020547</affiliation-url><afid>60020547</afid><affilname>Texas A and M University</affilname><name-variant>Texas A and M University</name-variant><affiliation-city>College Station</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020547</affiliation-url><afid>60020547</afid><affilname>Texas A and M University</affilname><name-variant>Texas A and M University</name-variant><affiliation-city>College Station</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031707</affiliation-url><afid>60031707</afid><affilname>Michigan State University</affilname><name-variant>Michigan State University</name-variant><affiliation-city>East Lansing</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7405614691</author-url><authid>7405614691</authid><authname>Huang H.</authname><surname>Huang</surname><given-name>Huan</given-name><initials>H.</initials><afid>60020547</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56573458300</author-url><authid>56573458300</authid><authname>McIntosh A.</authname><surname>McIntosh</surname><given-name>Avery L.</given-name><initials>A.L.</initials><afid>60020547</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:22235119900</author-url><authid>22235119900</authid><authname>Landrock K.</authname><surname>Landrock</surname><given-name>Kerstin K.</given-name><initials>K.K.</initials><afid>60020547</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16047817000</author-url><authid>16047817000</authid><authname>Landrock D.</authname><surname>Landrock</surname><given-name>Danilo</given-name><initials>D.</initials><afid>60020547</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602121941</author-url><authid>6602121941</authid><authname>Storey S.</authname><surname>Storey</surname><given-name>Stephen M.</given-name><initials>S.M.</initials><afid>60020547</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55464585500</author-url><authid>55464585500</authid><authname>Martin G.</authname><surname>Martin</surname><given-name>Gregory G.</given-name><initials>G.G.</initials><afid>60020547</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55495166800</author-url><authid>55495166800</authid><authname>Gupta S.</authname><surname>Gupta</surname><given-name>Shipra</given-name><initials>S.</initials><afid>60031707</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56582718500</author-url><authid>56582718500</authid><authname>Atshaves B.</authname><surname>Atshaves</surname><given-name>Barbara P.</given-name><initials>B.P.</initials><afid>60031707</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004428377</author-url><authid>7004428377</authid><authname>Kier A.</authname><surname>Kier</surname><given-name>Ann B.</given-name><initials>A.B.</initials><afid>60020547</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7102761020</author-url><authid>7102761020</authid><authname>Schroeder F.</authname><surname>Schroeder</surname><given-name>Friedhelm</given-name><initials>F.</initials><afid>60020547</afid></author><authkeywords>Cholesterol uptake | Hepatocyte | Human FABP1 | Lipoprotein</authkeywords><intid>1535348771</intid><source-id>16831</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929171050"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929171050?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929171050&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929171050&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009092"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929171050</prism:url><dc:identifier>SCOPUS_ID:84929171050</dc:identifier><eid>2-s2.0-84929171050</eid><dc:title>C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies</dc:title><dc:creator>Xu T.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>264-267</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.176</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021783</affiliation-url><afid>60021783</afid><affilname>Nantong University</affilname><name-variant>Affiliated Hospital of Nantong University</name-variant><affiliation-city>Nantong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021783</affiliation-url><afid>60021783</afid><affilname>Nantong University</affilname><name-variant>Affiliated Hospital of Nantong University</name-variant><affiliation-city>Nantong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640365000</author-url><authid>56640365000</authid><authname>Xu T.</authname><surname>Xu</surname><given-name>Tian</given-name><initials>T.</initials><afid>60021783</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004128300</author-url><authid>7004128300</authid><authname>Ke K.</authname><surname>Ke</surname><given-name>Kaifu</given-name><initials>K.</initials><afid>60021783</afid><afid>60021783</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004128300</author-url><authid>7004128300</authid><authname>Ke K.</authname><surname>Ke</surname><given-name>Kaifu</given-name><initials>K.</initials><afid>60021783</afid><afid>60021783</afid></author><authkeywords>C-reactive protein | Dose-response meta-analysis | Ischemic stroke | Prospective studies</authkeywords><intid>1785918912</intid><source-id>23774</source-id></entry></search-results>
